KOL | Erika RM von MutiusComprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany; Dr. v. Haunersches Kinderspital, University Hospital, LMU Munich, ... |
KOL简历 Erika RM von Mutius
| Year | |
|---|---|
| 2022 | Comprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany; Dr. v. Haunersches Kinderspital, University Hospital, LMU Munich, Munich, Germany; Institute of Asthma and Allergy Prevention (IAP), Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH). Institute for Asthma and Allergy Prevention, Helmholtz Centre Munich, 85764 Neuherberg, Germany |
| 2021 | Dr von Hauner Children's Hospital, Ludwig Maximilian University, Munich, Germany |
| 2020 | German Center for Lung Research, CPC-M From the Institute of Asthma and Allergy Prevention, Helmholtz Centre Munich, Munich, and the Asthma and Airway Disease Research Center, University of Arizona, Tucson. |
| 2019 | Dr. von Hauner Children's Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany. Institute for Asthma and Allergy Prevention, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany Dr von Hauner Children's Hospital, Ludwig Maximilian University German Center for Lung Research (DZL) |
| 2018 | Member of the German Centre for Lung Research, Munich, Germany Direktorin, Institut für Asthma und Allergieprävention Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Ingolstädter Landstraße 1, 85764 Neuherberg |
| 2017 | Children Hospital and Children Polyclinic in the Dr. von Haunersches Children Hospital, Ludwig-Maximilians-University, Lindwurmstr. 4, 80337 Munich, Germany Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL) |
Erika RM von Mutius：影响统计
运行报告
| Concept | World rank |
|---|---|
| mold problems kitchen | #1 |
| south bavarian | #1 |
| netcomi | #1 |
| asthma austria allergic | #1 |
| isolated cd4cd25hi tregs | #1 |
| early age risk | #1 |
| west germany munich | #1 |
| score total quantity | #1 |
| cowsheds peak | #1 |
| carriers hlx1 | #1 |
| stepwise procedure gene | #1 |
| homes farm dwellings | #1 |
| rs11071559 | #1 |
| protection hygiene hypothesis | #1 |
| endotoxin levels samples | #1 |
| coexpression igg1 | #1 |
| milk asthma | #1 |
| yoghurt asthma risk | #1 |
| maternal farm | #1 |
| comparison microbiome data | #1 |
| atopic disease bias | #1 |
| agriculture asthma | #1 |
| excessive sige production | #1 |
| epidemiologic phenotype | #1 |
| netcomi network construction | #1 |
| countries pasture study | #1 |
| preschool wheezing aor | #1 |
| regulatory responses protection | #1 |
| association occupational disinfectants | #1 |
| children acrossolar cohort | #1 |
| skin tests spt | #1 |
| allergoprotective capacity | #1 |
| innate immunity receptors | #1 |
| exposure farm children | #1 |
| snps wheeze | #1 |
| allergic rhinitis menarche | #1 |
| atopic dermatitis onset | #1 |
| epigenetic regulation mechanism | #1 |
| network differences groups | #1 |
| increased risks rhinoconjunctivitis | #1 |
| pasture cohort | #1 |
| ige levels exposure | #1 |
| maschildren | #1 |
| children isaac asthma | #1 |
| rs11079788 | #1 |
| protection childhood asthma | #1 |
| positive sensitization egg | #1 |
| lca pasture | #1 |
| children alliance asthma | #1 |
| single taxa groups | #1 |
| cd4creil13 | #1 |
| crohns disease atopy | #1 |
| aetiology early years | #1 |
| overweight marked differences | #1 |
| predominant obstruction | #1 |
| 17q21 polymorphisms ormdl3 | #1 |
| gabriel study | #1 |
| gpra polymorphisms | #1 |
| richness farming | #1 |
| immunity innate infant | #1 |
| fever spt cutoff | #1 |
| dresden east germany | #1 |
| association incident rhinoconjunctivitis | #1 |
| 457 iu | #1 |
| damage systemic inflammation | #1 |
| grass arabinogalactan | #1 |
| infant inflammation crp | #1 |
| 95 asthmatic children | #1 |
| personal cleanliness | #1 |
| lpastimulation | #1 |
| groups rural areas | #1 |
| wheezing male respiratory | #1 |
| newborn leukocytes surveys | #1 |
| allergic asthmatics asthmatics | #1 |
| cough soot | #1 |
| order covariates | #1 |
| consumption farm milk | #1 |
| 105 years richness | #1 |
| living environment children | #1 |
| allergies respiratory infections | #1 |
| protective farm asthma | #1 |
| tubes rnastabilizing solution | #1 |
| questionnaires childhood | #1 |
| wheezing children wheezing | #1 |
| associations maternal sensitization | #1 |
| food sensitization egg | #1 |
| lca male phenotype | #1 |
| asthma bacterial diversity | #1 |
| newonset allergic rhinitis | #1 |
| no2 allergic sensitisation | #1 |
| work ilc2s | #1 |
| jia domestic arthritis | #1 |
| cowsheds farm animals | #1 |
| lumbricoides crude measure | #1 |
| hypopharynx moraxella | #1 |
| bronchial hyperreactivity age | #1 |
| wheeze sensitisation | #1 |
| new onset wheeze | #1 |
| 95 hormonal contraceptives | #1 |
| visible mold homes | #1 |
| early phenotypes age | #1 |
| 28 dust samples | #1 |
| microbiome data package | #1 |
| anthroposophic lifestyle features | #1 |
| prediction quality snps | #1 |
| dampness bronchial hyperreactivity | #1 |
| mrna expression tregs | #1 |
| stepwise procedure risk | #1 |
| rural children w12 | #1 |
| ilcs administration | #1 |
| 5–13‐year | #1 |
| allergic rhinitis jia | #1 |
| dermatitis depending | #1 |
| bacterial exposures associations | #1 |
| farmers anthroposophic families | #1 |
| asthma german | #1 |
| europe protection | #1 |
| spts agreement | #1 |
| atopy allergen specificity | #1 |
| lps recognition development | #1 |
| asthma symptoms adolescence | #1 |
| farm animals cats | #1 |
| hc aa | #1 |
| feeding patterns risk | #1 |
| atopic eczema 95 | #1 |
| perinatal influences | #1 |
| bronchial obstruction hyperreactivity | #1 |
| wheeze farm living | #1 |
| menarche hormonal | #1 |
| diversity protective effects | #1 |
| loft farm milk | #1 |
| development allergic illnesses | #1 |
| bamse npsr1 | #1 |
| allergies protective pet | #1 |
| atopy interactions | #1 |
| risk mite sensitization | #1 |
| mold problems children | #1 |
| 3 mm spt | #1 |
| child environmental pollutants | #1 |
| followup solar | #1 |
| current contact asthma | #1 |
| selection bias responders | #1 |
| environmental differences finland | #1 |
| 17q21 polymorphisms | #1 |
| crude measure exposure | #1 |
| pierced ears asthma | #1 |
| indicators total quantity | #1 |
| life protective | #1 |
| occurrence generations | #1 |
| aetiology atopic disease | #1 |
| farm living | #1 |
| bronchial hyperreactivity wheezing | #1 |
| marked differences prevalence | #1 |
| transcription factors hlx1 | #1 |
| wheeze asthma questions | #1 |
| farmers nonfarmers children | #1 |
| environments pasture | #1 |
| allergy prevention studies | #1 |
| maternal farming | #1 |
| asthma asthma bacteria | #1 |
| dermatitis symptoms | #1 |
| expression 17q21 | #1 |
| failure☆ | #1 |
| jobs potential confounders | #1 |
| interaction npsr1 protein | #1 |
| ilt4 cord blood | #1 |
| munich leipzig | #1 |
| bronchial hyperreactivity adolescence | #1 |
| analyses isaac phase | #1 |
| 420lys | #1 |
| pattern atopic sensitization | #1 |
| managing wheezing | #1 |
| bmi allergic dermatitis | #1 |
| lower prevalence asthma | #1 |
| late introduction solids | #1 |
| network construction comparison | #1 |
| latent classes populations | #1 |
| stimulation 45yearold children | #1 |
| asthma interactions | #1 |
| rora snps | #1 |
| incident wheezing women | #1 |
| allergy cohort methods | #1 |
| 9 10yold children | #1 |
| cord blood offspring | #1 |
| lps foxp3 demethylation | #1 |
| usage preventive measures | #1 |
| children 7 yrs | #1 |
| identified polymorphisms asthma | #1 |
| serum ige levels | #1 |
| children unification | #1 |
| pcr sscp method | #1 |
| asthmatics hc | #1 |
| atopic dermatitis adolescence | #1 |
| fever milk consumption | #1 |
| microbial exposure asthma | #1 |
| environmental exposures protection | #1 |
| tregs foxp3 demethylation | #1 |
| gene expression ilt4 | #1 |
| sige spt | #1 |
| exposure gstm1 deficiency | #1 |
| solar 2nd followup | #1 |
| tnc asthma | #1 |
| immune responses birth | #1 |
| children beta 2agonists | #1 |
| prevalence atopic sensitisation | #1 |
| netcomi functionality | #1 |
| bronchial response wheeze | #1 |
| aa increased atp2a3 | #1 |
| allergen exposure life | #1 |
| childhood allergy children | #1 |
| prehireonset odds ratio | #1 |
| childrens bedrooms cowsheds | #1 |
| development allergies | #1 |
| allergies childhood phase | #1 |
| phenotypes atopic | #1 |
| allergic rhinitis predictor | #1 |
| igg nglycosylation populations | #1 |
| bacterial signals atopy | #1 |
| cumulative incidence finland | #1 |
| no2 traffic counts | #1 |
| farm lifestyles | #1 |
| leipzig munich | #1 |
| 1314 newborn infants | #1 |
| influential factors health | #1 |
| lukas2 lca | #1 |
| analysis step package | #1 |
| aor interquartile range | #1 |
| 585883 | #1 |
| oropharyngeal microbiota children | #1 |
| functionality network differences | #1 |
| farms farm homes | #1 |
| endotoxin levels stables | #1 |
| rora asthma susceptibility | #1 |
| ddhay fever children | #1 |
| selfreported nickel allergy | #1 |
| farm rural children | #1 |
| domestic cats child | #1 |
| children atopic sensitization | #1 |
| lpastimulation carriers | #1 |
| crowding dry cough | #1 |
| asthma farm children | #1 |
| data netcomi | #1 |
| transient wheeze asthma | #1 |
| sensitised children wheeze | #1 |
| farm milk exposure | #1 |
| atopic sensitization | #1 |
| farm cowsheds | #1 |
| jobs asthma risk | #1 |
| gabriel advanced surveys | #1 |
| authors grass arabinogalactans | #1 |
| development preschool wheezing | #1 |
| 6 years subtypes | #1 |
| hyperreaktivität | #1 |
| farming children | #1 |
| fpr2 aa | #1 |
| repeated episodes fever | #1 |
| humans hypopharynx moraxella | #1 |
| messenger surveys | #1 |
| sum indicators | #1 |
| genetic association tnc | #1 |
| 95 grass pollen | #1 |
| farm studies | #1 |
| unpasteurized cows milk | #1 |
| association ilt4 | #1 |
| bactoscan | #1 |
| work overload work | #1 |
| prenatal farm | #1 |
| farm asthma | #1 |
| germany prevalence differences | #1 |
| asthmatic farm children | #1 |
| normal censored | #1 |
| followup farm living | #1 |
| atopic smokers baseline | #1 |
| infant contact animals | #1 |
| solids development | #1 |
| asthma risk class | #1 |
| asthmaprotective farm | #1 |
| childhood asthma age | #1 |
| infant design | #1 |
| 5 years aor | #1 |
| mice atopic sensitization | #1 |
| exposure farm | #1 |
| prevent allergic diseases | #1 |
| work overload followup | #1 |
| cbmcs ormdl3 | #1 |
| wheeze classes | #1 |
| farm animals asthma | #1 |
| bhr str | #1 |
| asthma toll | #1 |
| wheezing 3rd year | #1 |
| protective farming | #1 |
| psychosocial characteristics children | #1 |
| farmers children | #1 |
| 95 puberty | #1 |
| peptidoglycan ppg birth | #1 |
| farming nasal samples | #1 |
| association haplotype studies | #1 |
| cattle childrens bedrooms | #1 |
| year environmental exposures | #1 |
| phase isaac programme | #1 |
| asthma puberty | #1 |
| vehicle traffic asthma | #1 |
| children leipzig | #1 |
| farm milk asthma | #1 |
| solar iii | #1 |
| association farm milk | #1 |
| barns farm dwellings | #1 |
| cd4cd25hi isolated cells | #1 |
| exposure farming environment | #1 |
| wheeze bronchial | #1 |
| tregs asthmatics | #1 |
| wheezing w12 | #1 |
| observing children | #1 |
| asthmatic children result | #1 |
| network construction netcomi | #1 |
| generations birth cohort | #1 |
| childhood asthma allergies | #1 |
| predictor igg1 galactosylation | #1 |
| phenotype health variables | #1 |
| igg4 ige expression | #1 |
| menarche allergic | #1 |
| eczema regions | #1 |
| 95 atopic eczema | #1 |
| introduction yogurt | #1 |
| asthma risk pasture | #1 |
| farming exposure childhood | #1 |
| life maternal atopy | #1 |
| farming protective farm | #1 |
| farm milk | #1 |
| farm protects | #1 |
| infant genetic polymorphism | #1 |
| 18 95 incidence | #1 |
| persistence bronchial hyperreactivity | #1 |
| egg aor | #1 |
| 95 late introduction | #1 |
| recurrent unremitting wheeze | #1 |
| tolllike receptor farmers | #1 |
| pasture cohort lca | #1 |
| pasture lukas2 | #1 |
| agents reduced risk | #1 |
| farm homes homes | #1 |
| igg1 galactosylation levels | #1 |
| infancy case status | #1 |
| allergies cohort studies | #1 |
| transient wheeze age | #1 |
| throat microbiota | #1 |
| 17q21 risk | #1 |
| il4ra association | #1 |
| stable dust extract | #1 |
| otus farming | #1 |
| muramic acid wheezing | #1 |
| asthma food sensitization | #1 |
| newborn interleukin17 leukocytes | #1 |
| current asthma age | #1 |
| allergic allergic dermatitis | #1 |
| tenascin neuropeptide receptor | #1 |
| cde source | #1 |
| moisture damage kitchen | #1 |
| sige cutoff | #1 |
| juvenile crohn disease | #1 |
| allergy protective | #1 |
| allergies year | #1 |
| incident wheezing asthma | #1 |
| moderate‐to‐adequate | #1 |
| 5–13‐year school children | #1 |
| hlx1 snps cbmcs | #1 |
| living area risk | #1 |
| allergy symptoms childhood | #1 |
| boys fever | #1 |
| higher specificity asthma | #1 |
| farming environment role | #1 |
| 1120 german schoolchildren | #1 |
| subsample predominant obstruction | #1 |
| demethylation foxp3 demethylation | #1 |
| clec4e aa | #1 |
| maternal atopy secretion | #1 |
| males pierced ears | #1 |
| atopic sensitization development | #1 |
| atopy microbial influences | #1 |
| review hygiene hypothesis | #1 |
| accuracy regression approach | #1 |
| allergies addition | #1 |
| coupled receptor polymorphisms | #1 |
| predictive models incidence | #1 |
| immune receptors birth | #1 |
| south bavarian population | #1 |
| ormdl3 gsdma expression | #1 |
| life inversely | #1 |
| allergies early phenotypes | #1 |
| paper online questionnaires | #1 |
| gene expression ormdl3 | #1 |
| asthma microbiome analysis | #1 |
| igg1 galactosylation predictor | #1 |
| actinomycetes alpine farms | #1 |
| crp early age | #1 |
| hlx1 polymorphisms | #1 |
| heating children | #1 |
| protective effects exposure | #1 |
| determinants airway responsiveness | #1 |
| unifying computational tool | #1 |
| protection yogurt | #1 |
| patients neutrophil inflammation | #1 |
| diversity microbial exposure | #1 |
| dgge asthma | #1 |
| tempo method | #1 |
| yogurt cows milk | #1 |
| aa clec4e | #1 |
| cd4cd25hi tcells | #1 |
| regression approach order | #1 |
| animal sheds 28 | #1 |
| city air pollution | #1 |
| 3785 adolescents | #1 |
| acrossolar | #1 |
| antipyretics reduced risk | #1 |
| asthma risk lca | #1 |
| prediction farm children | #1 |
| gpra polymorphisms asthma | #1 |
| farm milk meat | #1 |
| diversity consumed types | #1 |
| pollen concentration feeding | #1 |
| association atopic sensitization | #1 |
| atopic diseases association | #1 |
| insight asthma | #1 |
| bacterial groups prevalence | #1 |
| farming asthma | #1 |
| asthma arabinogalactan | #1 |
| age bacterial endotoxin | #1 |
| asthma turkish | #1 |
| edta tubes countries | #1 |
| cowshed dust cde | #1 |
| milkassociated cla | #1 |
| microbial exposure endotoxin | #1 |
| atopic embryonic | #1 |
| asthma diversity | #1 |
| seasonal rural | #1 |
| lower atopy asthma | #1 |
| atopic embryonic allergic | #1 |
| rnastabilizing solution | #1 |
| tbx21 hlx1 snps | #1 |
| airborne fungi actinomycetes | #1 |
| allergyrisk factors | #1 |
| associations hscrp values | #1 |
| east germany leipzig | #1 |
| farm childhood asthma | #1 |
| development atopic sensitisation | #1 |
| late onset menarche | #1 |
| abundances 6 otus | #1 |
| farming environment protective | #1 |
| male parents receptors | #1 |
| environmental allergens variety | #1 |
| pet contact infancy | #1 |
| reduced risk allergy | #1 |
| study prehireonset | #1 |
| asthma 105 years | #1 |
| agreement spts | #1 |
| farm fever | #1 |
| east germany allergic | #1 |
| dgge health outcomes | #1 |
| west germany allergic | #1 |
| environments asthma | #1 |
| secretion life | #1 |
| countries isaac phase | #1 |
| cla allergoprotective capacity | #1 |
| age dust microbiota | #1 |
| protective mechanisms asthma | #1 |
| pets farm animals | #1 |
| infant adolescent aging | #1 |
| 1133 children | #1 |
| richness asthma | #1 |
| sensitisation early | #1 |
| physiciandiagnosed asthma groups | #1 |
| preschool children rhinitis | #1 |
| exposures pieces | #1 |
| model hyperreactivity | #1 |
| epidemiological evidence consumption | #1 |
| 13 microbial influences | #1 |
| linens child dust | #1 |
| allergies existing cohort | #1 |
| girls allergic rhinitis | #1 |
| igein | #1 |
| wheezing invertedu shape | #1 |
| farm specific exposures | #1 |
| derp1lpa | #1 |
| farm environments asthma | #1 |
| farmingrelated exposures | #1 |
| changing gender ratio | #1 |
| polysaccharides cde | #1 |
| symptoms school age | #1 |
| employment new onset | #1 |
| kazal type spink5 | #1 |
| lca feeding patterns | #1 |
| asthma bacteria | #1 |
| children early phenotypes | #1 |
| 45yearold children protection | #1 |
| gabriel advanced study | #1 |
| wheeze environmental determinants | #1 |
| 035 iu specificity | #1 |
| rhinitis predictor | #1 |
| children predominant hyperreactivity | #1 |
| atopic sensitization early | #1 |
| allergies cohort | #1 |
| tnc npsr1 | #1 |
| atopy farm | #1 |
| psychosocial characteristics asthma | #1 |
| munich dresden | #1 |
| stepwise protocol bhr | #1 |
| il13cd4 cells ilcs | #1 |
| male poland quality | #1 |
| german peers | #1 |
| farming allergies | #1 |
| neonatal mice ahr | #1 |
| 95 allergen | #1 |
| protective 6 years | #1 |
| dust parameters development | #1 |
| worldwide asthma epidemic | #1 |
| persistence adolescence | #1 |
| unbalanced meat consumption | #1 |
| food allergy yogurt | #1 |
| 624 children | #1 |
| alpine farms | #1 |
| ppg lpa ppg | #1 |
| rhinoconjunctivitis sex | #1 |
| otitis fever | #1 |
| cohorte pasture | #1 |
| “hygiene hypothesis | #1 |
| anti‐asthmatic drugs | #1 |
| hlx1 polymorphisms influence | #1 |
| age asthma child | #1 |
| allergies personal cleanliness | #1 |
| doctor allergic rhinitis | #1 |
| children amish farms | #1 |
| copd sod3 | #1 |
| indoor bacterial microbiota | #1 |
| asthma rora | #1 |
| 17q21 locus method | #1 |
| isaac phase data | #1 |
| allergyprotective potential | #1 |
| tregs life | #1 |
| bhr fall | #1 |
| farm environments farms | #1 |
| symptoms gender ratio | #1 |
| childhood dampness | #1 |
| increased food diversity | #1 |
| occupational disinfectants asthma | #1 |
| protective exposures | #1 |
| protective atopic sensitization | #1 |
| farming environment development | #1 |
| ahr acinetobacter lwoffii | #1 |
| 2nd followup challenges | #1 |
| lukas2 birth cohorts | #1 |
| chapter 16 epidemiology | #1 |
| hygiene hypothesis endotoxin | #1 |
| dairy products protective | #1 |
| expiratory volume lca | #1 |
| protective effects asthma | #1 |
| asthmatics innate leukocytes | #1 |
| children road traffic | #1 |
| animal sheds barns | #1 |
| children farmers | #1 |
| respiratory symptoms childhood | #1 |
| preventive measures counselling | #1 |
| helminths protective | #1 |
| asthma concomitant asthma | #1 |
| soot benzene | #1 |
| current asthma soot | #1 |
| phenotypes lca | #1 |
| single microbial markers | #1 |
| persistence earlylife exposures | #1 |
| turkish children asthma | #1 |
| farm allergic rhinitis | #1 |
| 95 atopic sensitization | #1 |
| endotoxin exposure association | #1 |
| mrna expression year | #1 |
| living farm | #1 |
| ddhay fever | #1 |
| childhood bronchial hyperreactivity | #1 |
| farm children bavaria | #1 |
| 7 yrs determinants | #1 |
| cla content plasma | #1 |
| asthma genetic effects | #1 |
| asthma turkish children | #1 |
| environmental exposures asthma | #1 |
| ige seasonal allergens | #1 |
| bhr asthma child | #1 |
| bronchial hyperreactivity childhood | #1 |
| associations dna fingerprinting | #1 |
| allergic rhinitis childhood | #1 |
| children farm children | #1 |
| asthma concomitant bhr | #1 |
| covariates potential confounding | #1 |
| gsdma phytohemagglutinin | #1 |
| children indoor mould | #1 |
| early development wheeze | #1 |
| protection asthma | #1 |
| allergic illnesses | #1 |
| solar cohort | #1 |
| school age early | #1 |
| 95 asthma | #1 |
| endotoxin allergy | #1 |
| school children germany | #1 |
| spink5 kazal type | #1 |
| rora neuropeptide receptor | #1 |
| npsr1 tnc | #1 |
| 1 year occurrence | #1 |
| hrqol rural farm | #1 |
| cleanliness dust parameters | #1 |
| protective allergic diseases | #1 |
| allergoprotective | #1 |
| maturation gut microbiome | #1 |
| computing microbial associations | #1 |
| environmental factors sensitization | #1 |
| overweight munich | #1 |
| pierced ears association | #1 |
| sod3 sod3 snps | #1 |
| atopic sensitization birth | #1 |
| genetic interaction npsr1 | #1 |
| common inhalants | #1 |
| th2related genes cytokines | #1 |
| paediatric origins | #1 |
| subtypes atopic dermatitis | #1 |
| prehireonset | #1 |
| unprocessed farm milk | #1 |
| analyses provocation time | #1 |
| microbial exposure sum | #1 |
| acrossolar study | #1 |
| tbx21 hlx1 | #1 |
| alliance asthma | #1 |
| increased expression ormdl3 | #1 |
| ema protective farm | #1 |
| 1120 children | #1 |
| npsr1 messenger receptors | #1 |
| 115 iu | #1 |
| provocation time | #1 |
| indoor microbiota development | #1 |
| higher hscrp values | #1 |
| traditional farms | #1 |
| igg4 coexpression | #1 |
| regulatory triggering receptor | #1 |
| 18 months protective | #1 |
| pets associations | #1 |
| cowsheds cattle | #1 |
| protective diversity | #1 |
| 9 bronchodilators | #1 |
| spink5 420lys | #1 |
| questionnaire responses asthma | #1 |
| life chronic asthma | #1 |
| 30 amish | #1 |
| preschool children predictor | #1 |
| treatment childhood asthma | #1 |
| interquartile range asthma | #1 |
| birth tbx21 | #1 |
| patients treg cells | #1 |
| t1432c | #1 |
| allergies generations | #1 |
| infections hygiene hypothesis | #1 |
| occurrence allergy | #1 |
| children rural allergy | #1 |
| followup solar iii | #1 |
| validity food questionnaire | #1 |
| unremitting wheeze | #1 |
| atopic sensitisation fever | #1 |
| amish hutterite | #1 |
| histamine challenges age | #1 |
| classical definitions lca | #1 |
| protective asthma | #1 |
| estonia environmental differences | #1 |
| farm fungi humans | #1 |
| asthma rhinoconjunctivitis eczema | #1 |
| 95 nonatopic asthma | #1 |
| helminth parasites exposure | #1 |
| pets crowding | #1 |
| farm lung function | #1 |
| h4 acetylation offspring | #1 |
| hypersensitivity infections | #1 |
| aa ifih1 expression | #1 |
| phase stratified sample | #1 |
| tcells foxp3 | #1 |
| mold subclinical inflammation | #1 |
| arabinogalactan cde | #1 |
| coding region il4ra | #1 |
| aa immunity receptors | #1 |
| study questionnaire responses | #1 |
| childhood design | #1 |
| allergen exposure associations | #1 |
| polymorphisms tbx21 | #1 |
| 911 yrs | #1 |
| censored immunological | #1 |
| 812 children | #1 |
| wheeze farmers children | #1 |
| incident wheezing association | #1 |
| allergic rhinitis type | #1 |
| asthma consumption | #1 |
| data fetal growth | #1 |
| asthma wisc | #1 |
| gpra gene | #1 |
| unprocessed cows milk | #1 |
| farm children hrqol | #1 |
| domestic asthma child | #1 |
| farmrelated exposures | #1 |
| fever atopic | #1 |
| protective effects diversity | #1 |
| asthma symptoms adulthood | #1 |
| school university life | #1 |
| cleanliness matter | #1 |
| risk hutterite children | #1 |
| foxp3 demethylation tregs | #1 |
| lower atopic sensitization | #1 |
| peak airborne moulds | #1 |
| 95 endotoxin exposure | #1 |
| increased atp2a3 fpr2 | #1 |
| netcomi network | #1 |
| fever atopic sensitization | #1 |
| exposure protective | #1 |
| leur relation | #1 |
| prevalence environmental factors | #1 |
| wholeto | #1 |
| maternal farm exposure | #1 |
| gsdma expression | #1 |
| protective factors strategies | #1 |
| childhood asthma fever | #1 |
| hrqol protective | #1 |
| fever atopic dermatitis | #1 |
| wheeze active smoking | #1 |
| associations indoor mould | #1 |
| adolescents jobs | #1 |
| girls mechanism | #1 |
| 5 years predictor | #1 |
| environmental exposure age | #1 |
| allergic sensitization latex | #1 |
| tregs age | #1 |
| allergic diseases protective | #1 |
| repeated infections life | #1 |
| kitchen visible mold | #1 |
| maternal farming activities | #1 |
| dairying environment pollen | #1 |
| heattreated milk samples | #1 |
| groups netcomi | #1 |
| 1 ppg stimulation | #1 |
| yogurt diversity | #1 |
| ddhay fever 95 | #1 |
| asthma atopic disease | #1 |
| grass arabinogalactan mice | #1 |
| adolescent aging asthma | #1 |
| solids relation | #1 |
| predominant hyperreactivity subsample | #1 |
| environmental microbial | #1 |
| germany allergic | #1 |
| phase international | #1 |
| asthma allergies | #1 |
| prenatal animal contact | #1 |
| risk gene asthma | #1 |
| farm dairy products | #1 |
| asthmatics asthma phenotypes | #1 |
| childhood protective | #1 |
| asthma aor | #1 |
| adolescent agriculture | #1 |
| farm exposure asthma | #1 |
| girls late onset | #1 |
| advanced surveys | #1 |
| “atopic march | #1 |
| study rural environment | #1 |
| participation rates phase | #1 |
| pollen dairy farms | #1 |
| unprocessed cow | #1 |
| asthma bronchial response | #1 |
| association spink5 420lys | #1 |
| potential confounders jobs | #1 |
| swinesheds | #1 |
| asthma protective | #1 |
| 57 911yearold children | #1 |
| initial cohort pattern | #1 |
| epidemiologic phenotypes | #1 |
| neonatal immune mechanisms | #1 |
| predictor immune activation | #1 |
| supplementation milk cla | #1 |
| farm exposure igg4 | #1 |
| parasitic infections predictor | #1 |
| protective cheese consumption | #1 |
| 20 fall volume | #1 |
| farming environments | #1 |
| farm wheeze phenotypes | #1 |
| th2related genes | #1 |
| source arabinogalactan | #1 |
| preschool dermatitis questionnaires | #1 |
| atopy rural subjects | #1 |
| farm reduced prevalence | #1 |
| grass pollen 95 | #1 |
| influential factors phenotype | #1 |
| foxp3 cd4cd25hi | #1 |
| age increased diversity | #1 |
| harmful workplace exposure | #1 |
| methods 2nd followup | #1 |
| traditional upbringing | #1 |
| 15ans | #1 |
| tregs cd4cd25hi | #1 |
| asthma symptoms community | #1 |
| allergen exposure age | #1 |
| rural allergy endotoxin | #1 |
| rhinoconjunctivitis participation | #1 |
| microbes epigenetic mechanisms | #1 |
| 26 farms bavaria | #1 |
| moisture mold exposure | #1 |
| package functionality | #1 |
| health influential factors | #1 |
| allergies atopic dermatitis | #1 |
| children amish children | #1 |
| diseases farm | #1 |
| provocation time bhr | #1 |
| regular farm animal | #1 |
| immunity newborn mothers | #1 |
| aa nonallergic asthma | #1 |
| maternal atopy tregs | #1 |
| new microscope | #1 |
| protective farm environment | #1 |
| development childhood asthma | #1 |
| external microbial | #1 |
| quantitative confirmation associations | #1 |
| feeding overweight | #1 |
| studies microbial exposures | #1 |
| 035 iu sige | #1 |
| microorganisms farms | #1 |
| work overload school | #1 |
| yogurt year | #1 |
| persistence allergic rhinitis | #1 |
| barns samples | #1 |
| otus bacterial diversity | #1 |
| mold immune responsiveness | #1 |
| children preschool conjunctivitis | #1 |
| rora susceptibility gene | #1 |
| w12 ddhay fever | #1 |
| farms wheeze | #1 |
| hyperreactive children | #1 |
| lpastimulation cord blood | #1 |
| th2 th1 gsdma | #1 |
| exposure mattress dust | #1 |
| menarche hormonal contraceptives | #1 |
| associations transient sensitization | #1 |
| late introduction egg | #1 |
| phytohemagglutinin ormdl3 | #1 |
| sige association | #1 |
| farm animal exposure | #1 |
| animal contact infancy | #1 |
| children severe atopy | #1 |
| rs7164773 | #1 |
| germany breast feeding | #1 |
| specific exposures cows | #1 |
| farm dwellings homes | #1 |
| gasdermin gsdma | #1 |
| male saline solution | #1 |
| tbx21 | #1 |
| health services exposure | #1 |
| antibiotics allergies | #1 |
| ilt4 cb | #1 |
| offspring atopic mothers | #1 |
| 6 types cheese | #1 |
| complementary food year | #1 |
| protective childhood | #1 |
| microbial exposure patterns | #1 |
| association farm | #1 |
| actinomycetes cowsheds | #1 |
| str bhr | #1 |
| microorganisms animal sheds | #1 |
| gel variations gels | #1 |
| immune stimulation life | #1 |
| atopic dermatitis jobs | #1 |
| parents allergies | #1 |
| consumption allergic | #1 |
| treg marker genes | #1 |
| shop milk | #1 |
| tregs maternal atopy | #1 |
| dampness childhood | #1 |
| development asthma | #1 |
| life fungi humans | #1 |
| children automobiles child | #1 |
| associations pet contact | #1 |
| childhood gondii seropositivity | #1 |
| breastfeeding length | #1 |
| seasonal allergens | #1 |
| children diabimmune study | #1 |
| parsifal‐study | #1 |
| tnc risk gene | #1 |
| multicenter cohort prevalence | #1 |
| exposure muramic | #1 |
| menarche allergic rhinitis | #1 |
| spt atopic dermatitis | #1 |
| associations airwayrelated symptoms | #1 |
| fever blood samples | #1 |
| allergy‐protective effects | #1 |
| allergies viral infections | #1 |
| asthma west germany | #1 |
| germany dresden | #1 |
| wheezing fever | #1 |
| farm farm children | #1 |
| ml1 cohort studies | #1 |
| sige sensitizations symptoms | #1 |
| relation late introduction | #1 |
| asthma dresden | #1 |
| puberty infant | #1 |
| npsr1 interaction | #1 |
| diagnosed fever 95 | #1 |
| amish hutterite children | #1 |
| stepwise protocol phase | #1 |
| overweight dresden | #1 |
| npsr1 rora | #1 |
| muramic acid concentration | #1 |
| dzl | #1 |
| polymorphisms lps recognition | #1 |
| bifidobacterium breastfed infants | #1 |
| incidence indoor allergens | #1 |
| cowsheds childrens bedrooms | #1 |
| farm exposure exposure | #1 |
| ilcs neonatal mice | #1 |
| farm animals childhood | #1 |
| asthma richness | #1 |
| kitchen living area | #1 |
| cε germline transcript | #1 |
| solar study | #1 |
| cutoff 3 mm | #1 |
| farm nonfarm children | #1 |
| hyperreactivity expiratory volume | #1 |
| methods solar cohort | #1 |
| identification immune phenotypes | #1 |
| allergies endotoxin | #1 |
| feeding cattle cowsheds | #1 |
| association farm contact | #1 |
| farm children microorganisms | #1 |
| crobiome data | #1 |
| asthma indoor exposure | #1 |
| interaction rora | #1 |
| agreement association | #1 |
| auc spt | #1 |
| domestic child child | #1 |
| atopic sensitization aor | #1 |
| hrqol farm children | #1 |
| asthma german children | #1 |
| class pasture | #1 |
| lpa ppg stimulation | #1 |
| atopic dermatitis increase | #1 |
| personal cleanliness risk | #1 |
| adolescence bronchial hyperreactivity | #1 |
| nct02496468 | #1 |
| increased risk rhinoconjunctivitis | #1 |
| lukas2 umc | #1 |
| immune activation populations | #1 |
| farm exposure asthmatics | #1 |
| allergic rhinitis puberty | #1 |
| features anthroposophic lifestyle | #1 |
| increased prevalence cough | #1 |
| concomitant bhr 95 | #1 |
| immune responsiveness life | #1 |
| model bronchial hyperreactivity | #1 |
| antipyretics increased risk | #1 |
| prenatal animal | #1 |
| atopic dermatitis farm | #1 |
| anthropometric data overweight | #1 |
| benzene current wheeze | #1 |
| allergies topic surveys | #1 |
| regular farm | #1 |
| role th2 immunity | #1 |
| phenotypes atopic sensitization | #1 |
| current wheeze benzene | #1 |
| kitchen moisture damage | #1 |
| ormdl3 gasdermin | #1 |
| participants solar | #1 |
| food items year | #1 |
| pasture study tubes | #1 |
| lca clinical phenotypes | #1 |
| aor farm exposures | #1 |
| actinomycetes peak | #1 |
| 048 95 95 | #1 |
| positive sensitization | #1 |
| farm milk consumption | #1 |
| followup work discontent | #1 |
| airborne moulds actinomycetes | #1 |
| prognosis early wheeze | #1 |
| health urbanrural differences | #1 |
| blood ormdl3 | #1 |
| increased diversity food | #1 |
| consumption asthma | #1 |
| clinical examinations challenges | #1 |
| early life insight | #1 |
| farm indoor | #1 |
| parental questionnaires | #1 |
| allergic diseases cutoff | #1 |
| study parsifal | #1 |
| gene expression ilt3 | #1 |
| evidence allergy prevention | #1 |
| nickel allergy asthma | #1 |
| incident wheezing | #1 |
| non‐farm children | #1 |
| ranks performance | #1 |
| protection allergic diseases | #1 |
| insight environmental factors | #1 |
| egg positive sensitization | #1 |
| endotoxin level production | #1 |
| anthroposophic families validity | #1 |
| 168fold | #1 |
| allergic diseases questionnaires | #1 |
| samples farm dwellings | #1 |
| animal farms substances | #1 |
| asthma tregs | #1 |
| bacterial exposures | #1 |
| antiasthma drugs children | #1 |
| factor school behavior | #1 |
| inhaled steroids dresden | #1 |
| transient wheezing age | #1 |
| tobit regression ranks | #1 |
| gsdma expression secretion | #1 |
| wheezing atopic sensitization | #1 |
| fpr2 clec4e | #1 |
| allergic germany | #1 |
| ascaris lumbricoides exposure | #1 |
| mattress dust association | #1 |
| 12 months crowding | #1 |
| allergic diseases hrqol | #1 |
| west germany overweight | #1 |
| followup solar cohort | #1 |
| factors th1 | #1 |
| contact farm | #1 |
| 95 agmr | #1 |
| amish environment | #1 |
| interaction npsr1 polymorphisms | #1 |
| 12 months doctor | #1 |
| life antibiotic exposure | #1 |
| logistic models npsr1 | #1 |
| rs2738751 | #1 |
| infants karelia | #1 |
| fever farm | #1 |
| mite exposure risk | #1 |
| wheeze farming exposure | #1 |
| dresden munich | #1 |
| allergies | #1 |
| mite sensitization aor | #1 |
| obstruktive atemwegserkrankungen | #1 |
| common infections infants | #1 |
| allergy exposures | #1 |
| risk tcell phenotypes | #1 |
| topic puberty rhinitis | #1 |
| adolescent agriculture dust | #1 |
| strongest predictor atopy | #1 |
| ilcs inception | #1 |
| unhygienic contact | #1 |
| farm dwellings children | #1 |
| lumbricoides farmers children | #1 |
| pasture study spt | #1 |
| aa hcs | #1 |
| wheezerelated latent classes | #1 |
| treatment 9 bronchodilators | #1 |
| food diversity year | #1 |
| annual concentrations benzene | #1 |
| alpine farm environments | #1 |
| farming environments asthma | #1 |
| recurrence atopic dermatitis | #1 |
| farm living symptoms | #1 |
| spts specific ige | #1 |
| asthma questionnaire responses | #1 |
| infancy jia | #1 |
| respiratory sounds immunity | #1 |
| transmaternal asthma protection | #1 |
| human microbiota asthma | #2 |
| age asthma cohort | #2 |
| patients childhood symptoms | #2 |
| 95 school level | #2 |
| farming environment allergies | #2 |
| immune responses function | #2 |
| sputum extracellular | #2 |
| asthma symptoms fever | #2 |
| milk cd14 | #2 |
| neu5gc exposure | #2 |
| inflammatory diseases allergy | #2 |
| children nonfarm homes | #2 |
| current interpretation | #2 |
| animal exposure levels | #2 |
| card4 association | #2 |
| asthma hygiene hypothesis | #2 |
| university baseline | #2 |
| card4 21596 | #2 |
| c4ma3 asthma | #2 |
| prenatal farm exposure | #2 |
| nocturnal symptoms spirometry | #2 |
| atopic diseases subjects | #2 |
| values edna concentrations | #2 |
| polymorphisms il13 gene | #2 |
| environmental microorganisms | #2 |
| agriculture allergens | #2 |
| frequency nocturnal asthma | #2 |
| allergen levels socks | #2 |
| immunoglobulin nod1 | #2 |
| life rural children | #2 |
| cd14 1721 children | #2 |
| ga²len harmonization | #2 |
| probability incidence | #2 |
| olive pollen dander | #2 |
| severe exacerbations feno | #2 |
| test inhalent | #2 |
| eczema lessaffluent countries | #2 |
| cats eczema | #2 |
| cd4cd25hi foxp3 | #2 |
| maternal contact protective | #2 |
| associations hscrp levels | #2 |
| improvements fdr score | #2 |
| asthma phenotypes negative | #2 |
| wheeze bronchial responsiveness | #2 |
| cd14 genotypes asthma | #2 |
| influence cord | #2 |
| breathomics asthma | #2 |
| farming exposure | #2 |
| allergic rhinitis adolescence | #2 |
| lessaffluent countries adolescents | #2 |
| eczema allergic dermatitis | #2 |
| sod3 transcript | #2 |
| bacteriological properties | #2 |
| il4 gene | #2 |
| rora asthma | #2 |
| 17q21 | #2 |
| sensitized patients order | #2 |
| asthma parsifal | #2 |
| hc ca2 | #2 |
| halle west germany | #2 |
| maternal immunity gondii | #2 |
| associations atopy | #2 |
| eczema farm exposures | #2 |
| symptom control pa | #2 |
| rna russia | #2 |
| fdr clinical response | #2 |
| bronchitis east germany | #2 |
| lessaffluent countries | #2 |
| il4 il13 pathway | #2 |
| ors affluent countries | #2 |
| studies farms | #2 |
| participants dresden | #2 |
| children farm | #2 |
| pa interrelations | #2 |
| atopic sensitization 14 | #2 |
| demethylation foxp3 | #2 |
| childhood obesoty | #2 |
| role maternal exposures | #2 |
| germany asthma | #2 |
| current exposure cats | #2 |
| farming environment mother | #2 |
| specificity lca | #2 |
| multivariate analyses haying | #2 |
| environmental microorganisms children | #2 |
| farming families | #2 |
| amish farms | #2 |
| phase isaac | #2 |
| expression innate | #2 |
| viable listeria spp | #2 |
| childhood phase | #2 |
| bronchial hyperresponsiveness allergic | #2 |
| asthma observed | #2 |
| serum levels c4ma3 | #2 |
| socks alk samples | #2 |
| sensitization patterns inhalant | #2 |
| nonfarm children | #2 |
| order sensitized patients | #2 |
| followup university | #2 |
| fev1 score associations | #2 |
| alk samples | #2 |
| negative volatile organic | #2 |
| dairying eczema | #2 |
| hutterite farm children | #2 |
| bronchial hyperresponsiveness children | #2 |
| phase prevalence rates | #2 |
| bhr tirana | #2 |
| doctors diagnosed asthma | #2 |
| bronchial hyperresponsiveness exposure | #2 |
| exposure environmental microorganisms | #2 |
| 95 047 95 | #2 |
| adaptor protein rhinitis | #2 |
| beta1 endotoxin | #2 |
| farming anthroposophic | #2 |
| tregs demethylation | #2 |
| wheeze bronchial hyperresponsiveness | #2 |
| microbial exposure study | #2 |
| farming mothers ppg | #2 |
| association allergic diseases | #2 |
| socks dust | #2 |
| associations lessaffluent countries | #2 |
| eczema symptom prevalence | #2 |
| eczema conjunctivitis eczema | #2 |
| tbx21 gene | #2 |
| frequency nocturnal symptoms | #2 |
| endotoxin allergen exposure | #2 |
| exposure life | #2 |
| th17 lineage markers | #2 |
| coaacetate | #2 |
| measles vaccination infection | #2 |
| 95 protective factors | #2 |
| symptom control bmi | #2 |
| isaac prevalence rates | #2 |
| opposite direction children | #2 |
| pha farming mothers | #2 |
| dendritic cells dust | #2 |
| children bronchial obstruction | #2 |
| association opposite direction | #2 |
| allergic asthma degradation | #2 |
| collected dust indoor | #2 |
| alliance ages | #2 |
| artemisia olive pollen | #2 |
| highrisk predictors | #2 |
| pregnancy specific ige | #2 |
| farm milk pregnancy | #2 |
| histamine challenges | #2 |
| developing allergies | #2 |
| antit2 biological therapy | #2 |
| card4 protein rhinitis | #2 |
| atopy early life | #2 |
| leipzig halle | #2 |
| immunoglobulin life | #2 |
| nonfarming mothers lipid | #2 |
| nocturnal asthma life | #2 |
| affluent countries | #2 |
| current symptoms asthmaassociated | #2 |
| microbial agents association | #2 |
| environmental exposures mother | #2 |
| ages strongest associations | #2 |
| increase worldwide | #2 |
| parsifal study phenotypes | #2 |
| asthma cohort | #2 |
| low sensitization rates | #2 |
| environmental microbial exposure | #2 |
| 047 95 gg | #2 |
| munich participants | #2 |
| early immune maturation | #2 |
| influences development | #2 |
| farm animals symptoms | #2 |
| improvements fdr | #2 |
| study participants levels | #2 |
| exposure lifestyle factors | #2 |
| isaac atopic eczema | #2 |
| farming families allergies | #2 |
| exposure farming | #2 |
| atopic sensitization upregulation | #2 |
| snps inflammatory diseases | #2 |
| statistical analysis performance | #2 |
| newonset asthma symptoms | #2 |
| prediction asthma | #2 |
| association atopic children | #2 |
| atopic developing countries | #2 |
| ifnγ levels snps | #2 |
| levels alk samples | #2 |
| alk samples fieldworkers | #2 |
| strachan | #2 |
| interactions asthma | #2 |
| time breastfed children | #2 |
| alk samples levels | #2 |
| exposure farmers children | #2 |
| fieldworkers dust collection | #2 |
| children bronchial hyperresponsiveness | #2 |
| il13 gene linkage | #2 |
| protection allergy | #2 |
| allergic tolllike receptor | #2 |
| farms reference | #2 |
| cases objective measurements | #2 |
| life increased risk | #2 |
| onset male recurrence | #2 |
| consumption unpasteurized milk | #2 |
| asthma symptoms eczema | #2 |
| polymorphisms card4 | #2 |
| siblings atopic children | #2 |
| affluent countries associations | #2 |
| healthcare precision medicine | #2 |
| allergies farming status | #2 |
| lipid ppg | #2 |
| childhood lca | #2 |
| exposures farm | #2 |
| followup ndvi | #2 |
| current paracetamol 95 | #2 |
| asthmaassociated | #2 |
| nocturnal asthma severity | #2 |
| positive maternal record | #2 |
| atopic dermatitis wheeze | #2 |
| affluent countries eczema | #2 |
| adult arm alliance | #2 |
| increased risk employment | #2 |
| processed cow | #2 |
| th17 markers | #2 |
| dust endotoxin allele | #2 |
| study participants fieldworkers | #2 |
| lifelong farm exposure | #2 |
| igg4 ige levels | #2 |
| higher foxp3 | #2 |
| gels bands | #2 |
| atopic eczema causation | #2 |
| farming nonfarming families | #2 |
| individual level bhr | #2 |
| south bavaria | #2 |
| peptidoglycan ppg | #2 |
| premature respiratory | #2 |
| allele cd14 1721 | #2 |
| domestic child dust | #2 |
| bhr individual level | #2 |
| asthma child dermatitis | #2 |
| consumption unprocessed | #2 |
| role helminths | #2 |
| eczema farmers children | #2 |
| subsample children | #2 |
| quartile work discontent | #2 |
| messenger receptors tenascin | #2 |
| geneenvironment interactions asthma | #2 |
| animal sheds pregnancy | #2 |
| parent asthma | #2 |
| lipid lpa | #2 |
| farmlike indoor microbiota | #2 |
| cd14 maternal exposures | #2 |
| neu5gc role | #2 |
| childhood symptoms relapse | #2 |
| causation environmental associations | #2 |
| asthma symptoms children | #2 |
| pha th17 lineage | #2 |
| immunoglobulin analyses children | #2 |
| relapse newonset | #2 |
| asthma control pa | #2 |
| wheeze 12 | #2 |
| bhr west germany | #2 |
| gmcsf ifnγ levels | #2 |
| 19th century allergic | #2 |
| children affluent countries | #2 |
| asthma protection | #2 |
| early life prevalence | #2 |
| adult farmers role | #2 |
| foxp3 demethylation | #2 |
| doctors diagnosis aor | #2 |
| study design participation | #2 |
| alternaria animals animals | #2 |
| asthma meeting | #2 |
| allergic diseases allergies | #2 |
| life current symptoms | #2 |
| nonfarm homes children | #2 |
| nonfarming families | #2 |
| atopic smokers | #2 |
| cd4 cells offspring | #2 |
| 645 children | #2 |
| snps il4 gene | #2 |
| farmers child cross | #2 |
| imposed social isolation | #2 |
| data maternal weight | #2 |
| atopic dermatitis childhood | #2 |
| grass pollen dander | #2 |
| increase parent | #2 |
| development atopic diseases | #2 |
| severity spirometric measures | #2 |
| paracetamol fever | #2 |
| pha maternal farming | #2 |
| aa hc | #2 |
| school level 95 | #2 |
| affluent countries centers | #2 |
| higher greenness quartile | #2 |
| allergic disorders children | #2 |
| dander artemisia | #2 |
| dresden higher greenness | #2 |
| consumption farm | #2 |
| tirana mumbai | #2 |
| allele specific ige | #2 |
| work discontent | #2 |
| lower atopy | #2 |
| living farms | #2 |
| 14 260 | #2 |
| ages current paracetamol | #2 |
| c4ma3 biomarker | #2 |
| amish hutterite homes | #2 |
| tregs cord blood | #2 |
| positive spt sige | #2 |
| t2inflammation | #2 |
| th2 cytokines ilc2s | #2 |
| rhinitis adolescents | #2 |
| asthmaassociated aor | #2 |
| antibiotic asthma risk | #2 |
| age allergic rhinitis | #2 |
| allergies cd14 expression | #2 |
| traditional farm | #2 |
| protein rhinitis allergic | #2 |
| indoor bacterial | #2 |
| protect development | #2 |
| ppg pha | #2 |
| standardized procedure centres | #2 |
| bm190th | #2 |
| card4 21596 children | #2 |
| cd14 1721 | #2 |
| difference endotoxin levels | #2 |
| agmr 95 | #2 |
| fever west germany | #2 |
| genetic variation card4 | #2 |
| asthma crp | #2 |
| fieldworkers house dust | #2 |
| allele card4 21596 | #2 |
| atopic eczema phenotypes | #2 |
| farmers asthma symptoms | #2 |
| pattern missing values | #2 |
| excessive edna production | #2 |
| fieldworkers absolute levels | #2 |
| highdna | #2 |
| new onset wheezing | #2 |
| children dresden | #2 |
| bronchial challenge children | #2 |
| eczema affluent | #2 |
| cd14 1721 association | #2 |
| microbial exposure risk | #2 |
| antiige therapy response | #2 |
| antiidiotypic aspergillosis | #2 |
| farm children | #2 |
| microbial influences | #2 |
| interval156 | #2 |
| life pvalues | #2 |
| relation dust endotoxin | #2 |
| farmers children children | #2 |
| fev1 fdr fdr | #2 |
| allergies genetic variation | #2 |
| asthma adolescence | #2 |
| arg130gln polymorphism linkage | #2 |
| dust samples levels | #2 |
| fev1 fdr | #2 |
| organic waste storage | #3 |
| countries endotoxin levels | #3 |
| protection development | #3 |
| severity moisture damage | #3 |
| —study | #3 |
| asthma subphenotypes | #3 |
| asthma bordetella | #3 |
| il15 associations | #3 |
| 1q31 locus | #3 |
| eczema international study | #3 |
| role neu5gc | #3 |
| stat1 gene variations | #3 |
| protective farm | #3 |
| network construction | #3 |
| albania antibody specificity | #3 |
| cd14 association | #3 |
| children african ancestry | #3 |
| il5 il5 c746 | #3 |
| cohort alliance | #3 |
| cx3cr1 polymorphisms atopy | #3 |
| animal sheds | #3 |
| asthma tolllike receptors | #3 |
| domestic asthma | #3 |
| breastfeeding overweight | #3 |
| asthma pcdh1 | #3 |
| growing farm | #3 |
| allergic phenotype polymorphism | #3 |
| f78 | #3 |
| endotoxin milk | #3 |
| irf1 interferon expression | #3 |
| tlr2 amino acid | #3 |
| atopic asthma effects | #3 |
| asthma snp rs2786098 | #3 |
| ppg expression | #3 |
| bdnf polymorphisms asthma | #3 |
| eosinophil pathway | #3 |
| prenatal asthma protection | #3 |
| prenatal protection asthma | #3 |
| tlr2 receptor function | #3 |
| cowshed dust | #3 |
| atopic diseases mutations | #3 |
| c746t | #3 |
| 280met | #3 |
| eczema col29a1 | #3 |
| col29a1 polymorphisms | #3 |
| stat6 gene regulation | #3 |
| conjunctivitis paf | #3 |
| col29a1 expression eczema | #3 |
| atopic dermatitis aor | #3 |
| polymorphisms gm csf | #3 |
| endotoxin levels asthma | #3 |
| bavaria obesity | #3 |
| lukas2 birth | #3 |
| allergic diseases children | #3 |
| mmp9 variants mmp9 | #3 |
| responses innate | #3 |
| domestic arthritis | #3 |
| 9 mmp9 mmp9 | #3 |
| markers fetal growth | #3 |
| maternal tlr | #3 |
| children negative spts | #3 |
| allergy a20 induction | #3 |
| adam33 polymorphisms asthma | #3 |
| locus dennd1b | #3 |
| prenatal protection | #3 |
| rhinoconjunctivitis conjunctivitis | #3 |
| genetic variation crth2 | #3 |
| hygiene hypothesis | #3 |
| adam33 snps | #3 |
| asthma atopic sensitization | #3 |
| dennd1b asthma | #3 |
| sod3 extracellular matrix | #3 |
| t3085 | #3 |
| 1431c specific ige | #3 |
| asthma farming environment | #3 |
| stat6 haplotype | #3 |
| crosssectional population | #3 |
| amino acid cx3cr1 | #3 |
| eczema isaac phase | #3 |
| puberty risk factors | #3 |
| polymorphisms hlx1 gene | #3 |
| individual level centers | #3 |
| rural dwellings | #3 |
| col29a1 eczema | #3 |
| asthma identified | #3 |
| atopy dresden | #3 |
| experimental asthma progeny | #3 |
| parent prevalence | #3 |
| il15 gene asthma | #3 |
| duration prevalence | #3 |
| col29a1 polymorphisms susceptibility | #3 |
| perennial allergens paf | #3 |
| european science foundation | #3 |
| nf kappa polymorphism | #3 |
| protocadherin‐1 | #3 |
| role atopic sensitization | #3 |
| hlx1 gene variants | #3 |
| farms asthma | #3 |
| sod3 variants | #3 |
| gni rho | #3 |
| paf sensitisation | #3 |
| characteristics respiratory | #3 |
| putative functional role | #3 |
| life development | #3 |
| mmp9 variants risk | #3 |
| increased treg cells | #3 |
| forward initiative | #3 |
| asthma genetic association | #3 |
| role asthma prevalence | #3 |
| g1258a | #3 |
| eosinophil pathway genes | #3 |
| eosinophils matrix metalloproteinase | #3 |
| crude measure | #3 |
| hlx1 gene | #3 |
| allergy protection | #3 |
| bias asthma bias | #3 |
| pcdh1 asthma | #3 |
| associations pcdh1 | #3 |
| pcdh1 polymorphisms associations | #3 |
| work work overload | #3 |
| today1 | #3 |
| col29a1 genetic variants | #3 |
| isaac polymorphisms | #3 |
| occurrence rhinitis | #3 |
| susceptibility col29a1 expression | #3 |
| sensitisation affluent countries | #3 |
| asthma endotoxin levels | #3 |
| farming status | #3 |
| farm animals farm | #3 |
| bacterial diversity asthma | #3 |
| cowshed dust extract | #3 |
| asthma major | #3 |
| 53152 | #3 |
| sige asthma | #3 |
| role adam33 polymorphisms | #3 |
| rhinitis increased risk | #3 |
| dogs exposure | #3 |
| food correction | #3 |
| germany west german | #3 |
| c39134a | #3 |
| cx3cr1 polymorphisms polymorphism | #3 |
| farm dwellings | #3 |
| farming farm | #3 |
| dresden odds ratio | #3 |
| populations illness surveys | #3 |
| asthma cattle | #3 |
| atopic sensitisation | #3 |
| young adult europe | #3 |
| effects single snps | #3 |
| c2892 | #3 |
| eczema farmers | #3 |
| atopic female germany | #3 |
| life allergic diseases | #3 |
| culture techniques study | #3 |
| treatment asthma phenotypes | #3 |
| protein rhinitis | #3 |
| pcr sscp analysis | #3 |
| children isaac phase | #3 |
| prevalence asthma | #3 |
| 1000 enfants | #3 |
| fever aor | #3 |
| rhinoconjunctivitis paf | #3 |
| 45yearold children | #3 |
| allergic inflammation polymorphisms | #3 |
| atopic mothers | #3 |
| protection contre | #3 |
| c1407t | #3 |
| questionnaires physical examination | #3 |
| farm contact | #3 |
| allergic phenotypes correction | #3 |
| il5 c746t | #3 |
| overweight germany | #3 |
| ferme | #3 |
| cytokine cluster bhr | #3 |
| prevalence allergies | #3 |
| col29a1 variants eczema | #3 |
| 95ci nonatopic asthma | #3 |
| bhr haplotypes humans | #3 |
| persistent flexural eczema | #3 |
| t12888c | #3 |
| allergyprotective | #3 |
| dcs a20 induction | #3 |
| asthma amino acid | #3 |
| population german | #3 |
| bhr pcdh1 polymorphisms | #3 |
| il15 il15 associations | #3 |
| tlr2 polymorphisms | #3 |
| auc asthma | #3 |
| allergic disequilibrium rhinitis | #3 |
| eczema strong association | #3 |
| hlx1 gene development | #3 |
| seasonal allergens atopy | #3 |
| rare tlr2 mutations | #3 |
| crth2 influences development | #3 |
| wheezing neutrophils | #3 |
| anthroposophic children | #3 |
| disequilibrium rhinitis allergic | #3 |
| throat microbiota asthma | #3 |
| 1q31 locus dennd1b | #3 |
| german children munich | #3 |
| blatella | #3 |
| biomaterial collection | #3 |
| onset asthma child | #3 |
| nonatopic asthma 95ci | #3 |
| phase international study | #3 |
| microorganisms dust | #3 |
| blood allergen | #3 |
| paf allergic | #3 |
| children farming | #3 |
| asthma protection progeny | #3 |
| exposure helminths | #3 |
| age 7–10 years | #3 |
| lwoffii f78 | #3 |
| asthma genetic severity | #3 |
| childhood asthma community | #3 |
| ile117thr | #3 |
| wheeze allergy | #3 |
| children bronchial hyperreactivity | #3 |
| dennd1b chromosome | #3 |
| il15 gene variants | #3 |
| individual level questionnaires | #3 |
| food year | #3 |
| paracetamol risk | #3 |
| gni measurements | #3 |
| farm dust endotoxin | #3 |
| il5 c746 allergic | #3 |
| mmp9 influence development | #3 |
| moraxella colonization | #3 |
| arabinogalactan isolated | #3 |
| endotoxin dust samples | #3 |
| munich polymorphism | #3 |
| rural areas europe | #3 |
| hygiene hypothesis development | #3 |
| female fetus immunity | #3 |
| doctors diagnosis | #3 |
| 1431c | #3 |
| col29a1 polymorphisms eczema | #3 |
| microbiota farm | #3 |
| monocytes lps stimulation | #3 |
| asthma 1431c | #3 |
| united kingdom albania | #3 |
| environmental dusts | #3 |
| vivo expression irf1 | #3 |
| current asthma rhinoconjunctivitis | #3 |
| samples 1q31 locus | #3 |
| rhinoconjunctivitis atopic eczema | #3 |
| european ancestry asthma | #3 |
| progeny asthma | #3 |
| paf seasonal allergens | #3 |
| risk nonatopic asthma | #3 |
| 3099 children | #3 |
| substances protection | #3 |
| allergic asthmatics aa | #3 |
| regular contact | #3 |
| affluent countries atopy | #3 |
| jobrelated chronic stress | #3 |
| spt sige | #4 |
| asthma induction | #4 |
| 95 gene expression | #4 |
| wheezing onset | #4 |
| rare tlr2 | #4 |
| increase eczema prevalence | #4 |
| farm environment development | #4 |
| feeding prevalence | #4 |
| candidate genes wheeze | #4 |
| minimum battery | #4 |
| study centers phase | #4 |
| a20 induction | #4 |
| asthma symptoms adults | #4 |
| sas genetics | #4 |
| childhood protect | #4 |
| prevalence random | #4 |
| doctors diagnosis asthma | #4 |
| flexural eczema | #4 |
| asthma medication exposure | #4 |
| ilc2s human asthma | #4 |
| allergic ecuador eczema | #4 |
| crp blood leukocytes | #4 |
| factors wheeze | #4 |
| glu420lys | #4 |
| genes il4r | #4 |
| questionnaires adolescent eczema | #4 |
| immunity receptors | #4 |
| licheniformis spores | #4 |
| human genetic nod1 | #4 |
| adult lung disease | #4 |
| genetic rhinitis allergic | #4 |
| childhood asthma | #4 |
| col29a1 gene | #4 |
| incident sensitization | #4 |
| asthma hygiene | #4 |
| cough bronchitis | #4 |
| environmental dust samples | #4 |
| bacillus licheniformis spores | #4 |
| ige levels associations | #4 |
| children farms | #4 |
| parental allergic rhinitis | #4 |
| aetiology asthma | #4 |
| late phenotype | #4 |
| gene expression receptors | #4 |
| endotoxin relation | #4 |
| exposure cats | #4 |
| tlr2 mutations | #4 |
| col29a1 expression | #4 |
| allergies children | #4 |
| birth atopic dermatitis | #4 |
| antibiotics antipyretics | #4 |
| parent odds ratio | #4 |
| allergic dermatitis allergic | #4 |
| cord blood lipid | #4 |
| genetic nod1 | #4 |
| promoter region arg130gln | #4 |
| asthma phenotype children | #4 |
| questionnaires eczema | #4 |
| development atopic | #4 |
| asthma atopic diseases | #4 |
| dust personal | #4 |
| risk atopic dermatitis | #4 |
| stable dust | #4 |
| nonfarming | #4 |
| secretory receptors allergic | #4 |
| development atopic sensitization | #4 |
| lrti asthma | #4 |
| microbial compounds | #4 |
| predictors visits | #4 |
| wheeze bhr | #4 |
| 5 13 years | #4 |
| dietary habits children | #4 |
| inhalant patients | #4 |
| initial data analysis | #4 |
| occupational allergy risks | #4 |
| phase 2 allergies | #4 |
| lukas2 | #4 |
| fever eczema | #4 |
| prenatal asthma | #4 |
| neonatal window | #4 |
| gabriel advanced | #4 |
| wheeze ige levels | #4 |
| allergy international study | #4 |
| pro27ser | #4 |
| asthma snps | #4 |
| heating prevalence | #4 |
| questionnaires populations | #4 |
| participants fieldworkers | #4 |
| benzene no2 | #4 |
| german children bavaria | #4 |
| h20like homeobox | #4 |
| agreement spt | #4 |
| asthma auc | #4 |
| mother role | #4 |
| asthma symptoms association | #4 |
| n2267 | #4 |
| early identification atopy | #4 |
| birthcohort study | #4 |
| high‐sensitivity c‐reactive protein | #4 |
| atopic dermatitis birth | #4 |
| eczema flg mutations | #4 |
| anthroposophic families | #4 |
| 99th dahlem conference | #4 |
| early life basis | #4 |
| genotypes cd14 | #4 |
| environmental factors development | #4 |
| east germany bhr | #4 |
| children munich | #4 |
| fever 17 | #4 |
| asthma 3 | #4 |
| cheese consumption | #4 |
| common sensitizations | #4 |
| cromolyns | #4 |
| sounds rhinitis | #4 |
| children mattresses | #4 |
| risk factor symptoms | #4 |
| eczema questionnaires adolescent | #4 |
| permanovas | #4 |
| cd4cd25hi tregs | #4 |
| children maternal overweight | #4 |
| il4r tlr4 | #4 |
| fatty acids allergic | #4 |
| microbes asthma | #4 |
| predictor wheezing | #4 |
| cx3cr1 polymorphisms | #4 |
| current symptoms asthma | #4 |
| allergic diseases humans | #4 |
| adolescents duration | #4 |
| occurrence atopic dermatitis | #4 |
| infections early | #4 |
| t2high asthma | #4 |
| particle boluses | #4 |
| rs2786098 | #4 |
| leisure time activity | #4 |
| current asthma bhr | #4 |
| cowsheds | #4 |
| allergic il5 | #4 |
| asthma current symptoms | #4 |
| alliance cohort | #4 |
| lower risk allergy | #4 |
| life childhood | #4 |
| tolllike receptors receptor | #4 |
| fever year | #4 |
| exposure microbial | #4 |
| groups taxa | #4 |
| indoor pollen | #4 |
| lifetime prevalence asthma | #4 |
| cats pregnancy | #4 |
| c746 | #4 |
| stables farm milk | #4 |
| fetal growth asthma | #4 |
| atopic eczema allergic | #5 |
| n1046 | #5 |
| receptors innate immunity | #5 |
| ors positive association | #5 |
| verlaufsformen | #5 |
| participation behaviour | #5 |
| cats risk factor | #5 |
| ors atopy | #5 |
| 26 farms | #5 |
| helsinki alert | #5 |
| cow milk samples | #5 |
| dogs symptoms | #5 |
| young adults methods | #5 |
| milk odds | #5 |
| thr280met | #5 |
| nod1 variation | #5 |
| milk consumption age | #5 |
| tbx21 polymorphisms development | #5 |
| ormdl3 gsdma | #5 |
| mmp9 influence | #5 |
| associations wheeze | #5 |
| popular terms | #5 |
| severe atopy | #5 |
| rhinitis increase | #5 |
| lung health disease | #5 |
| ige regulation | #5 |
| mechanism environmental factors | #5 |
| allergic rhinitis wheeze | #5 |
| c2892t | #5 |
| atopic sensitization asthma | #5 |
| wisconsin infant | #5 |
| il13cd4 | #5 |
| combination hlx1 variants | #5 |
| inverse association overweight | #5 |
| eczema relation | #5 |
| tbx21 promoter activity | #5 |
| timing exposures | #5 |
| allergen 95 | #5 |
| adulthood asthma | #5 |
| allergic diseases exposure | #5 |
| atopy flexural eczema | #5 |
| risk atopic | #5 |
| neu5gc mice | #5 |
| linkage development | #5 |
| nonfarmers children | #5 |
| parental reports asthma | #5 |
| 2q14 | #5 |
| children validity | #5 |
| children current wheeze | #5 |
| influence ige | #5 |
| milk exposure | #5 |
| exposure rhinitis | #5 |
| consumption 4 years | #5 |
| atopy airway hyperresponsiveness | #5 |
| il13cd4 cells | #5 |
| allergystudy | #5 |
| processing intensity | #5 |
| tnc nps | #5 |
| farming mothers | #5 |
| taxa groups | #5 |
| cd14 gene expression | #5 |
| asthma child dust | #5 |
| communitybased random sample | #5 |
| pattern sensitization | #5 |
| airway responsiveness age | #5 |
| current symptoms rhinoconjunctivitis | #5 |
| ornonaffluent | #5 |
| incident wheeze | #5 |
| 14452 | #5 |
| environmental dust | #5 |
| tbx21 gene variants | #5 |
| combination hlx1 polymorphisms | #5 |
| visits predictors | #5 |
| hyperreactivity child | #5 |
| tests bronchitis | #5 |
| jf1 msf | #5 |
| life questionnaires switzerland | #5 |
| asthma medication 95 | #5 |
| 2nd followup | #5 |
| phänotypen | #5 |
| asthma girls | #5 |
| dresden | #5 |
| sensitization atopic | #5 |
| disinfectants asthma | #5 |
| genetic asthma | #5 |
| childhood isaac phase | #5 |
| atopic dermatitis age | #5 |
| moulds actinomycetes | #5 |
| 95 populationattributable risk | #5 |
| west german children | #5 |
| agriculture animals | #5 |
| 95 reverse causation | #5 |
| flexural eczema strength | #5 |
| delayed manifestation | #5 |
| genetic variants tbx21 | #5 |
| cd4cd25hi | #5 |
| moisture mold problems | #5 |
| female germany allergic | #5 |
| endotoxin protection | #5 |
| trigger factors asthma | #5 |
| rural subjects | #5 |
| asthma endotoxins | #5 |
| pregnancy year | #5 |
| subtypes risk | #5 |
| duration jobs | #5 |
| tbx21 combination | #5 |
| puberty menarche | #5 |
| rs3771300 | #5 |
| hlx1 polymorphisms development | #5 |
| hlx1 variants | #5 |
| cowshed | #5 |
| countries albania | #6 |
| fever atopy | #6 |
| protection allergies | #6 |
| responders frequency | #6 |
| complete screening | #6 |
| dipeptidyl peptidases tripeptidylpeptidases | #6 |
| asthma transition | #6 |
| 17q12q21 earlier onset | #6 |
| pierced ears | #6 |
| childhood aa | #6 |
| interactions farm exposures | #6 |
| eating environmental | #6 |
| primary preventive strategies | #6 |
| progression asthma | #6 |
| sounds surveys | #6 |
| farm nonfarm | #6 |
| rora npsr1 | #6 |
| no2 current asthma | #6 |
| tests asthma | #6 |
| lowgrade inflammation hscrp | #6 |
| longitudinal populations | #6 |
| current contact | #6 |
| cold air challenge | #6 |
| 5 regions tao | #6 |
| asthma austria | #6 |
| isaac programme | #6 |
| inversely asthma | #6 |
| systemic inflammation age | #6 |
| allergic immunologic receptors | #6 |
| onset disease germany | #6 |
| bavarian preschool children | #6 |
| children east germany | #6 |
| childhood asthma phenotypes | #6 |
| microorganisms samples | #6 |
| distinct underlying mechanisms | #6 |
| 939 children | #6 |
| german nationality | #6 |
| susceptibility gene asthma | #6 |
| yearly interviews | #6 |
| allergic epistasis | #6 |
| allergens needed | #6 |
| 14 genes tripeptidylpeptidases | #6 |
| hypertonic skin tests | #6 |
| asthma allergic sensitisation | #6 |
| devenues | #6 |
| natural atopic dermatitis | #6 |
| 7 years association | #6 |
| deubiquitinating enzyme tao | #6 |
| central europe asthma | #6 |
| fever wheezing | #6 |
| allergic diseases | #6 |
| 11094 | #6 |
| comprehensive questionnaires | #6 |
| food allergy 95 | #6 |
| sscp method | #6 |
| polymorphisms stat6 gene | #6 |
| lifestyle factors symptoms | #6 |
| children farming environment | #6 |
| rhinoconjunctivitis eczema | #6 |
| il33 17q12q21 | #6 |
| asthma genotypes | #6 |
| new locus time | #6 |
| childhood asthma genes | #6 |
| 16q12 region | #6 |
| dogs environmental exposure | #6 |
| dust collection | #6 |
| allergic markers | #6 |
| tripeptidylpeptidases subunit p40 | #6 |
| strategies disease | #6 |
| asthma context | #6 |
| data 7 years | #6 |
| sensitisation exposure | #6 |
| allergy tests children | #6 |
| nd132656 | #6 |
| european dairy farms | #6 |
| central europe interactions | #6 |
| rhinoconjunctivitis atopic | #6 |
| bolus dispersion | #6 |
| pair male nod2 | #6 |
| study rarer snps | #6 |
| steiner schools | #6 |
| overweight data | #6 |
| abschnitten | #6 |
| asthma authors | #6 |
| genetic variants time | #6 |
| prevent allergic | #6 |
| nonaffluent | #6 |
| tlr1 tlr10 | #6 |
| genetic variants 17q12q21 | #6 |
| atemwegserkrankungen | #6 |
| oropharyngeal microbiota | #6 |
| parsifal | #6 |
| pair deubiquitinating enzyme | #6 |
| lung barrier | #6 |
| children positive spt | #6 |
| allergoprotective properties | #6 |
| child dust | #7 |
| viral infections development | #7 |
| steiner school children | #7 |
| seasonal sensitivity allergic | #7 |
| symptoms adulthood | #7 |
| questionnaires allergic | #7 |
| inhalant age | #7 |
| wheeze 12 months | #7 |
| influence neonatal | #7 |
| breastfeeding prevalence | #7 |
| 15245 | #7 |
| endotoxin allergen | #7 |
| pasture study | #7 |
| levels farm | #7 |
| diversity introduction | #7 |
| strategies asthma | #7 |
| lymphoid cells asthma | #7 |
| polymorphisms il4 gene | #7 |
| atopic dermatitis association | #7 |
| bhr current asthma | #7 |
| asthma fever | #7 |
| environmental factors children | #7 |
| secretory receptors | #7 |
| cells dust | #7 |
| perennial allergen | #7 |
| childrens bedrooms | #7 |
| functional phenotypes | #7 |
| lung sod3 | #7 |
| asthma school age | #7 |
| centers increase | #7 |
| grass rphl | #7 |
| asthma environmental factors | #7 |
| farm life | #7 |
| preanalytix | #7 |
| infectious diseases phenotype | #7 |
| pasture birth | #7 |
| steiner school | #7 |
| environmental exposure endotoxin | #7 |
| indoor moisture | #7 |
| exposure farms | #7 |
| large centres | #7 |
| 5 harmonization | #7 |
| atopic europe | #7 |
| hypertonic sensitivity | #7 |
| infantis populations | #7 |
| paracetamol year | #7 |
| children international study | #7 |
| 95 endotoxin | #7 |
| exposure neu5gc | #7 |
| wheeze atopy | #7 |
| birth cohorts report | #7 |
| fieldworkers | #7 |
| log2fold | #7 |
| fetal development allergic | #7 |
| pregnancy atopic dermatitis | #7 |
| biomarker immune activation | #7 |
| lower risk asthma | #7 |
| inverse association consumption | #7 |
| genetic predisposition role | #7 |
| association cord blood | #7 |
| allergy antibiotics | #7 |
| foxp3 blood | #7 |
| questionnaires phase | #7 |
| allergic atopic embryonic | #7 |
| murine offspring | #7 |
| farm homes | #7 |
| stat1 gene | #7 |
| pbmcs asthmatics | #7 |
| birth function | #7 |
| fever atopic asthma | #7 |
| immunologic receptors allergic | #7 |
| amish children | #7 |
| children regular contact | #7 |
| isaac eczema | #7 |
| adult farmers | #7 |
| interleukin4 sequence analysis | #7 |
| school age asthma | #7 |
| reference exposure | #7 |
| juvenile inflammatory | #7 |
| children breast | #7 |
| chemokine cx3cl1 cx3cr1 | #7 |
| farm exposure | #7 |
| invading microorganism | #7 |
| children prognosis | #7 |
| childhoodonset disease | #7 |
| level variety | #7 |
| highrisk occupations | #7 |
| hypersensitivity male | #7 |
| nonfarm homes | #7 |
| rhinitis early childhood | #7 |
| aerosol bolus dispersion | #7 |
| hutterite children | #7 |
| european science | #7 |
| lipid peptidoglycan | #8 |
| agmr | #8 |
| asthma child conjunctivitis | #8 |
| airwayrelated symptoms | #8 |
| crohns disease polymorphisms | #8 |
| p4×10−9 | #8 |
| diversity year | #8 |
| university work | #8 |
| rs8076131 | #8 |
| ppg stimulation | #8 |
| international variations | #8 |
| study rural | #8 |
| asthma atopic sensitisation | #8 |
| indoor microbiota | #8 |
| sensitization mite | #8 |
| current asthma data | #8 |
| asthma physiciandiagnosed asthma | #8 |
| immunity gene expression | #8 |
| 17q12q21 | #8 |
| asthma analyses | #8 |
| amish child | #8 |
| p7×10−14 | #8 |
| chromosome 2q14 | #8 |
| proteins dendritic cells | #8 |
| allergy epidemiology | #8 |
| gabriela study | #8 |
| allergies childhood | #8 |
| genetic risk asthma | #8 |
| inhalant europe | #8 |
| surveyed children | #8 |
| asthma 08 | #8 |
| exposure dogs | #8 |
| chromosome childhoodonset disease | #8 |
| hrqol questions | #8 |
| p3×10−9 | #8 |
| early age exposure | #8 |
| association food diversity | #8 |
| antibiotics year | #8 |
| repeats sequence homology | #8 |
| 95 food allergy | #8 |
| eczema asthma child | #8 |
| influence cytokine | #8 |
| childhood asthma atopy | #8 |
| asthma bias | #8 |
| gabriela | #8 |
| igg1 galactosylation | #8 |
| diet year | #8 |
| fever atopic sensitisation | #8 |
| p11×10−8 | #8 |
| age 911 years | #8 |
| children anthroposophic | #8 |
| children anthroposophic families | #8 |
| allergy study | #8 |
| th2 cells ilc2s | #8 |
| asthmaprotective | #8 |
| atopic sensitization prevalence | #8 |
| invertedu shape | #8 |
| mice children | #8 |
| highthroughput sequencing data | #8 |
| 3113 children | #8 |
| childhoodonset disease elevation | #8 |
| finlande | #8 |
| sensitization patterns | #8 |
| il13 variants | #8 |
| il15 snps | #8 |
| amino acid asthma | #8 |
| children reference | #8 |
| dogs risk factor | #8 |
| asthma maternal smoking | #8 |
| c4ma3 | #8 |
| bronchial histamine challenge | #8 |
| association wheeze | #8 |
| age positive spts | #8 |
| asthma birth weight | #8 |
| austrian schoolchildren | #8 |
| cows milk age | #8 |
| hlx1 | #8 |
| 824 children | #8 |
| factor analysis factor | #8 |
| prevalence atopic | #9 |
| asthma early life | #9 |
| fcer1a susceptibility locus | #9 |
| 5 european | #9 |
| microbial substances | #9 |
| 1 npsr1 | #9 |
| 105 years age | #9 |
| life female germany | #9 |
| asthma antibiotics | #9 |
| longitudinal follow‐up | #9 |
| ige levels gwas | #9 |
| autriche | #9 |
| chromosome ige levels | #9 |
| relation environment | #9 |
| npsr1 snps | #9 |
| relation asthma | #9 |
| tbx21 promoter | #9 |
| germany munich | #9 |
| microbial exposure | #9 |
| young german | #9 |
| n7498 | #9 |
| cytokines environmental | #9 |
| drug development strategies | #9 |
| allergic seasonal risk | #9 |
| eczema weight | #9 |
| life ahr | #9 |
| association wheezing | #9 |
| farming environment | #9 |
| asthma risk | #9 |
| ausprägungen | #9 |
| partial nonresponders | #9 |
| allergic preschool conjunctivitis | #9 |
| symptoms 12 months | #9 |
| life prenatal exposure | #9 |
| animals supplementation | #9 |
| asthma symptoms baseline | #9 |
| study asthma | #9 |
| clinical response score | #9 |
| allergic inflammation patients | #9 |
| association stat6 variation | #9 |
| gwas approaches | #9 |
| subspecies bifidobacterium | #9 |
| ecuador eczema | #9 |
| unprocessed milk | #9 |
| bronchial hyper‐responsiveness | #9 |
| rad50 gene chromosome | #9 |
| random subsample | #9 |
| dennd1b | #9 |
| role human asthma | #9 |
| skinprick | #9 |
| cord blood cytokines | #9 |
| regulatory th17 cells | #9 |
| asthma respiratory conditions | #9 |
| asthma child | #9 |
| 1314 children | #9 |
| igg4 ige | #9 |
| exposure farming environments | #9 |
| rural farm | #9 |
| positive spts | #9 |
| ribosomal 16s risk | #9 |
| asthma child child | #9 |
| 1314yrolds | #9 |
| asthma infant | #9 |
| conjunctivitis cross | #9 |
| regular exposure | #9 |
| teenagers asthma | #9 |
| low levels hscrp | #9 |
| factors sensitization | #9 |
| atopic sensitization children | #9 |
| polymorphisms development | #9 |
| levels allergens | #9 |
| asthma allergy symptoms | #9 |
| col29a1 variants | #9 |
| kazal type | #9 |
| allergic phenotypes | #9 |
| leipzig east germany | #10 |
| association new onset | #10 |
| infection allergic | #10 |
| asthma chromosome | #10 |
| association atopic | #10 |
| centers prevalence rates | #10 |
| blood samples tubes | #10 |
| study occupational | #10 |
| farm exposures asthma | #10 |
| early life immunity | #10 |
| rural school children | #10 |
| latex children | #10 |
| reservoir method | #10 |
| endotoxin muramic acid | #10 |
| substances development | #10 |
| prevalence differences | #10 |
| 45 saline | #10 |
| new onset rhinitis | #10 |
| ige levels asthma | #10 |
| predictors health utilization | #10 |
| countries centres | #10 |
| airway hyperresponsiveness children | #10 |
| life allergen | #10 |
| hormonal factors role | #10 |
| phase protocol | #10 |
| house dust endotoxin | #10 |
| asthma nocturnal | #10 |
| consumption raw | #10 |
| indoor heating | #10 |
| gabriel advanced studies | #10 |
| context eczema | #10 |
| missing values paper | #10 |
| adult cases controls | #10 |
| 1992–2001 | #10 |
| n1138 | #10 |
| bias exposure | #10 |
| atopic dermatitis 95 | #10 |
| receptors immunity | #10 |
| new zealand bhr | #10 |
| genetic probability receptors | #10 |
| production cord blood | #10 |
| ilt3 ilt4 | #10 |
| ratio asthma | #10 |
| interrelations risk factors | #10 |
| mattress dust | #10 |
| mothers contact | #10 |
| bdnf gene variants | #10 |
| bhr prevalence | #10 |
| international study asthma | #10 |
| young german adults | #10 |
| mechanisms oral tolerance | #10 |
| humans hypersensitivity | #10 |
| farm children children | #10 |
| urban rural area | #10 |
| atopic dust | #11 |
| ige measurements | #11 |
| allergy risks | #11 |
| school beginners | #11 |
| protective development | #11 |
| active smoking association | #11 |
| newborn male polymorphism | #11 |
| atopy | #11 |
| overweight body mass | #11 |
| blood foxp3 | #11 |
| microbiome lung | #11 |
| fetal ige | #11 |
| children school entry | #11 |
| early life development | #11 |
| npsr1 polymorphisms | #11 |
| wheeze aor | #11 |
| tuberculosis notification rates | #11 |
| occupational disinfectants | #11 |
| asthma bacterial | #11 |
| tbx21 polymorphisms | #11 |
| farm exposures | #11 |
| symptoms allergic rhinoconjunctivitis | #11 |
| transient wheezing | #11 |
| parsifal study | #11 |
| cytokines allergic inflammation | #11 |
| wheeze year | #11 |
| allergic disease children | #11 |
| association respiratory health | #11 |
| children rural | #11 |
| reduced risk asthma | #11 |
| factors agriculture | #11 |
| genotyped polymorphisms | #11 |
| subsequent development asthma | #11 |
| asthma lower | #11 |
| health outcomes countries | #11 |
| farm buildings | #11 |
| pregnancy early life | #11 |
| allergic asthma conjunctivitis | #11 |
| samples persons | #11 |
| german schoolchildren | #11 |
| lebensbedingungen | #11 |
| asthma risk participants | #11 |
| persistent uncontrolled asthma | #11 |
| child environmental | #12 |
| age 105 years | #12 |
| early priming | #12 |
| rural environments | #12 |
| management childhood asthma | #12 |
| hypersensitivity immunity | #12 |
| farm | #12 |
| backgroundasthma | #12 |
| increase prevalence | #12 |
| young adults school | #12 |
| german multicentre | #12 |
| asthma candidate gene | #12 |
| 7 years data | #12 |
| munich west germany | #12 |
| overweight breast | #12 |
| female humans hypersensitivity | #12 |
| children low levels | #12 |
| standard deviation skewness | #12 |
| skin prick testing | #12 |
| infection analyses | #12 |
| stepwise protocol | #12 |
| multicentre allergy | #12 |
| incident asthma 95 | #12 |
| asthma epidemic | #12 |
| sensitization birth | #12 |
| polymorphisms bdnf gene | #12 |
| exposure asthma symptoms | #12 |
| participants allergic rhinitis | #12 |
| mattress dust samples | #12 |
| fever exposure | #12 |
| children background | #12 |
| asthma parent | #12 |
| ige grass | #12 |
| birth cohorts asthma | #12 |
| male respiratory | #12 |
| damage mold | #12 |
| doctor asthma | #12 |
| asthma disease humans | #12 |
| pet contact | #12 |
| validated questions | #12 |
| current paracetamol | #12 |
| children exposed children | #12 |
| asthmatic cohort | #12 |
| dermatitis phenotypes | #12 |
| east germany munich | #12 |
| symptoms atopic | #12 |
| association moisture | #12 |
| polymorphism asthma | #12 |
| healthy children asthma | #12 |
| 95 nox | #12 |
| transient wheeze | #12 |
| cattle child | #12 |
| bhr wheeze | #12 |
| eastern western germany | #13 |
| children raised | #13 |
| npsr1 | #13 |
| asthma bronchial | #13 |
| northern indiana | #13 |
| switzerland children | #13 |
| subjects jobs | #13 |
| farm dust | #13 |
| farm animal contact | #13 |
| farming exposures | #13 |
| wheezing ages | #13 |
| cord adult blood | #13 |
| ibd sle | #13 |
| hygiene hypersensitivity | #13 |
| children polymorphisms | #13 |
| spt specific ige | #13 |
| children inhaled steroids | #13 |
| occupational exposure disinfectants | #13 |
| allergic sensitisation children | #13 |
| asthma outcomes patients | #13 |
| asthma snp | #13 |
| childhood allergy | #13 |
| childhood isaac | #13 |
| nod1 gene | #13 |
| n349 | #13 |
| asthma rhinoconjunctivitis | #13 |
| atopic eczema symptoms | #13 |
| antibiotic exposure pregnancy | #13 |
| th1cells | #13 |
| dresden germany | #13 |
| rhinitis allergens | #13 |
| expression ormdl3 | #13 |
| asthma nocturnal symptoms | #13 |
| rural schoolchildren | #13 |
| polymorphisms influence | #13 |
| asthma mental health | #13 |
| groups phenotype | #13 |
| local immunity | #13 |
| asthma community | #13 |
| developing microbiota | #13 |
| sx1 | #13 |
| german children | #14 |
| atopic environmental | #14 |
| standardised questionnaires | #14 |
| introduction complementary food | #14 |
| incidence rhinitis | #14 |
| nonaffluent countries | #14 |
| preventive development | #14 |
| maternal sensitization | #14 |
| asthma bronchial hyperresponsiveness | #14 |
| diseases atopic | #14 |
| increased risk age | #14 |
| polymorphisms ormdl3 | #14 |
| innate infant | #14 |
| 10‐year‐old children | #14 |
| delayed introduction solids | #14 |
| asthma step | #14 |
| breast feeding children | #14 |
| farm rural | #14 |
| air challenge | #14 |
| 7 polymorphisms | #14 |
| positive spts age | #14 |
| upper respiratory symptoms | #14 |
| asthma1 | #14 |
| allergic sensitization age | #14 |
| late introduction | #14 |
| diabimmune study | #14 |
| detailed questionnaires | #14 |
| mrna expression vivo | #14 |
| 3099 | #14 |
| exacerbations fev1 | #14 |
| role lung microbiome | #14 |
| symptoms rhinoconjunctivitis | #14 |
| respiratory atopic | #14 |
| cross environmental exposure | #14 |
| untypical | #14 |
| farming lifestyle | #14 |
| changing gender | #14 |
| fx5 | #14 |
| il15 gene | #14 |
| burden prevalence | #14 |
| th2 commitment | #14 |
| rhinitis conjunctivitis | #14 |
| contact farm animals | #15 |
| diabimmune | #15 |
| children allele | #15 |
| 17q21 locus | #15 |
| allele2 | #15 |
| bronchial hyperreactivity | #15 |
| mold problems | #15 |
| ahr male mice | #15 |
| factors bronchial | #15 |
| ω3 polyunsaturated | #15 |
| respective tlrs | #15 |
| sensitization indoor allergens | #15 |
| street residence | #15 |
| asthma allergy | #15 |
| immunity asthma | #15 |
| allele evidence | #15 |
| children early | #15 |
| bronchial responsiveness children | #15 |
| nocturnal symptoms | #15 |
| epidemiological studies exposure | #15 |
| association asthma symptoms | #15 |
| unpasteurized | #15 |
| dogs children | #15 |
| skin prick tests | #15 |
| allergy risk | #15 |
| puberty rhinitis | #15 |
| rhinitis puberty | #15 |
| pregnancy protective | #15 |
| nonatopic asthma children | #16 |
| association atopy | #16 |
| microbial exposures | #16 |
| n1133 | #16 |
| polymorphisms atopy | #16 |
| chronic asthma children | #16 |
| burden childhood asthma | #16 |
| lung microbiome health | #16 |
| bacteria respiratory tract | #16 |
| 9 11 | #16 |
| endotoxin house | #16 |
| asthma asthma risk | #16 |
| allergic diseases childhood | #16 |
| exposure atopic | #16 |
| multi‐centre study | #16 |
| clinical response measures | #16 |
| increased food | #16 |
| hutterite | #16 |
| protocadherin1 | #16 |
| newborn phenotype | #16 |
| seasonal surveys questionnaires | #16 |
| 7 year | #16 |
| childhood asthma asthma | #16 |
| microbial environment | #16 |
| asthma farm | #16 |
| diseases allergy | #16 |
| wheeze trajectories | #16 |
| sas institute | #16 |
| 80 chromosomes | #16 |
| munich germany | #17 |
| asthma immune responses | #17 |
| bavarian | #17 |
| factors atopic | #17 |
| allergic asthma aa | #17 |
| aerosol bolus | #17 |
| epidemiologic dermatitis | #17 |
| ga2len skin | #17 |
| variants increase | #17 |
| child allergic | #17 |
| humans preschool haemophilus | #17 |
| levels microbial | #17 |
| atopy childhood | #17 |
| persistent sensitization | #17 |
| dust extract | #17 |
| asthma biomarkers humans | #17 |
| eczema exposure | #17 |
| age 7 years | #17 |
| function school | #17 |
| pregnancy gene expression | #17 |
| munich | #17 |
| asthma environment | #17 |
| neuropeptide receptor npsr1 | #17 |
| animals domestic | #17 |
| respiratory health children | #17 |
| rhinoconjunctivitis | #17 |
| asthma associations | #17 |
| single microbial | #17 |
| asthma 95 | #17 |
| immune adaptation | #18 |
| ormdl3 gene | #18 |
| measles infection | #18 |
| asthma exposure | #18 |
| atopy rhinitis | #18 |
| increase childhood | #18 |
| asthma phenotyping | #18 |
| edna concentrations | #18 |
| maternallyacquired mice mice | #18 |
| polymorphism genetic receptors | #18 |
| cb production | #18 |
| protective microbiota | #18 |
| type employment | #18 |
| meat children | #18 |
| asthma 6 years | #18 |
| underlying responses | #18 |
| pregnancy 6 years | #18 |
| maternal contact | #18 |
| female humans asthma | #18 |
| trajectories asthma | #18 |
| children german | #18 |
| current wheezers | #18 |
| anthroposophic lifestyle | #18 |
| col29a1 | #18 |
| childrens mattresses | #18 |
| preschool dna ribosomal | #18 |
| mef75 | #18 |
| 7 yrs | #18 |
| cbmcs | #18 |
| wheeze | #18 |
| eczema 95 | #18 |
| phenotypes children | #18 |
| german populations | #18 |
| child crosssectional studies | #19 |
| hscrp age | #19 |
| linkage disequilibrium polymorphisms | #19 |
| asthma bronchiale | #19 |
| german center | #19 |
| arg130gln | #19 |
| life diversity | #19 |
| life exposures | #19 |
| expression treg | #19 |
| susceptibility human | #19 |
| asthma allergy development | #19 |
| developing asthma | #19 |
| viable bacterial counts | #19 |
| children current | #19 |
| asthma report | #19 |
| sounds risk | #19 |
| receptors innate | #19 |
| microbial association networks | #19 |
| regulatory tolllike receptor | #19 |
| receptors innate immune | #19 |
| innate mice models | #19 |
| crp levels age | #19 |
| higher levels endotoxin | #19 |
| ilt4 | #19 |
| asthma | #19 |
| symptoms asthma | #19 |
| cary | #19 |
| seasonal risk | #19 |
| tcell phenotypes | #19 |
| disease atopic | #19 |
| 3 years life | #19 |
| farming activities | #19 |
| newonset symptoms | #19 |
| birth 13 years | #19 |
| atopy phenotypes | #19 |
| rural children | #19 |
| atopic dermatitis studies | #19 |
| poor symptom control | #19 |
| life asthma risk | #19 |
| breast feeding risk | #20 |
| disease germany | #20 |
| life farm | #20 |
| dermatitis early | #20 |
| infant colonization | #20 |
| specific ige food | #20 |
| westernized countries | #20 |
| inbred balb spores | #20 |
| isaac | #20 |
| symptoms wheeze | #20 |
| 6 haplotype | #20 |
| farm environments | #20 |
| gender ratio | #20 |
| npsr1 nps | #20 |
| asthma trajectories | #20 |
| haplotype studies | #20 |
| allergic disease prevalence | #20 |
| dust female humans | #20 |
| adults childhood | #20 |
| unhygienic | #20 |
| mice sod3 | #20 |
| animal exposure | #20 |
| school university | #20 |
| stables | #20 |
| gene expression measurements | #20 |
| atopy snps | #20 |
| unboiled | #20 |
| pvalues patients | #20 |
| asthma nonatopic asthma | #20 |
| children living | #20 |
| persistent uncontrolled | #20 |
| tlr2 receptor | #21 |
| asthma review | #21 |
| n1062 | #21 |
| c589t | #21 |
| network differences | #21 |
| plasma erythrocyte membranes | #21 |
| markers early | #21 |
| eczema atopy | #21 |
| rora | #21 |
| pregnancy production | #21 |
| pseudocroup | #21 |
| atopic asthma children | #21 |
| farm environment | #21 |
| development allergic diseases | #21 |
| studies eczema | #21 |
| environmental microbiome | #21 |
| hypersensitivity infant | #21 |
| children east | #21 |
| turkish children | #21 |
| children inhaled | #21 |
| bifidobacterium colonization | #21 |
| current asthma wheeze | #21 |
| bhr 95 | #21 |
| environment lifestyle | #21 |
| gstm1 deficiency | #21 |
| germany humans germany | #21 |
| prevalence rates symptoms | #21 |
| unremitting | #21 |
| ige igg4 | #21 |
| patients degradation | #21 |
| tripeptidylpeptidases | #21 |
| childhood background | #21 |
| 17q21 asthma | #22 |
| r753q | #22 |
| endotoxin house dust | #22 |
| alleles asthma | #22 |
| allergic rhinitis 95 | #22 |
| chromosome asthma | #22 |
| 95 prenatal exposure | #22 |
| childhood atopy | #22 |
| highschool | #22 |
| samples dust | #22 |
| npsr1 gene | #22 |
| β1→3glucans | #22 |
| asthmatic phenotypes | #22 |
| food diversity | #22 |
| lps risk | #22 |
| seasonal risk factors | #22 |
| living germany | #22 |
| effective airway | #22 |
| muramic acid | #22 |
| lower prevalences | #22 |
| exposure germany | #22 |
| respiratory diseases children | #22 |
| isaac childhood | #22 |
| immune maturation | #22 |
| objective sought | #22 |
| feeding obesity | #22 |
| gabriel | #22 |
| crth2 th2 cells | #22 |
| neonatal immune responses | #22 |
| breast feeding asthma | #23 |
| gross national | #23 |
| new onset | #23 |
| asthma 12 months | #23 |
| childhood allergies | #23 |
| farm childhood | #23 |
| child cross | #23 |
| association atopic asthma | #23 |
| single taxa | #23 |
| fecal microbiota children | #23 |
| 7 prevalence | #23 |
| hillerød | #23 |
| microbiota respiratory | #23 |
| bronchial challenge tests | #23 |
| nonlinear relations | #23 |
| asthma agents | #23 |
| southern bavaria | #23 |
| children adulthood | #23 |
| rapid alternative | #23 |
| traffic counts | #23 |
| symptoms atopic eczema | #23 |
| asthma cats | #23 |
| nonfarm | #23 |
| isaac phase | #23 |
| contact livestock | #24 |
| bronchitis child | #24 |
| countrys | #24 |
| dust endotoxin | #24 |
| gene expression immunity | #24 |
| children indoor | #24 |
| current symptoms | #24 |
| exposure road traffic | #24 |
| doctor diagnosed | #24 |
| asthma early | #24 |
| asthma aa | #24 |
| asthma prevention | #24 |
| west german | #24 |
| wheeze symptoms | #24 |
| tobit regression | #24 |
| asthma age | #24 |
| allergic respiratory symptoms | #24 |
| differences asthma prevalence | #24 |
| allergic dermatitis | #24 |
| 4 phenotypes | #24 |
| phenotypes childhood | #24 |
| 2fold risk | #24 |
| asthma cross | #24 |
| asthma bhr | #24 |
| asthma 5 years | #24 |
| haying | #24 |
| eczema susceptibility | #24 |
| igg1 ige | #25 |
| environmental determinants | #25 |
| risk atopic diseases | #25 |
| exposure paracetamol | #25 |
| methods association | #25 |
| prevention asthma | #25 |
| expression ige | #25 |
| il13 pathway | #25 |
| cytokines children | #25 |
| 5030 | #25 |
| sensitization early | #25 |
| antibiotic year | #25 |
| farm animals | #25 |
| car traffic | #25 |
| 2 12 months | #25 |
| levels mite | #26 |
| risk allergic sensitization | #26 |
| child conjunctivitis | #26 |
| farms humans | #26 |
| risk factors probability | #26 |
| written questionnaire | #26 |
| wheezing childhood | #26 |
| environmental asthma | #26 |
| early phenotypes | #26 |
| 5 european countries | #26 |
| early atopic | #26 |
| blood samples children | #26 |
| trendwise | #26 |
| microbiota asthma | #26 |
| allergen sensitisation | #26 |
| asthma syndrome | #26 |
| sputum eosinophils feno | #26 |
| clinical phenotypes children | #26 |
| 3rd year | #26 |
| card4 | #26 |
| fev1 bhr | #26 |
| increased treg | #26 |
| prevalence fever | #27 |
| muramic | #27 |
| visible mould | #27 |
| 035 iu | #27 |
| consumption raw milk | #27 |
| children asthma symptoms | #27 |
| npsr1 asthma | #27 |
| prevalence atopic eczema | #27 |
| prevention allergic diseases | #27 |
| asthma child cross | #27 |
| children parental asthma | #27 |
| single snps | #27 |
| specific ige levels | #27 |
| asthmatic participants | #27 |
| asthma childhood | #27 |
| asthma environmental | #27 |
| association childhood asthma | #27 |
| ilt3 | #27 |
| wheeze childhood | #27 |
| factors year | #27 |
| childhood origins | #27 |
| respiratory infections year | #27 |
| allergens europe | #27 |
| 9 11 years | #27 |
| host factors infection | #28 |
| pregnancy increase | #28 |
| atopic phenotypes | #28 |
| higher hrqol | #28 |
| il13 polymorphisms | #28 |
| recurrence persistence | #28 |
| childhood asthma risk | #28 |
| analysis lca | #28 |
| dust children | #28 |
| ige therapy | #28 |
| immune phenotypes | #28 |
| east germany | #28 |
| gene asthma | #28 |
| weekly diaries | #28 |
| early identification children | #28 |
| levels sensitization | #28 |
| feno fev1 | #28 |
| 10 years data | #28 |
| early years life | #29 |
| preschool environmental | #29 |
| anthroposophy | #29 |
| adult agriculture | #29 |
| pediatric asthma patients | #29 |
| farming | #29 |
| primary prevention asthma | #29 |
| polymorphisms identified | #29 |
| women males | #29 |
| questionnaires urban | #29 |
| bioair | #29 |
| rad50 gene | #29 |
| vivo age | #29 |
| acinetobacter lwoffii | #29 |
| dust indoor | #29 |
| polymorphisms il13 | #29 |
| enhanced expression genes | #29 |
| centers prevalence | #29 |
| mite sensitization | #29 |
| pblc | #29 |
| effective ways | #30 |
| il10 snps | #30 |
| biodiversity child | #30 |
| viral infections asthma | #30 |
| incidence recurrence | #30 |
| dismutase 3 | #30 |
| affluent | #30 |
| asthma childhood asthma | #30 |
| boys asthma | #30 |
| il10 polymorphisms | #31 |
| card4 nod1 | #31 |
| persons european ancestry | #31 |
| centres countries | #31 |
| children diagnosed asthma | #31 |
| bronchial obstruction | #31 |
| atopy children | #31 |
| traditional farming | #31 |
| enhancer marks | #31 |
| moisture damage | #31 |
| questionnaires asthma | #31 |
| atopic food | #31 |
| asthma atopic | #31 |
| ribosomal preschool dna | #31 |
| probability persistence | #31 |
| childhood infectious | #31 |
| gata3 gene | #32 |
| européens | #32 |
| transferase deficiency | #32 |
| obese children age | #32 |
| huge burden | #32 |
| atopic diseases | #32 |
| infants countries | #32 |
| asthma odds ratio | #32 |
| african ancestry asthma | #32 |
| living environments | #32 |
| rural regions | #32 |
| susceptibility asthma | #32 |
| cohorts asthma | #32 |
| association paracetamol | #32 |
| studies dermatitis | #32 |
| linked polymorphisms | #32 |
| allergic diseases age | #32 |
| microbial components | #32 |
| prick tests | #32 |
| epidemiology asthma | #32 |
| doctordiagnosed | #32 |
| preschool day | #32 |
| microbial environments | #32 |
| disease childhood | #32 |
| r2447x | #32 |
| symptoms childhood | #32 |
| germany leipzig | #32 |
| immune cell enhancer | #33 |
| multiancestry association study | #33 |
| multiancestry association | #33 |
| asthma associations loci | #33 |
| allergic genetic epigenesis | #33 |
| specificity skin tests | #33 |
| bhr fev1 | #33 |
| imputation data | #33 |
| eczema prevalence | #33 |
| genetic epigenesis allergic | #33 |
| health utilization children | #34 |
| fascinating | #34 |
| development atopy | #34 |
| indoor mould | #34 |
| asthma risk children | #34 |
| dust microbiota | #34 |
| bradykinin receptor gene | #34 |
| curve asthma | #34 |
| mite allergen exposure | #34 |
| year life | #34 |
| studies dust | #34 |
| participants questionnaire | #34 |
| bacterial farms | #34 |
| tests surveys | #34 |
| participants childhood | #34 |
| pregnancy maternal health | #34 |
| asthma atopic eczema | #34 |
| new onset symptoms | #34 |
| infant contact | #34 |
| clec4e | #34 |
| pattern frequency | #34 |
| endotoxins environmental | #34 |
| raw cows milk | #35 |
| farms female | #35 |
| asthma conjunctivitis | #35 |
| anthroposophic | #35 |
| germany haplotypes | #35 |
| diseases rhinitis | #35 |
| 95 atopic dermatitis | #35 |
| prick testing | #35 |
| tagging polymorphisms | #35 |
| urbanrural differences | #35 |
| children cross | #35 |
| asthma asthma phenotypes | #35 |
| preschool fatty acids | #35 |
| western lifestyle | #35 |
| wingedhelix | #35 |
| analysis steps | #35 |
| risk asthma | #35 |
| endotoxin levels | #35 |
| nonatopic mothers | #35 |
| western germany | #35 |
| feno lung function | #35 |
| prevalence childhood asthma | #36 |
| exposure genetic | #36 |
| skin test reactivity | #36 |
| maternal vitamin intake | #36 |
| maternal exposures | #36 |
| 16s rrna data | #36 |
| chapter 1 epidemiology | #36 |
| asthma dendritic cells | #36 |
| tolerance biomarkers | #36 |
| leipzig | #36 |
| 1 stimulation | #36 |
| nasal samples | #37 |
| native milk | #37 |
| lifestyle environment | #37 |
| case status | #37 |
| ril33 | #37 |
| 8263 | #37 |
| earlylife exposures | #37 |
| allemagne | #37 |
| asthma candidate | #37 |
| incidence persistence | #37 |
| reverse causation | #38 |
| amish | #38 |
| recurrence risk factors | #38 |
| life increased | #38 |
| nps npsr1 | #38 |
| wisc | #38 |
| mouse model asthma | #38 |
| foxp3 levels | #38 |
| allergy birth | #38 |
| asthma allergens | #38 |
| itchy | #38 |
| atopy prevalence | #38 |
| development allergic | #38 |
| dust asthma | #38 |
| endotoxin asthma | #38 |
| association ndvi | #38 |
| eczema environmental | #38 |
| ormdl3 expression | #38 |
| maximum expiratory flow | #38 |
| innate immunity genes | #38 |
| asthma cough | #38 |
| maternal health pregnancy | #39 |
| genetic rhinitis | #39 |
| haploview | #39 |
| protect children | #39 |
| c589 | #39 |
| traffic asthma | #39 |
| levels house | #39 |
| adulthood risk factors | #39 |
| seasonal perennial | #39 |
| ige switching | #39 |
| polymorphisms asthma | #39 |
| allergic symptoms children | #39 |
| diversity environmental | #39 |
| degradation patients | #39 |
| wheezing phenotypes | #39 |
| igg nglycosylation | #39 |
| preschool conjunctivitis | #40 |
| crosssectional studies | #40 |
| isolated polysaccharides | #40 |
| transcription 6 | #40 |
| antibiotics development | #40 |
| 4606 | #40 |
| symptoms allergic | #40 |
| biodiversity health | #40 |
| mite exposure | #40 |
| children bronchial | #40 |
| animal farms | #40 |
| eczema | #40 |
| discotheques | #41 |
| german cities | #41 |
| risk factors health | #41 |
| allergens age | #41 |
| farm residence | #41 |
| treg cells patients | #41 |
| asthma wheeze | #41 |
| eczema phenotypes | #41 |
| effects asthma | #41 |
| small airway dysfunction | #41 |
| stress young | #41 |
| allergic child | #41 |
| microbiome data | #42 |
| dust female | #42 |
| bronchiale | #42 |
| onset year | #42 |
| food questionnaire | #42 |
| 95 antibiotics | #42 |
| international patterns | #42 |
| pcdh1 | #42 |
| polymorphism single nucleotide | #42 |
| treg th17 cells | #43 |
| sensitized subjects | #43 |
| dermatitis food | #43 |
| subspecies infantis | #43 |
| worldwide variations | #43 |
| asthma food | #43 |
| time asthma | #43 |
| increased regulatory | #43 |
| asthma onset | #43 |
| diseases childhood | #44 |
| national institute allergy | #44 |
| work overload | #44 |
| developing countries children | #44 |
| atopic diseases asthma | #44 |
| microbiome asthma | #44 |
| increased risk symptoms | #44 |
| wide variations | #44 |
| cells cord | #44 |
| sequential switching | #44 |
| 97th | #44 |
| prevalence symptoms | #44 |
| asthma cystic fibrosis | #44 |
| atp2a3 | #44 |
| early childhood infections | #44 |
| followup physical activity | #44 |
| asthma food allergy | #44 |
| facklamia | #44 |
| gsdma | #44 |
| biodiversity hypothesis | #45 |
| questionnaire responses | #45 |
| severe atopic eczema | #45 |
| exposure early life | #45 |
| antiasthma drugs | #45 |
| fever 95 | #45 |
| dust endotoxins | #45 |
| birth 12 months | #45 |
| bamse | #45 |
| phenotype respiratory | #45 |
| animals pregnancy | #45 |
| 7445 | #45 |
| sensitization inhalant | #45 |
| traffic exposure | #45 |
| asthma cluster | #46 |
| prevalence diseases | #46 |
| adolescence differences | #46 |
| improvement reduction | #46 |
| evidence gene | #46 |
| atopic diseases children | #46 |
| farm animal | #46 |
| prevalence bhr | #46 |
| prevalence current wheeze | #46 |
| receptor tolllike receptors | #46 |
| asthma gwas | #46 |
| spt reactivity | #46 |
| humans hygiene | #46 |
| control physical | #46 |
| children atopic disease | #47 |
| germany east | #47 |
| 95 eczema | #47 |
| prevalence rhinoconjunctivitis | #47 |
| tirana | #47 |
| international study | #47 |
| efraim | #47 |
| factors asthma | #47 |
| wheeze phenotypes | #47 |
| franche | #47 |
| analysis step | #47 |
| breath volatile | #48 |
| asthma biological | #48 |
| airways diseases | #48 |
| frequent wheeze | #48 |
| perennial allergens | #48 |
| wheeze age | #48 |
| cluster children | #48 |
| polymorphisms il4 | #48 |
| asthma adjusted | #48 |
| lung function spirometry | #48 |
| doctordiagnosed asthma | #48 |
| prevalences asthma | #48 |
| halle | #48 |
| asthma risk loci | #48 |
| fungal flora | #48 |
| parental interviews | #48 |
| children paracetamol | #49 |
| n228 | #49 |
| risk factors incidence | #49 |
| fcer1a | #49 |
| milk farm | #49 |
| children female humans | #49 |
| chromosome susceptibility | #49 |
| pcrsscp | #50 |
| exposures asthma | #50 |
| longum subsp infantis | #50 |
| background atopic | #50 |
| diversity food | #50 |
| unpasteurized milk | #50 |
| bacterial markers | #50 |
| beta13glucans | #50 |
| physiciandiagnosed | #50 |
| maintenant | #51 |
| asthma dust | #51 |
| children cities | #51 |
| common chronic disease | #51 |
| allergy symptoms | #51 |
| identified polymorphisms | #51 |
| populationattributable risk | #51 |
| association atopic dermatitis | #51 |
| conjugated mice mice | #51 |
| igg1 igg4 | #51 |
| lwoffii | #51 |
| asthma maternal | #51 |
| microbial burden | #51 |
| country prevalence | #51 |
| association allergic | #51 |
| geneenvironment interactions | #52 |
| itchy rash | #52 |
| doctor diagnosis | #52 |
| infant study | #52 |
| epidemiologischen | #52 |
| eczema childhood | #52 |
| indoor endotoxin | #52 |
| ige sige | #52 |
| sensitization children | #52 |
| specific protective | #52 |
| milk consumption | #52 |
| 9357 | #52 |
| wheeze cough | #52 |
| prevalence wheeze | #52 |
| gpra | #52 |
| age wheezing | #52 |
| bmi asthma | #52 |
| children current asthma | #53 |
| atopic eczema children | #53 |
| life exposure | #53 |
| 2q32 | #53 |
| ige children | #53 |
| early life exposure | #53 |
| il13 gene | #53 |
| outdoor pollution | #53 |
| adam33 asthma | #53 |
| asthma odds | #54 |
| female germany life | #54 |
| estonian children | #54 |
| nonmicrobial | #54 |
| cross sectional studies | #54 |
| animals asthma | #54 |
| male prevalence | #54 |
| prevalence wheezing | #54 |
| year asthma | #55 |
| prevalence association | #55 |
| bacterial microbiota | #55 |
| cough wheeze | #55 |
| stepwise procedure | #55 |
| samples farm | #55 |
| visible mold | #56 |
| asthma atopy | #56 |
| adult asthma patients | #56 |
| random samples | #56 |
| strong protective | #56 |
| atopy development | #56 |
| maternal ige | #56 |
| immunoglobulin interleukin13 | #56 |
| alex study | #56 |
| tuberculosis notification | #56 |
| cd14 tolllike receptor | #56 |
| asthma allergic rhinoconjunctivitis | #57 |
| 3785 | #57 |
| prevention allergic | #57 |
| atopy wheeze | #57 |
| member 1 polymorphism | #57 |
| eczema flg | #57 |
| mononuclear lipid | #57 |
| pollutant exposure | #57 |
| mef50 | #57 |
| adam33 polymorphisms | #57 |
| diseases methods | #57 |
| derp1 | #57 |
| life atopic dermatitis | #57 |
| early asthma | #58 |
| total serum | #58 |
| diseases children | #58 |
| hypersensitivity immunoglobulin | #58 |
| reported parents | #58 |
| specificity asthma | #58 |
| stat6 gene | #58 |
| eczema female | #58 |
| asthma morbidity children | #59 |
| th17 lineage | #59 |
| german participants | #59 |
| finland estonia | #59 |
| milk cla | #59 |
| 6 years age | #59 |
| 1q31 | #59 |
| farm families | #59 |
| predictors incidence | #60 |
| beta 2agonists | #60 |
| iedap | #60 |
| birth school age | #60 |
| allergic surveys | #60 |
| development childhood | #60 |
| rna yield | #60 |
| preschool wheezing | #60 |
| breastfed children | #61 |
| exposure asthma | #61 |
| species colonization | #61 |
| seasonal skin tests | #61 |
| atopy eczema | #61 |
| implicated genes | #61 |
| large german | #62 |
| estonia finland | #62 |
| persistence asthma | #62 |
| life immune | #62 |
| respiratory sounds | #62 |
| childhoodonset asthma | #62 |
| asthma birth | #62 |
| immunoglobulin infant | #62 |
| development airway hyperresponsiveness | #62 |
| endotoxin level | #63 |
| exposure assessed | #63 |
| asthma breast | #63 |
| indoor allergen exposure | #63 |
| dermatitis risk | #63 |
| children role | #63 |
| cystic fibrosis abpa | #63 |
| children regions | #63 |
| atopic | #63 |
| total quantity | #63 |
| hyperreactivity bronchial | #63 |
| children centers | #64 |
| no2 benzene | #64 |
| helminth ascariasis ascaris | #64 |
| newborn lymphocyte | #64 |
| differential networks | #64 |
| allergenspecific ige | #64 |
| dust parameters | #64 |
| risk wheezing | #65 |
| animal contact | #65 |
| healthy controls children | #65 |
| childhood allergic diseases | #65 |
| dust extracts | #66 |
| preschool haemophilus humans | #66 |
| prevalence current asthma | #66 |
| allergic rhinitis age | #66 |
| sensitization allergic | #66 |
| atopic symptoms | #66 |
| umc | #66 |
| living area | #66 |
| immunological data | #66 |
| ga²len | #66 |
| biomarkers predictors | #67 |
| maternal atopy | #67 |
| respiratory allergies | #67 |
| ige expression | #67 |
| 2 questionnaires | #67 |
| pa obesity | #67 |
| antibiotic sales | #68 |
| weight boys | #68 |
| mère | #68 |
| early wheeze | #68 |
| ige allergens | #69 |
| hypersensitivity immunization | #70 |
| asthma complex | #70 |
| atopic disease children | #70 |
| sod3 | #70 |
| suisse | #70 |
| allergic disorders | #70 |
| gene gene interaction | #70 |
| prenatal vitamin | #71 |
| tlr2 tlr1 | #71 |
| small airway function | #71 |
| unprocessed | #71 |
| allergic sensitization children | #71 |
| barns | #71 |
| breathomics | #71 |
| atopic rhinitis | #71 |
| occurrence progression | #71 |
| 158 95 | #72 |
| factor asthma | #72 |
| children wheeze | #72 |
| persistent asthma children | #72 |
| molecular fingerprinting | #72 |
| infantis | #72 |
| association occupational exposure | #72 |
| gni | #73 |
| ormdl3 | #73 |
| sounds respiratory | #73 |
| onset allergic | #73 |
| european ancestry association | #73 |
| food allergy asthma | #74 |
| risk wheeze | #74 |
| west humans | #74 |
| health services children | #74 |
| severe eczema | #74 |
| exposure europe | #74 |
| children hrqol | #75 |
| maternal immunity | #75 |
| rfel | #75 |
| standardized procedure | #75 |
| asthmatic mothers | #75 |
| chromosome 17q21 | #75 |
| asthma genome | #75 |
| total serum ige | #75 |
| microbial molecules | #76 |
| symptoms eczema | #76 |
| rural differences | #76 |
| wheezing | #76 |
| eczema children | #76 |
| asthma case | #76 |
| allergy childhood | #76 |
| food inhalant | #76 |
| hyperresponsiveness bhr | #77 |
| diversity microbial | #77 |
| asthma healthy | #77 |
| sexspecific association | #77 |
| 9 mmp9 | #77 |
| mothers asthma | #78 |
| edta tubes | #78 |
| years odds | #78 |
| childhood | #78 |
| turkish origin | #78 |
| rhinitis atopic | #78 |
| blood cytokines | #78 |
| sensitisation children | #78 |
| findings prevalence | #78 |
| 6399 | #78 |
| wheezing illnesses | #78 |
| seasonal asthma | #79 |
| genes innate immunity | #79 |
| 95 protection | #79 |
| milk yoghurt | #79 |
| neuropeptide receptor | #79 |
| interactions snps | #79 |
| ige skin | #80 |
| cats child | #80 |
| dander | #80 |
| microbial agents | #81 |
| lower prevalence | #81 |
| prevalence respiratory | #81 |
| symptoms 12 | #81 |
| forkhead box protein | #81 |
| development atopic dermatitis | #81 |
| childhood wheeze | #81 |
| age 45 | #82 |
| laryngitis | #82 |
| concentrations so2 | #82 |
| introduction solids | #82 |
| age prevalence | #82 |
| bacterial viral infections | #82 |
| children european | #82 |
| 13 14 | #82 |
| ribosomal pcr | #82 |
| microbial stimulation | #83 |
| total fat content | #83 |
| study pcr | #83 |
| cleanliness | #83 |
| reporter genetic predisposition | #83 |
| gut commensals | #83 |
| study population patients | #83 |
| hypersensitivity risk | #83 |
| current wheezing | #83 |
| children siblings | #83 |
| 4732 | #84 |
| oligoarticular juvenile | #84 |
| tests child | #84 |
| control pa | #84 |
| new asthma | #84 |
| specific exposures | #84 |
| européenne | #85 |
| α1 antitrypsin | #85 |
| atopy risk | #85 |
| n134 | #85 |
| single nucleotide rna | #85 |
| bronchial responsiveness | #85 |
| wheeze prevalence | #86 |
| bifidobacterium species | #86 |
| comté | #86 |
| children feeding | #86 |
| infant inflammation | #86 |
| ige levels | #86 |
| truck traffic | #86 |
| hyper responsiveness | #86 |
| arabinogalactan | #86 |
| influential factors | #87 |
| exposure associations | #87 |
| 95 fever | #87 |
| genes asthma | #87 |
| age asthma | #87 |
| visits asthma | #87 |
| analysis respiratory | #87 |
| tolllike receptors tlrs | #88 |
| exposure tobacco smoke | #88 |
| asthma polymorphisms | #88 |
| rhinitis risk | #88 |
| pollution allergens | #88 |
| allergy tests | #88 |
| aged 6 | #89 |
| asthma children | #89 |
| bronchial hyper | #89 |
| rphl | #89 |
| asthma phenotypes | #89 |
| allergic seasonal surveys | #90 |
| critical time window | #90 |
| current exposure | #90 |
| children area | #90 |
| newborn leukocytes | #91 |
| joint workshop | #91 |
| development eczema | #91 |
| filaggrin mutations | #91 |
| newborn limit | #91 |
| asthma school | #91 |
| sensitisation | #92 |
| mononuclear polymorphism | #92 |
| preschool haemophilus | #93 |
| low levels exposure | #93 |
| experimental asthma | #93 |
| previous studies association | #93 |
| south germany | #93 |
| rs2305480 | #93 |
| east west germany | #93 |
| geführt | #93 |
| allergic rhinitis symptoms | #93 |
| zpbp2 | #94 |
| pertussis infection | #94 |
| tregulatory cells | #94 |
| fed children | #95 |
| eczema symptoms | #95 |
| asthma loci | #95 |
| 16q12 | #95 |
| greater consumption | #95 |
| university life | #95 |
| expression toll | #95 |
| nickel allergy | #95 |
| asthma common | #95 |
| international variation | #95 |
| allergic sensitisation | #96 |
| trigger factors | #96 |
| nonfarmers | #96 |
| dysbalance | #96 |
| onset wheeze | #96 |
| dust environmental | #96 |
| airway dysfunction | #96 |
| lps recognition | #96 |
| cumulative prevalence | #96 |
| expression th1 | #96 |
| anaphylaxie | #96 |
| inhalant allergens | #97 |
| schoolchildren aged | #97 |
| city air | #97 |
| indoor factors | #97 |
| 95 overweight | #97 |
| regulatory treg | #97 |
| tlr1 tlr2 | #98 |
| children germany | #98 |
| seasonal sensitivity | #98 |
| age 3 years | #98 |
| factors school | #98 |
| childhood adulthood | #98 |
| background asthma | #98 |
| rural school | #99 |
| eastern germany | #99 |
| asthma inflammation | #99 |
| seasonal surveys | #99 |
| earlyonset asthma | #99 |
| current wheeze | #99 |
| children atopic | #99 |
| comprehensive questionnaire | #99 |
| years aor | #99 |
| isaac questionnaire | #100 |
| childhood atopic dermatitis | #100 |
| preschool crosssectional studies | #100 |
| genetic factors susceptibility | #101 |
| summarised | #101 |
| raw cow | #101 |
| mef25 | #101 |
| weight girls | #101 |
| expression measurements | #101 |
| retinoid acid | #102 |
| effects respiratory | #102 |
| tenascin tnc | #102 |
| factors wheezing | #102 |
| risk factors persistence | #102 |
| ige concentrations | #102 |
| hdm exposure | #103 |
| children increased risk | #103 |
| 4264 | #103 |
| sensitization eczema | #103 |
| years early | #103 |
| irf1 gene | #103 |
| sensitization childhood | #104 |
| children relation | #104 |
| exposure milk | #104 |
| pollen concentration | #105 |
| high‐sensitivity | #105 |
| arabinogalactans | #105 |
| hyperreactivity | #105 |
| hutterites | #105 |
| blood ige | #106 |
| wheezing disorders | #106 |
| children contact | #106 |
| physiciandiagnosed asthma | #106 |
| prevalence atopy | #106 |
| questionnaires switzerland | #106 |
| animal dander | #106 |
| puberty age | #107 |
| underlying factor | #107 |
| socs4 | #107 |
| detailed questionnaire | #107 |
| inverse associations | #108 |
| overweight 95 | #108 |
| breast feeding | #108 |
| fever episodes | #108 |
| allergic perennial rhinitis | #109 |
| healthy children children | #109 |
| publication air pollution | #109 |
| air pollution children | #109 |
| moulds | #109 |
| complex syndrome | #109 |
| asthma wheezing | #109 |
| genotype germany | #110 |
| folgenden | #110 |
| p≤003 | #110 |
| atopic eczema humans | #110 |
| female germany | #110 |
| rs7216389 | #110 |
| il4ra | #111 |
| parental questionnaire | #111 |
| environmental study | #112 |
| female histones | #112 |
| 1314 | #112 |
| tbox transcription factor | #112 |
| olive pollen | #112 |
| milk samples | #112 |
| allergic | #113 |
| risk allergic | #113 |
| experimental allergic asthma | #113 |
| indoor asthma | #113 |
| flg variants | #113 |
| phenotypes asthma | #113 |
| occupational allergy | #114 |
| tests bronchial | #114 |
| asthma sensitization | #114 |
| parent reported | #114 |
| mould exposure | #114 |
| allergic disease | #114 |
| challenge data | #114 |
| cord blood ige | #115 |
| igg4 responses | #115 |
| cough children | #115 |
| increased diversity | #115 |
| foxp3 locus | #115 |
| notification rates | #115 |
| regulatory th17 | #116 |
| exclusive breast feeding | #116 |
| aged 9 | #116 |
| immune responsiveness | #116 |
| psychosocial characteristics | #117 |
| children underwent | #117 |
| glutathione transferase gst | #117 |
| living rural | #118 |
| allergic sensitization | #118 |
| west germany | #118 |
| indoor microbial | #118 |
| skinprick tests | #118 |
| ratio prevalence | #118 |
| germany humans | #118 |
| reference children | #118 |
| ancestry asthma | #119 |
| delayed introduction | #119 |
| skin prick | #119 |
| switching immunoglobulin | #119 |
| children wheezing | #119 |
| association chromosome | #120 |
| environment children | #120 |
| fibrolysis | #120 |
| childhood risk factors | #120 |
| levels endotoxin | #120 |
| dampness | #121 |
| aliments | #121 |
| symptom control | #121 |
| vitamin supplementation pregnancy | #121 |
| allergens asthma | #121 |
| lung function measurements | #121 |
| factors rural | #121 |
| common aeroallergens | #121 |
| 300 people | #122 |
| life early | #122 |
| preventive potential | #122 |
| tlr10 | #122 |
| frequency pattern | #123 |
| hayfever | #123 |
| urban traffic | #123 |
| germany prevalence | #124 |
| passive smoke exposure | #124 |
| atopic manifestations | #124 |
| severe eosinophilic asthma | #124 |
| active asthma | #124 |
| potted plants | #125 |
| immunologic tolllike receptor | #125 |
| common inhalant | #125 |
| il18r1 | #125 |
| sensitization development | #126 |
| eczema patients | #126 |
| 3 infections | #126 |
| paediatric studies | #126 |
| prevalence allergic diseases | #126 |
| asthma background | #126 |
| await | #126 |
| exposure pets | #126 |
| effects prevalence | #126 |
| 95 ors | #127 |
| allergens child | #127 |
| adaptive cells | #127 |
| exposure endotoxin | #127 |
| environmental allergens | #127 |
| caspase recruitment domain | #127 |
| parent questionnaire | #127 |
| prävalenz | #127 |
| test reactivity | #127 |
| bdnf polymorphisms | #128 |
| microbial markers | #129 |
| receptors male | #129 |
| bdnf gene | #129 |
| medall | #130 |
| common allergens | #131 |
| severe eosinophilic | #131 |
| protein allergy | #131 |
| hypersensitivity respiratory | #131 |
| test study | #131 |
| sensitization allergens | #131 |
| factors allergens | #131 |
| asthma objective | #131 |
| respiratory symptoms children | #131 |
| male occupational | #132 |
| immunoglobulin inflammation | #132 |
| effects development | #132 |
| diseases asthma | #132 |
| expression receptors | #132 |
| asthma adolescent | #132 |
| age 7 | #133 |
| bavaria | #133 |
| pollen prevalence | #133 |
| understanding natural | #133 |
| early age | #133 |
| dpp10 | #134 |
| 7 years age | #134 |
| allergy | #134 |
| body composition bmi | #135 |
| childhood risk | #135 |
| prevalence rhinitis | #135 |
| crth2 | #135 |
| 95 ages | #135 |
| 60 iu | #136 |
| eczema risk | #136 |
| bronchial response | #136 |
| allergic phenotype | #136 |
| asthma young | #136 |
| ga2len | #137 |
| snps asthma | #137 |
| 6 7 | #137 |
| exposure children | #137 |
| ms4a2 | #137 |
| mechanisms asthma | #137 |
| actinomycetes | #137 |
| régions | #138 |
| asthma development | #138 |
| pollutants allergens | #138 |
| snps interactions | #138 |
| mattress | #138 |
| asthma atopic dermatitis | #138 |
| reduced prevalence | #138 |
| sensitized children | #138 |
| pollution asthma | #139 |
| 3 14 | #139 |
| serum ige | #139 |
| milk animals | #139 |
| allergen levels | #139 |
| sebacate | #139 |
| listeria spp | #139 |
| exposure symptoms | #140 |
| tregs foxp3 | #140 |
| duration type | #140 |
| pasture | #140 |
| microbiota children | #140 |
| largest reduction | #140 |
| age 6 years | #141 |
| asthma genes | #141 |
| exposure indoor | #141 |
| questionnaires illness surveys | #142 |
| indoor allergens | #142 |
| asthma bronchitis | #142 |
| factors difference | #142 |
| cla content | #142 |
| susceptibility children | #142 |
| n183 | #142 |
| unifrac | #143 |
| pregnancy early | #143 |
| pet exposure | #144 |
| exposure year | #144 |
| inconclusive | #144 |
| snps chromosome | #144 |
| asthma defined | #144 |
| replication association | #144 |
| incident asthma | #144 |
| onset menarche | #145 |
| children allergy | #145 |
| dermatitis asthma | #145 |
| expositions | #145 |
| prematurely born children | #146 |
| interleukin13 interleukin4 | #146 |
| lower airways | #146 |
| prevalence skin | #146 |
| allergy testing | #146 |
| airway mechanics | #146 |
| health outcomes children | #146 |
| original article | #147 |
| study centers | #147 |
| biomarkers child | #147 |
| children 6 | #148 |
| association early | #148 |
| feno patients | #148 |
| germany west | #148 |
| indoor allergen | #149 |
| early immune | #149 |
| atopic outcomes | #149 |
| fall fev1 | #150 |
| perennial rhinitis allergic | #150 |
| pregnancy respiratory | #150 |
| 105 years | #151 |
| profound differences | #151 |
| wheeze children | #151 |
| prevalence childhood | #151 |
| confer protection | #151 |
| wheezing children | #151 |
| exposure increased | #152 |
| children review | #152 |
| distribution asthma | #152 |
| immunomodulatory molecules | #152 |
| established asthma | #152 |
| bhr | #152 |
| consumption dairy products | #152 |
| environmental exposure | #152 |
| asthma dermatitis | #153 |
| common respiratory | #153 |
| tagging single | #153 |
| wheeze asthma | #153 |
| hens egg | #153 |
| function measurements | #153 |
| cd28null | #154 |
| hormonal factors | #154 |
| neighboring countries | #155 |
| tests sex factors | #155 |
| onset association | #155 |
| bronchial challenge | #155 |
| association asthma | #156 |
| atopic children | #156 |
| development allergy | #157 |
| neu5gc | #157 |
| absolute levels | #157 |
| severity frequency | #157 |
| gene 3 | #157 |
| positive spt | #157 |
| paediatric asthma | #158 |
| lower diversity | #158 |
| asthma females | #158 |
| early environmental | #158 |
| bacterial lysates | #158 |
| children asthma | #159 |
| prevention allergy | #159 |
| patients controlled asthma | #159 |
| developing immune | #159 |
| allergic seasonal | #160 |
| reported prevalence | #160 |
| microbiome diversity | #160 |
| children homes | #160 |
| spts | #160 |
| children rhinitis | #160 |
| german adults | #160 |
| atopy asthma | #161 |
| newborn longitudinal | #161 |
| preventive measure | #161 |
| wheeze rhinitis | #161 |
| asthma presence | #161 |
| immune pathways | #162 |
| parental asthma | #162 |
| children lower | #162 |
| female humans allergic | #162 |
| perennial rhinitis | #163 |
| environmental associations | #163 |
| exposure prevalence | #163 |
| specific ige | #163 |
| sscp | #164 |
| sensitised | #164 |
| kindl | #164 |
| atopic dermatitis | #165 |
| atopic eczema | #165 |
| children sensitized | #165 |
| asthma ige | #165 |
| epidemiologie | #166 |
| 5q31 | #166 |
| illness surveys questionnaires | #166 |
| ige asthma | #166 |
| feeding child | #166 |
| infant respiratory | #166 |
| studies exposure | #167 |
| preadolescent children | #167 |
| adolescent allergens | #167 |
| disease life | #167 |
| preschool cross | #167 |
| air pollutant concentrations | #167 |
| year children | #168 |
| years lung | #168 |
| current asthma | #168 |
| stratification patients | #169 |
| regulatory treg cells | #169 |
| 2688 | #169 |
| workplace young | #169 |
| airway size | #169 |
| chronic inflammatory disease | #170 |
| inhalant | #171 |
| adolescent analysis | #171 |
| sensitization pollen | #171 |
| nucleotide rna | #171 |
| aged 13 | #171 |
| endotoxins female | #172 |
| nucleotide pregnancy | #172 |
| studien | #172 |
| ifnγ levels | #172 |
| prevalence current | #172 |
| skin prick test | #172 |
| sheds | #172 |
| unifying concept | #173 |
| risk score model | #173 |
| risk atopy | #174 |
| antipyretics | #174 |
| female humans questionnaires | #175 |
| small airway | #175 |
| mice asthma | #175 |
| patients nocturnal | #175 |
| school level | #176 |
| asthma attack | #176 |
| serine protease inhibitor | #176 |
| repeated infections | #176 |
| sensitization common | #176 |
| sensitization pattern | #177 |
| wheezers | #177 |
| life respiratory function | #177 |
| situ hybridization infant | #177 |
| 9p24 | #178 |
| genetic severity | #178 |
| childhood infections | #178 |
| aa patients | #178 |
| sensitization asthma | #178 |
| sputum neutrophils | #179 |
| studies environmental | #179 |
| traffic characteristics | #179 |
| childhood adolescence | #179 |
| standardized methodology | #179 |
| nocturnal asthma | #179 |
| objective measurements | #179 |
| w12 | #179 |
| socks | #180 |
| asthma genetic | #180 |
| breastfed infant | #180 |
| children environmental | #181 |
| environmental predictors | #181 |
| bacterial count | #181 |
| mattresses | #181 |
| lung function testing | #181 |
| dermatitis children | #182 |
| vitamin asthma | #182 |
| immunemediated diseases | #182 |
| dust levels | #182 |
| differences hrqol | #182 |
| children levels | #183 |
| environmental microbiology | #183 |
| vocational training | #183 |
| german population | #183 |
| exposure humans | #183 |
| mögliche | #183 |
| tlr signaling | #183 |
| life prevalence | #185 |
| school district | #185 |
| incidence allergic | #185 |
| work asthma | #186 |
| protein child | #187 |
| asthma body | #188 |
| selfselection | #188 |
| development allergic disease | #188 |
| tests children | #188 |
| childhood early adulthood | #188 |
| qpcrs | #188 |
| environmental exposures | #188 |
| jf1 | #189 |
| tlr genes | #189 |
| type duration | #190 |
| early wheezing | #190 |
| inversely | #190 |
| bacterial groups | #190 |
| muscle mass patients | #190 |
| wheezing age | #190 |
| association antibiotic | #190 |
| mother pregnancy | #190 |
| blood gene | #191 |
| cd14 gene | #191 |
| dry cough | #191 |
| atopic dermatitis children | #191 |
| longum subsp | #192 |
| pyroglyphidae | #192 |
| adjusted irr | #192 |
| cε | #193 |
| adam33 | #193 |
| milk serum | #193 |
| model allergic | #193 |
| prevalence severity | #195 |
| eosinophilic asthma | #195 |
| estonian | #195 |
| caspase recruitment | #196 |
| germany switzerland | #197 |
| enthusiasm | #197 |
| review asthma | #197 |
| questionnaire data | #198 |
| earlylife | #198 |
| decreased prevalence | #199 |
| representative population | #199 |
| rhinitis eczema | #199 |
| upper lower airways | #200 |
| complex interplay | #202 |
| bacteria role | #202 |
| allergy infectious diseases | #202 |
| paediatrician | #203 |
| patients europe | #203 |
| bronchial hyperresponsiveness bhr | #203 |
| difference prevalence | #204 |
| phenotyped | #204 |
| patients aa | #204 |
| amebocyte | #205 |
| new locus | #205 |
| dermatitis atopic | #205 |
| 13 years age | #205 |
| 3034 | #206 |
| allergen specific | #206 |
| asthma methods | #207 |
| asthma respiratory symptoms | #207 |
| factors atopy | #207 |
| diagnosed asthma | #208 |
| studies germany | #208 |
| karelia | #208 |
| allergic asthmatics | #208 |
| male phenotype | #208 |
| newborn logistic | #209 |
| higher diversity | #209 |
| studies cytokines | #209 |
| glycolylneuraminic acid | #209 |
| innate adaptive immunity | #209 |
| col4a3 | #209 |
| sensitization age | #209 |
| prevalence obesity | #209 |
| bronchial provocation | #210 |
| symptoms children | #210 |
| epithelial barrier function | #210 |
| core microbiome | #210 |
| bhr asthma | #210 |
| cats dogs | #211 |
| low prevalence | #211 |
| influence development | #211 |
| exposure sensitization | #211 |
| methodssubjects | #212 |
| birth 6 | #212 |
| asthma animals | #212 |
| asthma allergic | #212 |
| tlr4 cd14 | #212 |
| atopic dermatitis asthma | #212 |
| patients uncontrolled asthma | #213 |
| distinct clusters | #213 |
| 1872 | #213 |
| cohort methods | #213 |
| exposure allergens | #213 |
| reverse causality | #214 |
| workplace exposure | #214 |
| asthma allergic diseases | #214 |
| prevalence allergic | #214 |
| expression cd14 | #214 |
| 00035 | #214 |
| rural environment | #214 |
| life allergic | #215 |
| mast cell chymase | #216 |
| regulatory responses | #216 |
| obesity overweight | #216 |
| atopic female | #218 |
| il2rb | #218 |
| microbial products | #219 |
| geneticist | #219 |
| child dna | #219 |
| causation | #219 |
| disinfectants | #219 |
| steiner | #220 |
| allergy development | #220 |
| variants asthma | #220 |
| pierced | #220 |
| homogenised | #221 |
| schistosoma schistosomiasis | #221 |
| method participants | #221 |
| 90 children | #222 |
| increased asthma | #222 |
| sensitization rates | #222 |
| symptoms baseline | #223 |
| environmental epidemiology | #223 |
| groups asthma | #224 |
| sibship size | #225 |
| german study | #225 |
| sensitization allergen | #226 |
| german | #226 |
| alpha1 antitrypsin | #226 |
| conjunctivitis allergic | #226 |
| provocative concentration | #227 |
| school age | #227 |
| data asthma | #228 |
| allergic diseases asthma | #228 |
| lung health | #228 |
| 95 obesity | #228 |
| specific stimulation | #228 |
| test spt | #228 |
| tuberculosis prevalence | #229 |
| understanding asthma | #229 |
| road traffic | #229 |
| healthy worker | #229 |
| wheezing asthma | #229 |
| asthma allergic rhinitis | #230 |
| butyryl | #230 |
| umwelt | #230 |
| cord blood cells | #230 |
| asthma phenotype | #230 |
| allergy prevention | #231 |
| cord blood cb | #231 |
| subgroup children | #232 |
| nonallergic asthma | #232 |
| living conditions | #232 |
| discontent | #232 |
| health variables | #232 |
| 20 fall | #232 |
| innate leukocytes | #233 |
| lively | #233 |
| prevalence overweight | #233 |
| hyperreactive | #234 |
| complementary food | #234 |
| dermatophagoides pteronyssinus | #234 |
| fourth grade | #235 |
| n144 | #235 |
| specific allergen | #236 |
| resequenced | #236 |
| exposure pregnancy | #236 |
| levels asthma | #236 |
| finland france | #238 |
| puberty girls | #238 |
| incidence asthma | #239 |
| strategies prevention | #239 |
| neutrophilic asthma | #240 |
| preschool cytokines | #241 |
| regulatory th1 | #242 |
| immune development | #243 |
| age exposure | #243 |
| th2 immunity | #243 |
| receptor 1 | #245 |
| adjusted odds ratio | #245 |
| adaptor protein polymorphism | #245 |
| muropeptides | #246 |
| fungal dna ribosomal | #246 |
| fever asthma | #247 |
| prick test | #247 |
| nasal microbiota | #247 |
| role development | #247 |
| patients healthcare | #248 |
| children analysis | #248 |
| class analysis | #249 |
| factors allergic | #249 |
| baseline incidence | #249 |
| clinical science | #250 |
| therapy severe | #250 |
| biological therapy | #251 |
| tlr2 gene | #251 |
| communism | #252 |
| asthma symptoms | #253 |
| china factors | #253 |
| contact animals | #253 |
| cold air | #253 |
| hormonal influences | #254 |
| lowgrade inflammation | #255 |
| atopic disease | #255 |
| preschool dermatitis | #256 |
| h4 acetylation | #256 |
| low pa | #256 |
| 454pyrosequencing | #257 |
| body mass children | #257 |
| adolescent asthma | #257 |
| human asthma | #257 |
| association expression | #258 |
| niaid | #258 |
| epidemiological studies | #259 |
| airborne fungi | #259 |
| prediction quality | #259 |
| age 6 | #260 |
| life asthma | #260 |
| exposure early | #260 |
| rhinitis allergic | #260 |
| 2051 | #260 |
| life symptoms | #260 |
| eczema atopic | #261 |
| early life | #261 |
| westernization | #261 |
| discriminate | #261 |
| interferon expression | #262 |
| spink5 | #262 |
| utilization health services | #262 |
| alpha1antitrypsin | #263 |
| milk pregnancy | #263 |
| physician diagnosed | #263 |
| development immune | #263 |
| protein 15 | #263 |
| children associations | #264 |
| exposure traffic | #265 |
| latex sensitization | #265 |
| indoor exposures | #265 |
| tightly linked | #265 |
| nox concentrations | #266 |
| increase asthma | #266 |
| early work | #267 |
| settled dust | #267 |
| age 13 years | #267 |
| pollen sensitization | #268 |
| fever children | #269 |
| rhinitis | #269 |
| prick | #269 |
| symptom prevalence | #270 |
| allergen extracts | #270 |
| hypersensitivity immune | #270 |
| conditions asthma | #271 |
| child chromosomes | #272 |
| relation body mass | #272 |
| dipeptidyl peptidases | #273 |
| study centres | #273 |
| objective markers | #274 |
| asthma control patients | #274 |
| inflammatory properties | #275 |
| exposure female | #276 |
| host microbiome | #276 |
| future asthma | #277 |
| extracellular polysaccharides | #277 |
| dust samples | #277 |
| male microbiota | #277 |
| increased exposure | #278 |
| study birth | #279 |
| remedy | #280 |
| hire | #280 |
| tests allergens | #280 |
| questionnaires adolescent | #281 |
| adolescent animals | #282 |
| 6 years | #282 |
| allergies asthma | #282 |
| child dermatitis | #282 |
| randomeffects | #284 |
| collection methods | #284 |
| impulse oscillometry | #284 |
| 17 children | #285 |
| population burden | #285 |
| allergic symptoms | #286 |
| differences asthma | #287 |
| cells ilc2s | #287 |
| tests respiratory | #287 |
| geometric ratio | #288 |
| gg 95 | #288 |
| hdms | #289 |
| pollution air | #289 |
| epidemiological surveys | #289 |
| role asthma | #290 |
| risk factors children | #290 |
| data normalization | #290 |
| asthma increased | #291 |
| allergic manifestations | #291 |
| eczema food | #292 |
| asthma factors | #292 |
| recruitment domain | #293 |
| exposure environmental | #293 |
| answered | #293 |
| indoor exposure | #293 |
| environnement | #293 |
| allergic perennial | #293 |
| longitudinal cohort study | #293 |
| cohort participants | #293 |
| asthma data | #294 |
| cbmc | #294 |
| mucosal surfaces | #296 |
| pollution respiratory | #297 |
| smoke pollution | #297 |
| global synthesis | #298 |
| bifidobacterium | #298 |
| exposure benzene | #299 |
| unification | #299 |
| exposure allergic | #299 |
| paxgene | #299 |
| obesity asthma | #299 |
| nonatopic | #299 |
| infancy development | #300 |
| risk allergy | #303 |
| asthma drugs | #306 |
| analysis phase | #307 |
| reported association | #307 |
| lumbricoides | #307 |
| severe exacerbations | #308 |
| antigens dermatophagoides | #308 |
| exposure childhood | #309 |
| neonatal immune | #309 |
| messenger tlymphocytes | #309 |
| ige sensitization | #309 |
| mucosal microbiota | #309 |
| 2623 | #309 |
| factors early | #311 |
| controlled asthma | #311 |
| atopic march | #312 |
| midexpiratory | #312 |
| birth cohort studies | #312 |
| allergy age | #313 |
| asthma inflammatory | #313 |
| skin examination | #314 |
| signal transducer activator | #314 |
| variance animals antigens | #315 |
| jusqu | #315 |
| genotyping data | #315 |
| bacillus spores | #315 |
| independent study | #316 |
| 2 toll | #316 |
| older siblings | #317 |
| adjustment covariates | #318 |
| pregnancy expression | #318 |
| child comorbidity | #318 |
| compared children | #319 |
| fpr2 | #320 |
| bmi united states | #320 |
| il5 il13 | #320 |
| chronic airway inflammation | #321 |
| mfi20 | #321 |
| moisturizer | #323 |
| children birth | #324 |
| maximal expiratory | #325 |
| ige responses | #325 |
| airway hyperresponsiveness ahr | #326 |
| 2 yrs | #326 |
| stratified sample | #326 |
| ichthyosis vulgaris | #327 |
| flg mutations | #327 |
| bedrooms | #328 |
| selfadministered questionnaire | #328 |
| active smoking | #328 |
| recurrent wheeze | #328 |
| extracellular dna | #329 |
| male milk | #330 |
| glycolylneuraminic | #330 |
| floor dust | #331 |
| reference equations | #331 |
| dermatophagoides asthma | #331 |
| demethylation | #331 |
| pollutant levels | #331 |
| accuracy analysis | #331 |
| asthma biomarkers | #333 |
| onset asthma | #333 |
| streptococcaceae | #333 |
| upper respiratory | #334 |
| development sensitization | #334 |
| reduced lung function | #334 |
| children controls | #335 |
| asthma china | #336 |
| boluses | #336 |
| 1st year | #337 |
| prevalence surveys | #337 |
| predictive risk factors | #337 |
| risk current | #337 |
| childhood atopic | #338 |
| 3113 | #338 |
| risk eczema | #339 |
| respiratory outcomes | #339 |
| medical advice | #340 |
| asthma parents | #340 |
| exposure development | #341 |
| humans prevalence | #341 |
| adultonset asthma | #341 |
| filaggrin gene | #342 |
| persistent wheeze | #342 |
| kitchen | #342 |
| nonatopic asthma | #343 |
| age introduction | #343 |
| age 9 | #344 |
| breast fed | #345 |
| stat6 transcription | #346 |
| hypersensitivity | #346 |
| 90th | #348 |
| childhood onset | #349 |
| increasing prevalence | #350 |
| rates asthma | #350 |
| prevalence | #350 |
| exposed children | #350 |
| factors surveys | #351 |
| th1 th2 cells | #353 |
| activator transcription | #354 |
| repeated episodes | #356 |
| freeways | #358 |
| genetic interaction | #359 |
| purposepatients | #359 |
| kazal | #360 |
| regression approach | #360 |
| subsequent asthma | #360 |
| asthma disease | #361 |
| children cohort | #361 |
| eurotium | #361 |
| strength association | #361 |
| cord blood | #363 |
| age 3 | #363 |
| expression asthma | #363 |
| farming practices | #364 |
| allergic outcomes | #364 |
| food sensitization | #364 |
| annual concentrations | #365 |
| austria germany | #365 |
| children reported | #366 |
| chronic inflammatory disorders | #366 |
| lactadherin | #368 |
| atopic status | #369 |
| single snp | #370 |
| adolescent air | #370 |
| earlylife exposure | #370 |
| expression tlr2 | #370 |
| testing procedures | #371 |
| conclusionwe | #371 |
| 1159 | #371 |
| austria switzerland | #371 |
| time activity | #373 |
| east west | #373 |
| obesity prevalence | #373 |
| asthmatic symptoms | #374 |
| performance accuracy | #374 |
| paragraphs | #374 |
| asthma current | #374 |
| 22 countries | #374 |
| foxp3 tregs | #375 |
| smoking asthma | #375 |
| upper respiratory tract | #376 |
| asthma cases | #376 |
| cows milk | #377 |
| statistical approaches | #377 |
| positional cloning | #377 |
| associations exposure | #377 |
| population studies | #379 |
| mite allergens | #379 |
| parental reports | #379 |
| dietary strategies | #381 |
| pieces | #382 |
| inverse association | #383 |
| preschool cohort studies | #384 |
| measles vaccination | #384 |
| unifying | #384 |
| normal lung function | #385 |
| bronchial | #386 |
| latex | #386 |
| impaired lung function | #386 |
| chronic asthma | #386 |
| alliance | #388 |
| gene environment | #389 |
| allergie | #390 |
| haplotype analyses | #391 |
| immunological analysis | #391 |
| critical window | #391 |
| potential association | #391 |
| 11 year | #392 |
| cde | #393 |
| 14 year | #394 |
| risk sensitization | #394 |
| mmp9 gene | #394 |
| early feeding | #394 |
| polymorphism gene | #395 |
| increased risk asthma | #395 |
| linear regressions | #395 |
| immunological mechanisms | #396 |
| th2 th1 | #398 |
| study polymorphisms | #399 |
| respiratory health | #399 |
| salmeterol xinafoate | #399 |
| receptor cx3cr1 | #400 |
| antiviral responses | #401 |
| 2033 | #402 |
| regions countries | #402 |
| receptor polymorphisms | #402 |
| length time | #403 |
| analysis asthma | #403 |
| exposure animals | #403 |
| plea | #404 |
| study agreement | #405 |
| timothy grass | #405 |
| allergens | #405 |
| production ifngamma | #406 |
| cells asthma | #406 |
| allergen exposure | #406 |
| 071 | #407 |
| mugwort | #407 |
| childhood allergic | #407 |
| data cohort | #409 |
| geneenvironment interaction | #409 |
| mold exposure | #410 |
| living room | #411 |
| common occurrence | #411 |
| endotoxin exposure | #411 |
| blood rna | #413 |
| gene variations | #413 |
| blood cb | #413 |
| ige synthesis | #414 |
| germany | #415 |
| childhood exposure | #416 |
| facemasks | #416 |
| mite allergen | #416 |
| house dust | #417 |
| illness asthma | #418 |
| bronchial hyperresponsiveness | #418 |
| 7 years | #418 |
| extended haplotypes | #419 |
| age 2 years | #420 |
| alimentary | #420 |
| population sample | #420 |
| halfwidth | #421 |
| prenatal factors | #421 |
| tnc | #424 |
| confers protection | #424 |
| cytokine secretion | #426 |
| parasitic infections | #427 |
| asthma eczema | #427 |
| asthma treatment | #428 |
| childhood eczema | #429 |
| duration breastfeeding | #429 |
| childrens hospitals | #430 |
| tlr1 | #430 |
| allergic conditions | #431 |
| clinical examinations | #432 |
| 441 | #433 |
| risk overweight | #433 |
| respiratory allergic | #434 |
| specific sensitization | #434 |
| tobit | #438 |
| allergy diagnosis | #438 |
| decrements | #438 |
| age odds ratio | #438 |
| conundrum | #440 |
| annual prevalence | #441 |
| asthma gene | #441 |
| population asthma | #442 |
| inception | #443 |
| male odds | #443 |
| fecal microbiota | #443 |
| chronic inflammatory diseases | #443 |
| cell phenotypes | #444 |
| persisting | #444 |
| asthma effects | #444 |
| observed differences | #445 |
| increase bmi | #445 |
| specific serum | #446 |
| asthma respiratory | #446 |
| exposure respiratory | #448 |
| allergic rhinoconjunctivitis | #449 |
| ethnic origin | #449 |
| allergy food | #450 |
| 033 | #450 |
| adult asthmatics | #451 |
| n149 | #452 |
| associations asthma | #452 |
| including asthma | #455 |
| school entry | #456 |
| dermatophagoides farinae | #457 |
| pregnancy increased risk | #457 |
| germany health | #458 |
| external environment | #460 |
| mice role | #460 |
| allergic risk | #460 |
| provocation tests | #460 |
| airway hyper | #462 |
| westernized | #463 |
| asthma higher | #464 |
| rural health | #464 |
| asthma control test | #465 |
| environmental factors | #466 |
| cells innate | #467 |
| opposite effects | #467 |
| postal questionnaire | #467 |
| alex | #468 |
| severity asthma | #468 |
| immunocap | #468 |
| so2 concentrations | #469 |
| nod1 signaling | #470 |
| early identification | #470 |
| clinical asthma | #470 |
| exposure | #471 |
| microbial counts | #471 |
| asthma rhinitis | #471 |
| emphasised | #471 |
| antibiotics children | #473 |
| birth cohorts | #473 |
| fodder | #473 |
| yrs | #474 |
| 1133 | #474 |
| cross sectional survey | #476 |
| champ | #476 |
| exposure antibiotics | #477 |
| early exposure | #481 |
| risk severity | #482 |
| childhood environment | #483 |
| asthma association | #484 |
| total immunoglobulin | #484 |
| subphenotypes | #485 |
| atopic disorders | #486 |
| immunity genes | #486 |
| children | #486 |
| prospective birth cohort | #487 |
| phenotypes | #487 |
| potential confounding | #489 |
| exposure data | #489 |
| genes environment | #490 |
| studies rhinitis | #490 |
| multicenter cohort | #491 |
| snp association | #494 |
| uncontrolled asthma | #495 |
| polymorphisms association | #495 |
| age 10 | #496 |
| lifestyles | #496 |
| housing animal | #497 |
| southern germany | #497 |
| children jia | #497 |
| asthma severe | #498 |
| individual level | #498 |
| phenotype polymorphism | #498 |
| respiratory hypersensitivity | #500 |
| omega6 fatty acids | #500 |
| birth age | #501 |
| lung function children | #503 |
| asthma susceptibility | #503 |
| sensitizations | #504 |
| white children | #505 |
| diet diversity | #505 |
| methods studies | #505 |
| tests specific | #505 |
| ranks | #508 |
| allergy children | #508 |
| prevalence rates | #509 |
| rna samples | #509 |
| childhood respiratory | #509 |
| housing humans | #510 |
| stimulation lps | #511 |
| perennial | #511 |
| il15 | #513 |
| age 10 years | #514 |
| europe female | #514 |
| asthma prevalence | #515 |
| children exposed | #515 |
| asthma bronchiolitis | #516 |
| levels children | #516 |
| infections asthma | #516 |
| receptor tlr | #516 |
| cities china | #516 |
| cd4cd25high | #517 |
| dpps | #518 |
| atopic conditions | #519 |
| th2 immune | #519 |
| haplotype association | #520 |
| eczema asthma | #522 |
| neutrophils eosinophils | #522 |
| age 1 year | #523 |
| polymorphisms snps | #523 |
| children maternal | #523 |
| p0041 | #523 |
| risk factors asthma | #523 |
| time window | #524 |
| rural areas | #524 |
| adolescence age | #525 |
| maternal vitamin | #525 |
| trans fatty acids | #526 |
| obesity body mass | #528 |
| bmi increased risk | #528 |
| baseline participants | #528 |
| blood humans | #529 |
| allergens animals | #529 |
| 117 95 | #529 |
| c‐reactive protein | #529 |
| edifice | #530 |
| persistent asthma | #530 |
| obesity smoking | #531 |
| environmental bacteria | #531 |
| samples children | #532 |
| protect | #532 |
| oral tolerance | #533 |
| allergic airway inflammation | #534 |
| children methods | #535 |
| immune stimulation | #536 |
| topic rhinitis | #537 |
| il4r | #538 |
| blood eosinophil counts | #539 |
| industrialised | #540 |
| human microbiota | #541 |
| adolescence early adulthood | #541 |
| airway symptoms | #542 |
| lipopolysaccharide receptors | #543 |
| pregnancy asthma | #543 |
| rubella virus | #543 |
| immunological markers | #543 |
| cypress | #544 |
| pathomechanisms | #545 |
| regulatory cell | #546 |
| 17q12 | #547 |
| antitrypsin alpha | #547 |
| greenness | #548 |
| oligoarticular | #549 |
| floorcoverings | #549 |
| hypersensitivity humans | #550 |
| epidemic proportions | #553 |
| isotype switching | #553 |
| association children | #553 |
| lung microbiome | #554 |
| multidisciplinary study | #554 |
| children parental | #555 |
| mental health patients | #555 |
| asthma status | #556 |
| overweight prevalence | #556 |
| allergic rhinitis asthma | #558 |
| aqlq | #558 |
| 1129 | #559 |
| blood eosinophils | #560 |
| letzten | #560 |
| activity body | #561 |
| reduced exposure | #564 |
| 2 immunity | #566 |
| inhaled steroids | #566 |
| hormonal contraceptives | #566 |
| 077 | #567 |
| immune regulatory | #569 |
| initial observations | #570 |
| tripeptidyl | #570 |
| exposure matrix | #570 |
| health urban | #571 |
| asthma symptom | #571 |
| diseases prevalence | #575 |
| hcs patients | #575 |
| levels total | #575 |
| affluence | #575 |
| creactive protein levels | #579 |
| atopic asthma | #579 |
| oro | #580 |
| followups | #580 |
| age controls | #581 |
| association obesity | #581 |
| flanking regions | #582 |
| asthma population | #582 |
| fdr | #582 |
| tlr6 | #584 |
| uht | #584 |
| asthma severity | #584 |
| function asthma | #585 |
| bacterial microbiome | #588 |
| gsdmb | #589 |
| longum | #590 |
| n63 | #590 |
| skin test | #591 |
| 1 antitrypsin | #592 |
| endotoxin concentrations | #593 |
| holiday | #593 |
| il1rl1 | #596 |
| gasdermin | #596 |
| factors respiratory | #596 |
| model asthma | #597 |
| advising | #598 |
| zeigen | #598 |
| total specific | #598 |
| pathogenesis asthma | #598 |
| genetic environmental | #600 |
| galactosylation | #600 |
| active immunity | #601 |
| factors humans | #602 |
| 048 | #603 |
| pregnancy maternal | #603 |
| humans human | #604 |
| hladqa1 | #604 |
| statistical analyses | #604 |
| sensitization | #606 |
| agents asthma | #606 |
| microbes | #606 |
| microbiome studies | #607 |
| ige production | #608 |
| 2 inflammation | #610 |
| allergic rhinitis | #610 |
| infant feeding practices | #611 |
| bolus | #612 |
| regulatory molecules | #612 |
| work life | #612 |
| 11–13 | #612 |
| pollen allergens | #616 |
| albania | #619 |
| chronic stress | #619 |
| aged allergens | #619 |
| urban populations | #620 |
| body plethysmography | #621 |
| arthropod proteins | #621 |
| life age | #621 |
| deep phenotyping | #622 |
| radioallergosorbent | #623 |
| unstimulated | #623 |
| functional features | #625 |
| endotoxin | #627 |
| data prevalence | #627 |
| 779 | #627 |
| crosssectional | #629 |
| protective properties | #629 |
| smoking surveys | #632 |
| school children | #632 |
| models asthma | #633 |
| feeding patterns | #635 |
| settled | #635 |
| exacerbating | #635 |
| child asthma | #636 |
| children atopic dermatitis | #637 |
| standardized questionnaire | #637 |
| lifetime prevalence | #638 |
| european children | #639 |
| igg glycosylation | #639 |
| factors urban | #639 |
| clustering approach | #641 |
| innate immunity | #642 |
| grass pollen | #642 |
| humans microbiota | #643 |
| years increased | #645 |
| symptoms | #646 |
| innate lung | #647 |
| pollen concentrations | #648 |
| pets | #650 |
| health rural | #650 |
| life children | #650 |
| kindern | #650 |
| participation rates | #650 |
| glucocorticoid induced | #652 |
| helsinki | #653 |
| comprehensive analysis | #654 |
| dermatitis allergic | #654 |
| prospective studies association | #656 |
| 16 countries | #658 |
| common chronic | #659 |
| age 1 | #662 |
| latent classes | #662 |
| conclusion data | #663 |
| cd14 expression | #664 |
| abpa | #665 |
| di2ethylhexyl | #665 |
| hygiene | #665 |
| pvalues | #666 |
| hypertonic saline | #667 |
| chemokine cx3cl1 | #668 |
| adult lung | #669 |
| standardized questionnaires | #670 |
| birth cohort | #671 |
| central european | #672 |
| susceptibility locus | #672 |
| cellules | #673 |
| études | #674 |
| jobs | #676 |
| ilc2s | #677 |
| age 45 years | #679 |
| common infections | #680 |
| random sample | #681 |
| dairy farm | #681 |
| protective | #681 |
| female forced | #681 |
| egg allergy | #682 |
| cohorte | #683 |
| dietary habits | #685 |
| recurrent wheezing | #685 |
| childhood experiences | #686 |
| factors air | #688 |
| european community | #692 |
| doctor | #693 |
| major gene | #693 |
| turkish | #694 |
| factors skin | #695 |
| physical examination | #699 |
| rhinitis symptoms | #702 |
| risk obesity | #703 |
| sensitization food | #703 |
| hypersensitivity inflammation | #703 |
| microbial flora | #703 |
| tao | #707 |
| microbial interactions | #708 |
| 459 | #708 |
| dramatic increase | #708 |
| immune activation | #709 |
| perpetuation | #709 |
| population surveys | #712 |
| immunologic tlymphocytes | #712 |
| children time | #713 |
| pregnancy children | #718 |
| bacterial spores | #720 |
| mediated diseases | #721 |
| allergy asthma | #722 |
| ratio aor | #724 |
| sensitized patients | #727 |
| function children | #727 |
| 95 males | #734 |
| alias | #734 |
| il4 il13 | #738 |
| population adolescent | #741 |
| linkage chromosome | #741 |
| nonasthmatic | #742 |
| fractional exhaled | #742 |
| farms | #743 |
| treg cell | #745 |
| type 5 | #748 |
| traffic air | #748 |
| ifih1 | #749 |
| children low | #753 |
| earlier study | #754 |
| total lung | #755 |
| environment interactions | #758 |
| h20 | #758 |
| aeroallergens | #759 |
| moderate levels | #764 |
| indoor dust | #766 |
| edn1 | #768 |
| air trapping | #768 |
| hscrp levels | #769 |
| allergists | #769 |
| pulmonary function tests | #769 |
| pattern recognition receptors | #770 |
| blood leukocytes | #770 |
| hyperresponsiveness | #770 |
| asthma adults | #771 |
| strabismus surgery | #772 |
| nucleotide receptors | #773 |
| term impact | #773 |
| incidence longitudinal | #773 |
| volume humans | #777 |
| rhinitis children | #781 |
| studies asthma | #784 |
| new associations | #784 |
| factors incidence | #785 |
| children allergic | #785 |
| factors tobacco | #788 |
| nonallergic | #788 |
| shortness breath | #789 |
| asthma therapy | #791 |
| gis | #793 |
| male metaanalysis | #793 |
| children health | #794 |
| βdiversity | #795 |
| airway hyperresponsiveness | #795 |
| distinct trajectories | #796 |
| natural habitat | #796 |
| pc20 | #798 |
| personalization | #798 |
| protective effects | #799 |
| card15 | #799 |
| 45 years | #800 |
| pair 1 chromosomes | #801 |
| confer | #802 |
| allergen | #805 |
| age 4 years | #806 |
| infant food | #807 |
| dairy farms | #808 |
| bifidobacterium longum | #810 |
| exposure age | #810 |
| tenascin | #810 |
| pteronyssinus | #811 |
| subclinical inflammation | #811 |
| peak flow | #813 |
| bacillus licheniformis | #813 |
| boiled | #814 |
| initial data | #814 |
| onset age | #815 |
| foe | #816 |
| foxp3 | #817 |
| brevibacterium | #818 |
| positive skin | #819 |
| 0053 | #820 |
| food infant | #821 |
| skin tests | #822 |
| breastfeeding duration | #822 |
| spt | #827 |
| studies respiratory | #830 |
| trier | #830 |
| prevention strategies | #831 |
| asthma health | #832 |
| current analysis | #833 |
| rad50 | #833 |
| promoter polymorphisms | #834 |
| regularly | #835 |
| farinae | #835 |
| igg4 | #835 |
| snps haplotypes | #835 |
| adolescent age | #837 |
| exhaled breath | #838 |
| cx3cr1 | #838 |
| toll receptors | #839 |
| public health problem | #839 |
| parental smoking | #839 |
| asthma bronchi | #839 |
| subsequent development | #840 |
| cladosporium | #841 |
| chronification | #844 |
| fetal blood | #845 |
| modifies | #845 |
| potted | #849 |
| innate | #849 |
| bacterial endotoxin | #850 |
| maternal exposure | #850 |
| allergen sensitization | #852 |
| inspections | #854 |
| 17q | #855 |
| infant health | #856 |
| provocation | #856 |
| infant infant | #858 |
| repeatedly | #861 |
| age 5 | #861 |
| paracetamol | #862 |
| questionnaires young adult | #864 |
| asthma lung | #864 |
| receptors tlrs | #864 |
| volatile organic | #865 |
| ige | #866 |
| airway eosinophilia | #866 |
| birth cohort study | #866 |
| outdoor air pollution | #874 |
| cumulative incidence | #874 |
| latent class analysis | #875 |
| dermatitis | #878 |
| hmos | #878 |
| microbiome humans | #879 |
| 1940 | #880 |
| 057 | #880 |
| 12q | #884 |
| ifngamma tnfalpha | #886 |
| 856 | #888 |
| brink | #888 |
| oscillometry | #890 |
| european populations | #891 |
| bacterial counts | #892 |
| subsample | #895 |
| exposure study | #895 |
| asthma incidence | #896 |
| esl | #896 |
| impact asthma | #900 |
| inflammation airway | #902 |
| immunoglobulin ige | #902 |
| breastfed | #904 |
| respiration disorders | #905 |
| allergen induced | #907 |
| adult asthma | #908 |
| shortness | #908 |
| microbiome composition | #910 |
| children overweight | #910 |
| microbiota development | #912 |
| cow milk | #917 |
| complex disease | #917 |
| immunity innate | #919 |
| 710 | #920 |
| peripheral blood samples | #920 |
| methods cross | #920 |
| estonia | #923 |
| prospective birth | #927 |
| sectional population | #928 |
| sounds | #928 |
| ilcs | #929 |
| biomérieux | #929 |
| participants baseline | #932 |
| 026 | #939 |
| lactococcus lactis | #939 |
| 13 years | #940 |
| dermatophagoides | #940 |
| potential confounders | #940 |
| floors | #942 |
| life style | #944 |
| microbiome host | #949 |
| 055 | #950 |
| environmental effects | #952 |
| identification genes | #952 |
| 454 pyrosequencing | #953 |
| solids | #954 |
| polymorphisms | #954 |
| asthma exercise | #954 |
| 1120 | #954 |
| genotyped | #954 |
| human life | #955 |
| infections child | #957 |
| children countries | #959 |
| fever | #959 |
| rhinitis asthma | #961 |
| exposures | #961 |
| domestic | #961 |
| nasal secretions | #964 |
| disease asthma | #964 |
| immunoglobulin male | #965 |
| cytokines female | #965 |
| obesity children | #966 |
| innsbruck | #970 |
| readings | #971 |
| fev | #973 |
| immunization immunoglobulin | #973 |
| onset child child | #974 |
| teenagers | #975 |
| orphan receptor | #976 |
| gondii infection | #976 |
| bmi physical activity | #977 |
| nucleotide promoter | #978 |
| respiratory conditions | #979 |
| receptor gene | #981 |
| xinafoate | #981 |
| 682 | #981 |
| yearly | #982 |
| 1333 | #983 |
| small effects | #984 |
| child cohort | #986 |
| adolescents asthma | #987 |
| 12 months age | #990 |
| c3h hej | #991 |
| 068 | #991 |
| pasteurization | #991 |
| hercules | #992 |
| function development | #992 |
| asthma humans | #992 |
| design methods | #994 |
| sectional | #994 |
| immunoglobulin class | #995 |
| diagnosis asthma | #998 |
| respiratory symptoms | #1001 |
| bradykinin receptors | #1003 |
| yoghurt | #1005 |
| rural population | #1006 |
| maternally | #1006 |
| ppg | #1006 |
| linens | #1009 |
| preventive measures | #1010 |
| pt15 | #1012 |
| asthma outcomes | #1014 |
| timeframe | #1016 |
| 039 | #1017 |
| phytohemagglutinin | #1017 |
| association physical activity | #1018 |
| median levels | #1019 |
| strongest associations | #1020 |
| asthma medication | #1021 |
| western countries | #1022 |
| sought | #1024 |
| raw milk | #1027 |
| asthma adult | #1029 |
| outcome variables | #1030 |
| upper airways | #1031 |
| genomewide association | #1033 |
| 096 | #1033 |
| asthmatic children | #1035 |
| veillonella | #1037 |
| cell child | #1038 |
| breastmilk | #1039 |
| dairying | #1039 |
| nod1 | #1042 |
| disease children | #1046 |
| milieu | #1046 |
| missing values | #1047 |
| exposure conditions | #1048 |
| controls age | #1051 |
| severe allergic | #1057 |
| il5 | #1058 |
| hobbies | #1059 |
| infant gut | #1059 |
| metalloprotease | #1060 |
| pregnancy prospective | #1062 |
| class switching | #1064 |
| signaling adaptor | #1065 |
| rural | #1066 |
| predictor | #1066 |
| skin sensitization | #1068 |
| 8 12 | #1068 |
| gnp | #1069 |
| central europe | #1070 |
| margarine | #1070 |
| moraxella | #1070 |
| prevalence prospective | #1071 |
| expression humans | #1072 |
| interrelation | #1075 |
| cross sectional study | #1077 |
| large population | #1077 |
| box transcription | #1079 |
| west east | #1079 |
| trflp | #1080 |
| factors child | #1081 |
| risk development | #1081 |
| life respiratory | #1082 |
| study areas | #1083 |
| cells tregs | #1083 |
| allergic airway | #1083 |
| children prevalence | #1086 |
| sufferers | #1086 |
| maternal asthma | #1089 |
| gene expression data | #1090 |
| lca | #1090 |
| exposure delayed | #1091 |
| longduration | #1094 |
| disintegrin | #1095 |
| proteins polymorphism | #1096 |
| nationality | #1096 |
| 930 | #1097 |
| supplementary data | #1098 |
| overweight bmi | #1101 |
| forkhead | #1103 |
| enfants | #1103 |
| studies evidence | #1104 |
| conjunctivitis | #1104 |
| adolescence adulthood | #1105 |
| cd14 | #1106 |
| 248 | #1116 |
| weight risk | #1116 |
| risk gene | #1117 |
| characteristically | #1117 |
| associations observed | #1118 |
| meat consumption | #1119 |
| prevalences | #1122 |
| association exposure | #1123 |
| intermediate phenotypes | #1125 |
| newonset | #1126 |
| lung function decline | #1127 |
| sscp analysis | #1127 |
| il12b | #1127 |
| based clustering | #1128 |
| taxonomies | #1130 |
| endotoxins | #1130 |
| age birth | #1132 |
| expiratory flow | #1132 |
| 859 | #1134 |
| based birth | #1136 |
| pet ownership | #1144 |
| log2 | #1144 |
| gondii | #1145 |
| allergic asthma | #1145 |
| pediatric asthma | #1146 |
| patients severe asthma | #1146 |
| skewness | #1152 |
| 837 | #1152 |
| humans respiratory | #1153 |
| regions china | #1154 |
| environmental tobacco | #1154 |
| disease cohort | #1156 |
| dust mite | #1156 |
| 862 | #1158 |
| deciphering | #1159 |
| countries prevalence | #1160 |
| epidemiological evidence | #1164 |
| anti ige | #1165 |
| 027 | #1165 |
| rarer | #1168 |
| preschool cohort | #1169 |
| inbred balb receptors | #1172 |
| crowding | #1173 |
| genomewide | #1176 |
| receptors ige | #1178 |
| farmers | #1179 |
| phase behaviour | #1180 |
| croup | #1183 |
| serum immunoglobulin | #1184 |
| contre | #1184 |
| food allergens | #1186 |
| asthma bronchodilator | #1189 |
| new paradigm | #1189 |
| levels measured | #1190 |
| exhaled | #1194 |
| respiratory tract | #1196 |
| censored | #1197 |
| children association | #1200 |
| management children | #1206 |
| rorc | #1207 |
| bacterial taxa | #1208 |
| fungi humans | #1211 |
| sedentary lifestyle | #1211 |
| risk childhood | #1214 |
| flg | #1215 |
| regulatory cells tregs | #1216 |
| risk children | #1218 |
| food hypersensitivity | #1218 |
| orphan | #1219 |
| bradykinin | #1220 |
| eosinophilic inflammation | #1221 |
| day life | #1223 |
| factor activity | #1225 |
| 047 | #1229 |
| male pregnancy | #1233 |
| balb ovalbumin | #1234 |
| age menarche | #1236 |
| gene variants | #1236 |
| th1 th2 | #1236 |
| adult allergens | #1240 |
| european population | #1241 |
| antitrypsin | #1243 |
| small children | #1243 |
| ulm | #1247 |
| protective factors | #1250 |
| objective aim | #1251 |
| pertussis | #1252 |
| early years | #1252 |
| peripheral blood leukocytes | #1253 |
| food items | #1253 |
| airway hyperreactivity | #1253 |
| shop | #1256 |
| questionnaires | #1256 |
| debated | #1257 |
| lung function | #1260 |
| telephone interviews | #1260 |
| mite | #1262 |
| studies gene | #1263 |
| disease case | #1264 |
| yogurt | #1267 |
| temperature humidity | #1268 |
| overweight children | #1274 |
| occupational exposures | #1277 |
| fev1 forced | #1281 |
| pollution indoor | #1281 |
| children exposure | #1282 |
| shannon | #1284 |
| infections risk | #1284 |
| immunomodulating | #1289 |
| diseases occupational | #1289 |
| pollution exposure | #1292 |
| potential risk factors | #1293 |
| 182 | #1295 |
| body sites | #1296 |
| tests risk | #1299 |
| age baseline | #1301 |
| gme | #1302 |
| explain | #1303 |
| topic polymorphism | #1303 |
| venipuncture | #1306 |
| endotypes | #1309 |
| lymphocytes regulatory | #1312 |
| factor development | #1312 |
| industrially | #1314 |
| th1 cytokines | #1314 |
| 038 | #1318 |
| sought determine | #1320 |
| epidemiological survey | #1322 |
| harmonization | #1322 |
| cell numbers | #1322 |
| objective investigate | #1327 |
| cleaning | #1329 |
| neuraminic | #1329 |
| lrti | #1330 |
| concerted | #1330 |
| prevalence rural | #1331 |
| zusammenfassung | #1331 |
| respiratory allergy | #1332 |
| gambia | #1332 |
| induced sputum | #1335 |
| sponsorship | #1335 |
| loft | #1337 |
| passive smoking | #1340 |
| 897 | #1342 |
| mass breast | #1343 |
| multiple testing | #1346 |
| puberty | #1347 |
| airway function | #1349 |
| th2 cells | #1351 |
| oxide feno | #1353 |
| expired | #1353 |
| irf1 | #1353 |
| atopic humans | #1354 |
| toxoplasma gondii | #1355 |
| 267 | #1357 |
| reduction risk | #1358 |
| 16 18 | #1358 |
| science foundation | #1359 |
| asthmatics | #1359 |
| 2 innate | #1360 |
| lung microbiota | #1363 |
| 279 | #1366 |
| france germany | #1366 |
| maternal immune | #1367 |
| asthma female | #1369 |
| innate lymphoid | #1374 |
| whey proteins | #1378 |
| preventive strategies | #1381 |
| austria | #1382 |
| total ige | #1383 |
| common forms | #1383 |
| lactococcus | #1386 |
| studies lung | #1387 |
| management asthma | #1388 |
| environmental | #1389 |
| disagreement | #1389 |
| childhood adult | #1390 |
| early intervention | #1395 |
| milk proteins | #1403 |
| q21 | #1404 |
| risk developing | #1404 |
| severe atopic | #1404 |
| fef25 | #1406 |
| airway inflammation | #1407 |
| air samples | #1410 |
| indoor | #1412 |
| dust exposure | #1415 |
| sige | #1417 |
| baseline followup | #1417 |
| bronchodilators | #1418 |
| immune mechanisms | #1418 |
| microbial | #1419 |
| il13 | #1421 |
| hapmap | #1421 |
| bronchitis | #1422 |
| longitudinal cohort | #1422 |
| male multivariate | #1427 |
| pulmonary eosinophilia | #1429 |
| pair 17 | #1429 |
| asthmatic | #1433 |
| timepoint | #1433 |
| chronic inflammatory | #1435 |
| exhaled nitric | #1440 |
| irak4 | #1442 |
| induced airway | #1443 |
| centres | #1444 |
| inflammatory pathways | #1444 |
| studies europe | #1445 |
| overweight | #1445 |
| age 5 years | #1446 |
| bronchodilator response | #1448 |
| airway responses | #1451 |
| factors prevalence | #1454 |
| asthma clinical | #1460 |
| agricultural workers | #1460 |
| unique opportunity | #1461 |
| infancy | #1461 |
| immunizations | #1463 |
| 706 | #1464 |
| barcelona | #1464 |
| a20 | #1466 |
| association polymorphism | #1468 |
| hand eczema | #1468 |
| recognition receptors | #1470 |
| surveys questionnaires | #1470 |
| asthma compared | #1472 |
| immunity | #1473 |
| leur | #1474 |
| operating characteristics | #1474 |
| adolescence | #1475 |
| nod2 signaling | #1476 |
| 362 | #1477 |
| innate immune responses | #1478 |
| 1 levels | #1478 |
| meeting | #1479 |
| dgge | #1480 |
| otitis | #1482 |
| paediatricians | #1490 |
| immunologic mechanisms | #1493 |
| strongest predictor | #1494 |
| peptidases | #1494 |
| populationbased cohort | #1504 |
| flexural | #1505 |
| ionomycin | #1505 |
| tlr2 | #1506 |
| birch pollen | #1507 |
| structured interviews | #1508 |
| tlr2 tlr4 | #1509 |
| igg1 | #1511 |
| understood | #1512 |
| sulphur dioxide | #1514 |
| bacterial composition | #1514 |
| ergosterol | #1515 |
| living environment | #1517 |
| epidemiological data | #1517 |
| moderate asthma | #1517 |
| pasteurized | #1518 |
| latent class | #1520 |
| child welfare | #1521 |
| rôle | #1524 |
| pollution levels | #1524 |
| 153 | #1527 |
| hladq | #1527 |
| respiratory tract infections | #1530 |
| differences prevalence | #1533 |
| underlying mechanisms | #1536 |
| jia | #1536 |
| dust | #1542 |
| 245 | #1551 |
| factors development | #1552 |
| wisconsin | #1555 |
| birthday | #1558 |
| previous 12 months | #1558 |
| children aged | #1564 |
| children increased | #1566 |
| antibiotic exposure | #1567 |
| austrian | #1573 |
| born children | #1578 |
| china female humans | #1579 |
| licheniformis | #1584 |
| children risk | #1584 |
| current studies | #1588 |
| treatment asthma | #1595 |
| trans fatty | #1596 |
| explained | #1596 |
| breastfed infants | #1598 |
| study populations | #1599 |
| tract diseases | #1602 |
| development progression | #1603 |
| 775 | #1603 |
| air microbiology | #1604 |
| regulatory | #1605 |
| disease process | #1607 |
| ascariasis | #1610 |
| male prospective | #1611 |
| erythrocyte membranes | #1612 |
| neuropeptide | #1612 |
| peak expiratory | #1613 |
| cells1 | #1613 |
| familial aggregation | #1617 |
| candidate gene | #1622 |
| cells th2 | #1624 |
| ige antibodies | #1624 |
| early gene | #1626 |
| precision medicine | #1627 |
| short communication | #1627 |
| tolerogenic | #1628 |
| questionnaires young | #1632 |
| studies recurrence | #1634 |
| tcell responses | #1635 |
| newborn infants | #1641 |
| gata3 | #1641 |
| th2 cytokines | #1644 |
| th2 | #1645 |
| nutritional factors | #1647 |
| style male | #1653 |
| population based study | #1653 |
| topic surveys | #1653 |
| card | #1655 |
| traffic volume | #1656 |
| microbial diversity | #1656 |
| 034 | #1656 |
| smoke exposure | #1657 |
| cells transcription | #1661 |
| northern europe | #1661 |
| expiratory volume | #1664 |
| respiratory | #1666 |
| opportunity | #1667 |
| linear discriminant analysis | #1671 |
| followup study | #1677 |
| asthmatic agents | #1678 |
| cheese | #1688 |
| epidemiologic evidence | #1688 |
| employment | #1692 |
| microbiome | #1693 |
| obesity risk | #1694 |
| innate immune | #1694 |
| early introduction | #1694 |
| gitr | #1696 |
| health‐related quality | #1697 |
| aux | #1701 |
| th2 th17 | #1702 |
| phenotyping | #1704 |
| gene interaction | #1704 |
| adulthood | #1706 |
| 476 | #1710 |
| fungal diversity | #1712 |
| provocative | #1716 |
| singlenucleotide polymorphisms | #1717 |
| house dust mite | #1718 |
| mere | #1718 |
| 029 | #1723 |
| life hrqol | #1730 |
| airflow obstruction | #1732 |
| asthma control | #1733 |
| gabon | #1733 |
| genotyping | #1734 |
| anti asthmatic | #1735 |
| innate adaptive | #1739 |
| factors breast | #1742 |
| factors children | #1746 |
| cytokine genes | #1746 |
| 5 7 | #1748 |
| inverse relationship | #1749 |
| helminth parasites | #1749 |
| preschool clinical trials | #1751 |
| inconsistencies | #1753 |
| molds | #1754 |
| masks | #1756 |
| male polymorphism | #1756 |
| fivefold | #1760 |
| gstm1 gstt1 | #1760 |
| chronic airway | #1761 |
| refugees | #1761 |
| bacterial diversity | #1764 |
| susceptibility gene | #1767 |
| street | #1768 |
| environmental tobacco smoke | #1769 |
| association body mass | #1772 |
| soot | #1778 |
| cells airway | #1778 |
| helminth infections | #1779 |
| peptidoglycan | #1782 |
| occupational exposure | #1782 |
| cd4cd25 | #1782 |
| allergic reaction | #1788 |
| exposure assessment | #1789 |
| nucleotide polymorphisms | #1799 |
| generations | #1800 |
| 054 | #1801 |
| helminths | #1801 |
| key feature | #1801 |
| rubella | #1807 |
| life factors | #1809 |
| single nucleotide receptors | #1812 |
| treg cells | #1812 |
| feno | #1817 |
| protein 3 | #1821 |
| censoring | #1821 |
| factors health | #1822 |
| dna fingerprinting | #1823 |
| breastfeeding | #1825 |
| signal transducer | #1828 |
| asthma morbidity | #1828 |
| respiratory illnesses | #1831 |
| 112 | #1831 |
| leisure time | #1834 |
| generational | #1837 |
| vocational | #1838 |
| foxp3 expression | #1841 |
| il4 | #1843 |
| heterogeneous disease | #1843 |
| regulatory cells | #1843 |
| otus | #1845 |
| fetal growth | #1845 |
| forkhead transcription | #1849 |
| sampling methods | #1854 |
| causally | #1855 |
| idiopathic arthritis | #1857 |
| 95 risk factors | #1859 |
| disease incidence | #1878 |
| hypertonic | #1879 |
| friend | #1884 |
| diseases lung | #1886 |
| unraveling | #1886 |
| interleukin33 | #1891 |
| predispose | #1892 |
| age 4 | #1893 |
| aor | #1894 |
| age 2 | #1895 |
| life | #1898 |
| microbe | #1899 |
| lung male | #1900 |
| population level | #1901 |
| interleukin5 | #1901 |
| hrqol | #1903 |
| occupational stress | #1904 |
| jedoch | #1908 |
| brought | #1909 |
| vital capacity | #1909 |
| predictive models | #1914 |
| feeding practices | #1917 |
| coeliac disease | #1918 |
| confounded | #1924 |
| weight breast | #1929 |
| experimental models | #1932 |
| basics | #1932 |
| p0012 | #1933 |
| helminthiasis | #1934 |
| pregnancy prevalence | #1936 |
| child humans | #1938 |
| barrier function | #1941 |
| european commission | #1944 |
| aetiology | #1945 |
| percentiles | #1946 |
| juvenile idiopathic | #1946 |
| cell markers | #1949 |
| galactans | #1951 |
| moisture | #1959 |
| raised | #1959 |
| blood eosinophil | #1960 |
| invading | #1960 |
| immune mediated | #1960 |
| asthmatic subjects | #1960 |
| child female | #1966 |
| lps stimulation | #1966 |
| regulatory region | #1973 |
| 658 | #1975 |
| phenomena infant | #1977 |
| dwellings | #1985 |
| children severe | #1991 |
| dollar | #1994 |
| natural environments | #1997 |
| helper type | #1998 |
| studie | #1999 |
| descriptions | #2000 |
| agriculture | #2000 |
| 041 | #2004 |
| respiratory viral | #2010 |
| infectious agents | #2011 |
| richness | #2012 |
| physical activity pa | #2014 |
| lower frequencies | #2015 |
| life risk | #2018 |
| postnatal exposure | #2019 |
| regulation genetic | #2020 |
| children data | #2020 |
| diary | #2020 |
| physician diagnosis | #2021 |
| bedding | #2024 |
| underline | #2025 |
| relate | #2026 |
| age | #2027 |
| 939 | #2030 |
| bovine milk | #2038 |
| chymase | #2038 |
| ige mediated | #2040 |
| outdoor air | #2041 |
| subsamples | #2046 |
| mass child | #2047 |
| conflicting | #2056 |
| cx3c | #2057 |
| 858 | #2059 |
| schoolage children | #2063 |
| peanuts | #2068 |
| association snps | #2070 |
| standardize | #2072 |
| asthma diagnosis | #2073 |
| early childhood | #2075 |
| bronchial epithelial cells | #2075 |
| polarizing | #2076 |
| discrepant | #2080 |
| asthma quality | #2086 |
| women association | #2087 |
| gastrointestinal microbiome | #2095 |
| confounders | #2097 |
| abstracts | #2098 |
| clinical phenotypes | #2098 |
| dusts | #2099 |
| environment interaction | #2100 |
| symptoms age | #2101 |
| 19th century | #2103 |
| male maternal | #2103 |
| disequilibrium | #2104 |
| tregs | #2109 |
| reduced levels | #2111 |
| bacterial colonization | #2111 |
| dairy products | #2114 |
| permutation | #2116 |
| prevalence children | #2118 |
| alternata | #2118 |
| children higher | #2121 |
| 5q | #2125 |
| child preschool | #2128 |
| protection | #2128 |
| glucans | #2132 |
| year | #2133 |
| th2 cell | #2134 |
| common disease | #2139 |
| mild asthma | #2141 |
| dietary interventions | #2142 |
| animals child | #2145 |
| exhalation | #2145 |
| indoors | #2149 |
| sibling | #2153 |
| offspring mothers | #2154 |
| epigenetic regulation | #2155 |
| schoolchildren | #2157 |
| immune modulation | #2157 |
| ionization time | #2158 |
| studies food | #2161 |
| interleukin4 | #2163 |
| blood samples | #2166 |
| food allergy | #2173 |
| blood sampling | #2175 |
| stat6 | #2178 |
| west | #2178 |
| consumption | #2180 |
| spirometry | #2181 |
| forced expiratory | #2184 |
| utero exposure | #2186 |
| industrialized | #2190 |
| children age | #2192 |
| subsequent risk | #2193 |
| respiratory infections | #2196 |
| topic united states | #2207 |
| occupational diseases | #2208 |
| actinomycetales | #2210 |
| acinetobacter | #2212 |
| 146 | #2213 |
| communicable | #2213 |
| indoor outdoor | #2215 |
| lung epithelial cells | #2215 |
| onset disease | #2220 |
| early development | #2220 |
| female finland | #2221 |
| lung mice | #2229 |
| guardians | #2231 |
| preschool | #2232 |
| 079 | #2234 |
| 18 months | #2236 |
| 12th | #2242 |
| diesel exhaust | #2242 |
| childhood overweight | #2245 |
| th17 cell | #2246 |
| spirometric | #2247 |
| bacteria fungi | #2247 |
| immune regulation | #2248 |
| whooping | #2249 |
| preventive | #2249 |
| bacterial load | #2251 |
| functional relevance | #2252 |
| bmi risk | #2257 |
| christianity | #2258 |
| specific immunoglobulin | #2259 |
| 108 | #2259 |
| patients responders | #2267 |
| résultats | #2268 |
| environmental influences | #2271 |
| decanoic | #2274 |
| consistently | #2277 |
| preventative | #2280 |
| commensals | #2282 |
| cla | #2282 |
| 031 | #2286 |
| objective measures | #2287 |
| association childhood | #2292 |
| foxp3 cells | #2293 |
| avenues | #2296 |
| gene interactions | #2299 |
| 11 years | #2301 |
| asthma study | #2312 |
| normal children | #2318 |
| receptor 2 | #2322 |
| box protein | #2325 |
| 0042 | #2326 |
| limulus | #2329 |
| 056 | #2334 |
| studies children | #2336 |
| 064 | #2338 |
| methodsthe | #2338 |
| variation genotype | #2341 |
| ascaris | #2349 |
| omega3 fatty acids | #2352 |
| 922 | #2353 |
| prrs | #2353 |
| spss | #2354 |
| 035 | #2358 |
| treg | #2361 |
| strongest | #2364 |
| adaptive immune response | #2366 |
| regular | #2368 |
| throat | #2371 |
| microbial composition | #2376 |
| viral respiratory | #2377 |
| populationbased cohort study | #2379 |
| diseases respiratory | #2380 |
| immunologically | #2386 |
| expiratory | #2386 |
| breath | #2395 |
| genetic variation | #2396 |
| human immune | #2397 |
| urban environments | #2401 |
| blood institute | #2402 |
| diaries | #2405 |
| bronchodilator agents | #2405 |
| models male | #2413 |
| cord | #2416 |
| adequately | #2417 |
| ripk1 | #2419 |
| 7000 | #2422 |
| finnish | #2423 |
| gstt1 | #2428 |
| pathway genes | #2430 |
| early adulthood | #2435 |
| african ancestry | #2443 |
| partly | #2445 |
| toll receptor | #2457 |
| attributable | #2459 |
| motor vehicles | #2461 |
| questionnaires sweden | #2462 |
| luciferase reporter | #2464 |
| disease review | #2468 |
| vitamin intake | #2468 |
| enhancer elements | #2474 |
| genetic ancestry | #2477 |
| crosssectional survey | #2479 |
| 095 | #2496 |
| peers | #2497 |
| case control study | #2498 |
| questionnaire | #2500 |
| cytokines humans | #2508 |
| children adolescent | #2508 |
| forkhead box | #2509 |
| tolllike receptors | #2512 |
| interleukin13 | #2525 |
| tolllike receptor | #2525 |
| airway responsiveness | #2525 |
| 239 | #2527 |
| style | #2528 |
| common cold | #2528 |
| artemisia | #2530 |
| uncontrolled | #2540 |
| forced expiratory volume | #2541 |
| young adulthood | #2552 |
| inverse | #2553 |
| switzerland | #2553 |
| modify | #2556 |
| european countries | #2564 |
| pregnancy prenatal | #2568 |
| 060 | #2569 |
| siblings | #2572 |
| th2 response | #2576 |
| activator | #2584 |
| suggested | #2584 |
| myristate | #2585 |
| disease development | #2586 |
| sectional survey | #2586 |
| human microbiome | #2588 |
| 030 | #2590 |
| ω3 | #2590 |
| air pollutant | #2602 |
| immunoglobulin levels | #2603 |
| damp | #2605 |
| large sample | #2608 |
| health children | #2616 |
| viral infections | #2623 |
| humans immunoglobulin | #2624 |
| 241 | #2625 |
| mold | #2626 |
| adverse health effects | #2628 |
| polymorphism | #2633 |
| chronic respiratory diseases | #2637 |
| illness surveys | #2638 |
| prenatal exposure | #2638 |
| translate | #2640 |
| molecular patterns | #2641 |
| imputation | #2641 |
| 141 | #2643 |
| cb | #2643 |
| early | #2646 |
| evenness | #2647 |
| life illness | #2651 |
| stockholm | #2652 |
| virus diseases | #2657 |
| exhaled nitric oxide | #2657 |
| groups children | #2665 |
| 739 | #2668 |
| urban rural | #2672 |
| il4 il5 | #2673 |
| gene expression levels | #2678 |
| confounder | #2678 |
| girls boys | #2684 |
| urgently | #2684 |
| categorised | #2687 |
| onwards | #2687 |
| positive association | #2689 |
| 0048 | #2696 |
| 061 | #2699 |
| host factors | #2699 |
| effects prenatal | #2700 |
| 793 | #2703 |
| 063 | #2712 |
| leukocytes mononuclear | #2717 |
| prenatally | #2721 |
| il23r | #2721 |
| respiratory function | #2731 |
| progression disease | #2732 |
| interaction genetic | #2738 |
| risk allele | #2739 |
| worldwide | #2739 |
| reaction polymorphism | #2739 |
| contacted | #2742 |
| 95 children | #2754 |
| preschool chromosomes | #2755 |
| complete data | #2756 |
| female fetal | #2760 |
| modern | #2764 |
| milk | #2766 |
| species level | #2770 |
| effects air | #2770 |
| potential benefits | #2771 |
| rhinovirus | #2775 |
| urban health | #2778 |
| centile | #2786 |
| gstm1 | #2787 |
| messenger receptors | #2787 |
| questionnaire study | #2796 |
| prematurely | #2800 |
| emergency department visits | #2801 |
| 893 | #2802 |
| prospective longitudinal | #2809 |
| functional variants | #2810 |
| personalized treatment | #2812 |
| 812 | #2815 |
| detailed | #2816 |
| package | #2826 |
| stat1 | #2827 |
| standardized | #2829 |
| nocturnal | #2831 |
| toll | #2843 |
| dietary factors | #2848 |
| asthma patients | #2853 |
| alternaria | #2854 |
| infant formula | #2856 |
| children mothers | #2861 |
| antibiotic treatment | #2871 |
| tobacco smoke | #2878 |
| deubiquitinating | #2878 |
| lci | #2886 |
| living | #2887 |
| respondent | #2888 |
| human bronchial | #2894 |
| persistence | #2899 |
| east | #2902 |
| complement receptors | #2906 |
| male parents | #2911 |
| intrapulmonary | #2914 |
| life span | #2915 |
| 3 mm | #2916 |
| epidemiologic methods | #2917 |
| 645 | #2919 |
| 913 | #2923 |
| transitioning | #2925 |
| male gender | #2928 |
| virtually | #2928 |
| il33 | #2940 |
| listeria | #2942 |
| matrix assisted | #2944 |
| antibiotic | #2947 |
| clinical manifestation | #2956 |
| pollen | #2957 |
| visiting | #2958 |
| reduced risk | #2961 |
| written | #2965 |
| notification | #2966 |
| 074 | #2968 |
| asthma management | #2969 |
| birth | #2974 |
| study prevalence | #2975 |
| mould | #2979 |
| 073 | #2982 |
| 8th | #2983 |
| patients asthma | #2985 |
| 804 | #2985 |
| primary prevention | #2989 |
| 2 months | #2990 |
| year age | #2996 |
| critical period | #2996 |
| forced vital | #3004 |
| 293 | #3010 |
| allergic inflammation | #3011 |
| genetic receptor | #3013 |
| tlr5 | #3022 |
| forced | #3024 |
| confounding factors | #3040 |
| methodological issues | #3047 |
| polymorphism single | #3050 |
| fungal dna | #3054 |
| frequency genetic | #3059 |
| 3 years | #3060 |
| epigenetic mechanisms | #3065 |
| doubt | #3065 |
| tlrs | #3068 |
| findings studies | #3069 |
| dna extraction | #3069 |
| snps genes | #3071 |
| vaccinations | #3079 |
| economic development | #3082 |
| preschool children | #3087 |
| adaptive immune responses | #3087 |
| rapid increase | #3089 |
| rural area | #3089 |
| viewpoints | #3090 |
| overweight obesity | #3093 |
| 066 | #3096 |
| genetic variations | #3098 |
| homes | #3099 |
| analysed | #3103 |
| malditof | #3106 |
| invited | #3110 |
| delayed effects | #3119 |
| environment | #3123 |
| 0036 | #3125 |
| europe humans | #3126 |
| inhalation exposure | #3126 |
| menarche | #3129 |
| hdm | #3131 |
| 12 months | #3141 |
| filaggrin | #3142 |
| cow | #3143 |
| preschool dna | #3154 |
| vital | #3157 |
| pha | #3159 |
| baseline follow | #3182 |
| multifaceted | #3184 |
| clarified | #3188 |
| distinct | #3192 |
| bronchodilator | #3194 |
| pleiotropy | #3196 |
| monitoring female | #3197 |
| genetic receptors | #3197 |
| aor 95 | #3198 |
| 037 | #3201 |
| development disease | #3206 |
| disease genotype | #3207 |
| volume 1 | #3208 |
| 069 | #3209 |
| suburban | #3211 |
| bronchial asthma | #3213 |
| surveys | #3214 |
| messages | #3216 |
| university students | #3218 |
| epidemiological | #3227 |
| housekeeping | #3227 |
| catarrhalis | #3235 |
| functional effects | #3245 |
| 050 | #3251 |
| agents child | #3252 |
| health surveys | #3257 |
| beds | #3257 |
| 08 | #3258 |
| 360 | #3259 |
| genetic epigenesis | #3260 |
| systemic inflammation | #3261 |
| missing data | #3261 |
| prospective cohort | #3264 |
| eventually | #3266 |
| enhanced expression | #3270 |
| spores | #3271 |
| automobiles | #3272 |
| 3rd | #3275 |
| nested case | #3280 |
| premature birth | #3283 |
| 4th | #3289 |
| appreciation | #3296 |
| 19th | #3300 |
| european ancestry | #3301 |
| 098 | #3306 |
| lab | #3308 |
| cells toll | #3314 |
| influential | #3317 |
| surveys humans | #3318 |
| corynebacterium | #3318 |
| weight children | #3327 |
| child | #3332 |
| idiotypic | #3338 |
| subtle | #3341 |
| logistic regression models | #3343 |
| th17 cells | #3349 |
| age children | #3352 |
| noncommunicable diseases | #3354 |
| acid receptor | #3354 |
| influencing | #3358 |
| 509 | #3361 |
| 086 | #3367 |
| ifn γ | #3371 |
| 166 | #3372 |
| manifests | #3374 |
| 566 | #3377 |
| polymorphisms genes | #3377 |
| genetic variants | #3379 |
| rooms | #3380 |
| gut microbiome | #3384 |
| genetic background | #3388 |
| differed | #3397 |
| 0004 | #3398 |
| benzene | #3408 |
| genetic protein structure | #3408 |
| turn | #3409 |
| protecting | #3409 |
| alternaria alternata | #3418 |
| gg | #3421 |
| tlr | #3421 |
| occupational asthma | #3423 |
| maternal health | #3433 |
| sociodemographics | #3436 |
| 092 | #3443 |
| factors smoking | #3445 |
| air pollution | #3445 |
| guangzhou | #3448 |
| epithelial barrier | #3461 |
| disease genetic | #3465 |
| trends prevalence | #3467 |
| airflow limitation | #3468 |
| 049 | #3468 |
| cytokine responses | #3469 |
| th2 cytokine | #3470 |
| omega6 | #3470 |
| rye | #3480 |
| 089 | #3484 |
| 043 | #3484 |
| humans linkage | #3484 |
| 18s | #3488 |
| ambient air pollution | #3494 |
| counselling | #3496 |
| skin patients | #3497 |
| aged children | #3500 |
| total population | #3501 |
| evidences | #3507 |
| postal | #3507 |
| raw | #3512 |
| heating | #3515 |
| onset symptoms | #3519 |
| 95th | #3523 |
| 032 | #3525 |
| respiratory mucosa | #3525 |
| analysing | #3529 |
| schoolaged children | #3540 |
| innate immune response | #3541 |
| older children | #3542 |
| microbiota | #3544 |
| 059 | #3548 |
| bronchial epithelial | #3550 |
| seasonal | #3551 |
| parent | #3557 |
| 5p | #3565 |
| molecular biomarkers | #3566 |
| microbiota composition | #3568 |
| 042 | #3570 |
| coevolution | #3578 |
| tract humans | #3594 |
| minor allele | #3596 |
| plausibility | #3603 |
| children parents | #3604 |
| birch | #3605 |
| parents children | #3606 |
| linkage disequilibrium | #3610 |
| cough | #3612 |
| association polymorphisms | #3618 |
| objectively | #3623 |
| genotype humans | #3626 |
| cats | #3627 |
| claimed | #3628 |
| relating | #3629 |
| environment female | #3630 |
| pollution | #3634 |
| risk alleles | #3638 |
| broad spectrum | #3641 |
| hej | #3643 |
| odds | #3644 |
| 0011 | #3652 |
| lung volume | #3654 |
| skewed | #3670 |
| contact | #3674 |
| publication child child | #3677 |
| resides | #3679 |
| complex diseases | #3680 |
| 251 | #3681 |
| 1995 | #3684 |
| genetic control | #3686 |
| disequilibrium male | #3686 |
| toxoplasma | #3686 |
| 046 | #3688 |
| adult blood | #3691 |
| monocytogenes | #3691 |
| host immune | #3691 |
| 655 | #3695 |
| gene frequency | #3697 |
| il17 | #3701 |
| biological agents | #3703 |
| gloves | #3704 |
| 456 | #3704 |
| study gwas | #3705 |
| cette | #3725 |
| mice models | #3726 |
| 577 | #3727 |
| allocate | #3730 |
| desorption ionization | #3735 |
| genetic gene | #3735 |
| hyper | #3748 |
| ovalbumin ova | #3753 |
| 094 | #3755 |
| glutathione transferase | #3755 |
| vehicle emissions | #3759 |
| helperinducer | #3763 |
| adaptive immunity | #3764 |
| coeliac | #3765 |
| positive bacteria | #3766 |
| regressions | #3766 |
| function decline | #3771 |
| 824 | #3786 |
| housing | #3795 |
| gm csf | #3797 |
| time trends | #3798 |
| sympathomimetics | #3802 |
| multicenter studies | #3807 |
| nutrition examination | #3820 |
| weight child | #3825 |
| tcells | #3832 |
| girls | #3834 |
| bethesda | #3837 |
| health problem | #3838 |
| relation | #3838 |
| receptors immunologic | #3843 |
| 076 | #3846 |
| models immunological | #3854 |
| exposure risk | #3861 |
| epistasis | #3865 |
| tremendous | #3867 |
| loci genetic | #3869 |
| immunoglobulin | #3873 |
| utero | #3873 |
| respiratory diseases | #3876 |
| berlin | #3876 |
| maternal smoking | #3881 |
| lymphoid cells | #3891 |
| parental | #3899 |
| positively | #3912 |
| 368 | #3920 |
| 319 | #3920 |
| colonisation | #3922 |
| volatile organic compounds | #3934 |
| confounding | #3940 |
| arthropod | #3942 |
| 051 | #3943 |
| maternal serum | #3946 |
| airway resistance | #3947 |
| maternal fetal | #3948 |
| human milk | #3950 |
| denaturing | #3950 |
| asthma exacerbations | #3957 |
| progeny | #3957 |
| faced | #3958 |
| genetic predisposition | #3958 |
| exacerbations | #3960 |
| epigenetic modifications | #3970 |
| culturing | #3971 |
| viable | #3982 |
| ecuador | #3991 |
| congresses | #3995 |
| health utilization | #3999 |
| ndvi | #4004 |
| 381 | #4005 |
| r5 | #4019 |
| newborn infant premature | #4023 |
| variation humans | #4026 |
| messenger reverse | #4026 |
| capita | #4029 |
| infant nutritional | #4032 |
| pellucida | #4033 |
| phase 2 | #4035 |
| environments | #4036 |
| ema | #4036 |
| single nucleotide | #4050 |
| occupational | #4052 |
| dipeptidyl | #4055 |
| genetic risk | #4060 |
| positive associations | #4061 |
| tlr9 | #4064 |
| humans polymorphism | #4069 |
| reverse | #4070 |
| prevotella | #4081 |
| dairy | #4093 |
| 493 | #4094 |
| 023 | #4107 |
| unbalanced | #4109 |
| clarification | #4112 |
| coding region | #4113 |
| 052 | #4118 |
| chronic disease | #4118 |
| effects exposure | #4120 |
| ethnically | #4120 |
| children 2 | #4126 |
| 087 | #4136 |
| positional | #4136 |
| salmeterol | #4139 |
| urban population | #4151 |
| luminex | #4154 |
| th17 | #4162 |
| researcher | #4163 |
| chronic respiratory | #4163 |
| 011 | #4170 |
| mrna expression | #4180 |
| husbandry | #4180 |
| sulfur dioxide | #4182 |
| th1 cells | #4183 |
| 424 | #4185 |
| rgs | #4187 |
| ruled | #4189 |
| respiratory infection | #4193 |
| protected | #4194 |
| zealand | #4204 |
| lifestyle | #4210 |
| risk loci | #4212 |
| finland | #4213 |
| preterm delivery | #4220 |
| populationbased sample | #4221 |
| growing body | #4222 |
| whey | #4236 |
| androstadienes | #4237 |
| inflammatory disease | #4243 |
| disease genotype humans | #4247 |
| body height | #4248 |
| adult onset | #4250 |
| increasing trend | #4252 |
| inhaled | #4253 |
| participated | #4256 |
| indoor environments | #4256 |
| neonatal mice | #4262 |
| children born | #4269 |
| healthy individuals | #4289 |
| metagenome | #4300 |
| ordinal | #4303 |
| influenced | #4314 |
| cx3cl1 | #4318 |
| ephedrine | #4318 |
| immunologic receptors | #4322 |
| activity pa | #4324 |
| 1 gene | #4337 |
| male mothers | #4339 |
| male obesity | #4345 |
| years life | #4346 |
| phytohemagglutinins | #4349 |
| nucleotide | #4353 |
| children study | #4356 |
| 093 | #4358 |
| diagnostics | #4359 |
| healthy children | #4370 |
| 410 | #4375 |
| urban area | #4379 |
| rationale | #4393 |
| poaceae | #4397 |
| protects | #4404 |
| fluticasone | #4405 |
| age 12 | #4405 |
| stratified | #4414 |
| lpa | #4417 |
| exposure levels | #4418 |
| cephalometry | #4418 |
| percentile | #4421 |
| hypopharynx | #4424 |
| 95ci | #4425 |
| female sex | #4428 |
| 15 years | #4429 |
| onset | #4434 |
| crohn disease | #4437 |
| participating | #4439 |
| pupils | #4442 |
| dr3 | #4449 |
| secondary prevention | #4449 |
| receptors protein | #4451 |
| chances | #4457 |
| rash | #4457 |
| goblet | #4459 |
| confers | #4461 |
| patients cystic fibrosis | #4466 |
| increased prevalence | #4468 |
| respiratory viruses | #4468 |
| 457 | #4474 |
| 0022 | #4496 |
| culture techniques | #4499 |
| severe asthma | #4499 |
| prevalence risk factors | #4499 |
| microorganisms | #4511 |
| genetic effects | #4516 |
| infant | #4517 |
| trajectories | #4530 |
| no2 | #4538 |
| inflammatory diseases | #4542 |
| statistical | #4545 |
| butter | #4551 |
| assisted laser | #4555 |
| gramnegative bacteria | #4558 |
| structural equation modeling | #4559 |
| receptor alpha | #4564 |
| control children | #4572 |
| 49 | #4573 |
| ahr | #4583 |
| population prevalence | #4583 |
| prevalence estimates | #4588 |
| 080 | #4591 |
| neutrophilic | #4598 |
| adaptor protein | #4600 |
| haplotypes humans | #4600 |
| airway | #4601 |
| knowledge gaps | #4603 |
| strikingly | #4630 |
| daily practice | #4632 |
| lactis | #4634 |
| detectability | #4660 |
| str | #4661 |
| aiming | #4676 |
| random | #4676 |
| pef | #4683 |
| 299 | #4688 |
| accumulating | #4695 |
| measles | #4697 |
| 1014 | #4699 |
| hscrp | #4700 |
| gstp1 | #4725 |
| current evidence | #4730 |
| tlc | #4741 |
| associations | #4745 |
| bacterial communities | #4747 |
| immune | #4749 |
| obstructive lung | #4753 |
| lactic acid bacteria | #4754 |
| genetic risk factors | #4755 |
| transcriptomics | #4768 |
| lifestyle factors | #4772 |
| pathophysiologic | #4775 |
| lung development | #4777 |
| unclear | #4782 |
| exposure air | #4785 |
| immune responses | #4795 |
| quantity | #4804 |
| pulmonary function | #4809 |
| filament proteins | #4812 |
| plateau | #4814 |
| helminth | #4821 |
| albuterol | #4823 |
| respects | #4823 |
| adult air | #4837 |
| 399 | #4838 |
| female food | #4841 |
| implicating | #4844 |
| pointed | #4848 |
| feeding | #4851 |
| new cases | #4858 |
| haplotype analysis | #4874 |
| ont | #4886 |
| hcs | #4889 |
| occupations | #4896 |
| 624 | #4896 |
| respiratory illness | #4897 |
| newborn male | #4902 |
| studies effects | #4919 |
| hyperventilation | #4927 |
| asthma chronic | #4928 |
| dans | #4930 |
| contributors | #4940 |
| postnatal development | #4944 |
| respective | #4955 |
| starts | #4964 |
| tolerance induction | #4965 |
| blood mononuclear | #4969 |
| natal | #4973 |
| 322 | #4975 |
| airway disease | #4975 |
| predisposition disease | #4986 |
| eosinophils | #4994 |
| potential effects | #5005 |
| explore | #5011 |
| adaptor | #5012 |
| epidemiology | #5018 |
| laser desorption | #5018 |
| serine protease | #5020 |
| functionality | #5023 |
| inbred c57bl models | #5024 |
| inhalation | #5049 |
| livestock | #5058 |
| 95 | #5062 |
| paediatric | #5065 |
| manifestation | #5069 |
| milk human | #5071 |
| inflammatory markers | #5072 |
| grass | #5072 |
| 219 | #5083 |
| genetic analyses | #5084 |
| covariates | #5089 |
| held | #5091 |
| hormonal | #5091 |
| alpha1 | #5092 |
| urgent | #5094 |
| habits | #5099 |
| unexposed | #5099 |
| 097 | #5100 |
| genomewide significance | #5100 |
| il3 | #5102 |
| highrisk | #5105 |
| lysate | #5106 |
| gwas | #5119 |
| latent | #5125 |
| smoke | #5126 |
| 103 | #5130 |
| crucial | #5133 |
| 12 years | #5134 |
| regional differences | #5144 |
| mononuclear | #5153 |
| decades | #5159 |
| traffic | #5159 |
| dysbiosis | #5183 |
| 383 | #5186 |
| lung epithelial | #5191 |
| fingerprinting | #5191 |
| reflect | #5193 |
| p40 | #5196 |
| butyrates | #5200 |
| 070 | #5204 |
| age onset | #5209 |
| airways | #5210 |
| window | #5232 |
| hallmarks | #5241 |
| taxa | #5242 |
| recruited | #5243 |
| bronchopulmonary | #5247 |
| isotype | #5247 |
| crp levels | #5256 |
| psychosocial factors | #5267 |
| quartile | #5274 |
| inflammatory disorders | #5279 |
| dietary supplementation | #5280 |
| gprotein | #5283 |
| international | #5289 |
| early phase | #5305 |
| 123 | #5306 |
| environmental variables | #5314 |
| cutoff | #5318 |
| coupled receptor | #5329 |
| excessive | #5333 |
| 136 | #5336 |
| comprehensively | #5339 |
| gene expression | #5348 |
| immunology | #5348 |
| suppressive | #5348 |
| meat | #5350 |
| disease susceptibility | #5359 |
| supernatants | #5369 |
| new strategies | #5380 |
| illumina | #5384 |
| serum proteins | #5392 |
| 233 | #5406 |
| substantial | #5412 |
| discussions | #5423 |
| smad3 | #5429 |
| vitamin supplementation | #5436 |
| sensitized | #5441 |
| certainty | #5443 |
| 337 | #5450 |
| geometric | #5456 |
| 224 | #5465 |
| marks | #5470 |
| hypothesis | #5473 |
| growing evidence | #5475 |
| epidemiologic | #5476 |
| challenge | #5476 |
| phenotype | #5481 |
| healthy control subjects | #5495 |
| cytokines disease | #5496 |
| floor | #5496 |
| 373 | #5496 |
| road | #5504 |
| aged asthma | #5537 |
| alter | #5539 |
| 556 | #5544 |
| term exposure | #5547 |
| 454 | #5550 |
| coexpression | #5570 |
| predisposition | #5574 |
| 512 | #5578 |
| 45 | #5580 |
| lose | #5584 |
| 321 | #5595 |
| methacholine | #5602 |
| figures | #5602 |
| 2nd | #5610 |
| 258 | #5610 |
| 062 | #5630 |
| ld | #5634 |
| 14 years | #5637 |
| airflow | #5642 |
| contribute | #5645 |
| aa | #5661 |
| bacterial species | #5667 |
| protein coupled | #5668 |
| 081 | #5668 |
| notable | #5679 |
| contraceptives | #5682 |
| hints | #5688 |
| cytokine expression | #5693 |
| prebiotics | #5694 |
| commission | #5700 |
| 134 | #5704 |
| offspring | #5704 |
| cows | #5713 |
| cytokine production | #5722 |
| tlr7 | #5725 |
| presentations | #5727 |
| stepwise | #5729 |
| fecal samples | #5753 |
| animal humans | #5764 |
| 021 | #5770 |
| house | #5777 |
| rna expression | #5788 |
| cold | #5790 |
| maternal | #5797 |
| predominance | #5812 |
| persists | #5817 |
| humans immunity | #5824 |
| comprehensive | #5824 |
| cholecalciferol | #5831 |
| snps | #5833 |
| hen | #5848 |
| commensal | #5856 |
| 384 | #5863 |
| mites | #5878 |
| 078 | #5881 |
| bangladesh | #5887 |
| study genotype | #5888 |
| drug development | #5891 |
| sleeping | #5898 |
| workplace | #5900 |
| immunoglobulin igg | #5902 |
| paf | #5910 |
| study associations | #5924 |
| encourage | #5930 |
| adjust | #5930 |
| helper | #5938 |
| differ | #5944 |
| western europe | #5945 |
| investigate association | #5947 |
| questionnaire survey | #5947 |
| male risk | #5953 |
| 0017 | #5958 |
| 216 | #5963 |
| eastern europe | #5978 |
| promoter polymorphism | #5989 |
| disease prevalence | #5991 |
| longitudinal data | #5995 |
| interleukin15 | #5996 |
| adaptive immune | #5999 |
| calling | #6002 |
| patients symptoms | #6008 |
| 367 | #6008 |
| panels | #6009 |
| doseresponse relationship | #6012 |
| box | #6020 |
| pathogen interactions | #6022 |
| immune tolerance | #6023 |
| tract infections | #6029 |
| obese children | #6032 |
| adult population | #6032 |
| diversity | #6047 |
| existing methods | #6054 |
| risk variants | #6060 |
| prevalent | #6063 |
| eastern | #6064 |
| gmcsf | #6064 |
| modifier | #6066 |
| persisted | #6067 |
| restricted | #6068 |
| comparability | #6070 |
| 122 | #6072 |
| implication | #6077 |
| unselected | #6082 |
| ors | #6082 |
| ovalbumin | #6086 |
| microflora | #6091 |
| interleukin17 | #6094 |
| time flight | #6103 |
| 099 | #6113 |
| recruiting | #6117 |
| conferred | #6117 |
| genetic polymorphisms | #6122 |
| causality | #6128 |
| repeated | #6132 |
| fev1 | #6134 |
| fecal | #6135 |
| ahead | #6140 |
| 24 years | #6146 |
| programme | #6152 |
| 16 years | #6157 |
| town | #6158 |
| intermediate filament | #6161 |
| avec | #6163 |
| welfare | #6164 |
| gathered | #6166 |
| keeping | #6173 |
| constituent | #6182 |
| toluene | #6192 |
| determining | #6193 |
| genomewide association study | #6196 |
| narcotic | #6202 |
| conferring | #6205 |
| gross | #6216 |
| genuine | #6233 |
| populations | #6233 |
| illnesses | #6241 |
| institute | #6243 |
| administration inhalation | #6246 |
| prematurity | #6246 |
| protease inhibitor | #6252 |
| odds ratio 95 | #6262 |
| parents | #6266 |
| indoor environment | #6270 |
| study groups | #6270 |
| proposal | #6285 |
| offers | #6287 |
| irr | #6291 |
| communicable diseases | #6301 |
| nested | #6303 |
| alpha 1 | #6304 |
| tests | #6307 |
| young age | #6316 |
| outdoor | #6321 |
| allele frequencies | #6326 |
| infrequent | #6326 |
| interferons | #6343 |
| peptidase | #6346 |
| immunity mucosal | #6349 |
| 067 | #6355 |
| lymphocytes helper | #6360 |
| studies association | #6370 |
| 090 | #6375 |
| adjustments | #6385 |
| bivariate | #6388 |
| protective factor | #6390 |
| iu | #6394 |
| levels serum | #6400 |
| decreased risk | #6401 |
| immunological | #6409 |
| selection bias | #6410 |
| cell subsets | #6411 |
| genetic determinants | #6417 |
| infant premature | #6418 |
| 119 | #6439 |
| questions | #6448 |
| hypothesized | #6466 |
| mmp9 | #6467 |
| adverse health | #6475 |
| lower respiratory | #6475 |
| 287 | #6486 |
| 274 | #6490 |
| premature | #6493 |
| omalizumab | #6501 |
| sleep disturbance | #6507 |
| 238 | #6507 |
| gst | #6507 |
| links | #6512 |
| murine model | #6515 |
| infant feeding | #6523 |
| adam | #6524 |
| repeated measurements | #6527 |
| increased expression | #6529 |
| fev1 fvc | #6530 |
| diseases risk | #6548 |
| implied | #6555 |
| centers | #6567 |
| 1012 | #6571 |
| statements | #6572 |
| completion | #6598 |
| disease onset | #6602 |
| 283 | #6602 |
| children adults | #6604 |
| pollutant | #6605 |
| hospital admissions | #6617 |
| promoter region | #6624 |
| consumed | #6647 |
| accessible | #6653 |
| host pathogen | #6653 |
| adjusted 95 | #6654 |
| intervention studies | #6660 |
| playing | #6672 |
| candidate genes | #6684 |
| 138 | #6684 |
| bacterium | #6709 |
| cell responses | #6711 |
| systematic search | #6715 |
| cytokines dendritic | #6716 |
| washout | #6720 |
| nod2 | #6730 |
| impulse | #6732 |
| haplotypes | #6732 |
| cells disease | #6734 |
| 0009 | #6734 |
| ova | #6739 |
| focuses | #6745 |
| 126 | #6750 |
| n10 | #6757 |
| cities | #6761 |
| quartiles | #6763 |
| height weight | #6765 |
| mumps | #6769 |
| plethysmography | #6771 |
| eosinophilic | #6783 |
| disease mechanisms | #6787 |
| 065 | #6794 |
| developing | #6798 |
| 330 | #6807 |
| remained | #6813 |
| chronic exposure | #6823 |
| microbiology | #6831 |
| growing | #6846 |
| elucidated | #6846 |
| mz | #6852 |
| microorganism | #6861 |
| 305 | #6868 |
| cream | #6874 |
| lower incidence | #6887 |
| functional studies | #6890 |
| beef | #6896 |
| incidences | #6900 |
| inert | #6911 |
| academia | #6924 |
| supplementary | #6934 |
| zona | #6939 |
| multivariate logistic | #6941 |
| tertiles | #6948 |
| specific effects | #6949 |
| 1 diabetes | #6962 |
| 044 | #6965 |
| pathogenic bacteria | #6972 |
| lung | #6972 |
| maturation | #6975 |
| specialists | #6986 |
| infections | #6991 |
| transducer | #6998 |
| obesity bmi | #6999 |
| attendance | #7012 |
| summarizes | #7024 |
| infectious diseases | #7025 |
| shaping | #7027 |
| ribosomal 16s | #7033 |
| organic compounds | #7037 |
| 231 | #7041 |
| 028 | #7042 |
| confirming | #7043 |
| evidence association | #7046 |
| explaining | #7053 |
| amelioration | #7060 |
| concert | #7095 |
| 313 | #7102 |
| 019 | #7109 |
| type 1 diabetes | #7111 |
| linoleic acid | #7111 |
| triggering | #7114 |
| breath tests | #7117 |
| serum total | #7117 |
| 164 | #7122 |
| increased incidence | #7128 |
| th1 | #7132 |
| homeobox | #7134 |
| male membrane | #7135 |
| health humans | #7136 |
| homozygote | #7150 |
| consenting | #7153 |
| compare | #7155 |
| daily life | #7165 |
| increased risks | #7167 |
| agents anti | #7184 |
| likewise | #7184 |
| spatial variation | #7197 |
| develop | #7209 |
| health nutrition | #7223 |
| irritable bowel syndrome | #7227 |
| discusses | #7228 |
| helper cell | #7228 |
| spore | #7229 |
| cohort | #7231 |
| grow | #7238 |
| 163 | #7243 |
| influences | #7244 |
| beta1 | #7244 |
| analyses | #7255 |
| 0015 | #7268 |
| standardised | #7277 |
| 058 | #7278 |
| 053 | #7283 |
| handling | #7288 |
| urbanization | #7299 |
| herpesviridae | #7299 |
| 022 | #7309 |
| internationality | #7310 |
| single nucleotide polymorphisms | #7317 |
| personalized | #7355 |
| attending | #7374 |
| air pollutants | #7376 |
| 199 | #7387 |
| rome | #7392 |
| university | #7411 |
| linoleic | #7424 |
| potential risk | #7443 |
| histories | #7457 |
| 9 months | #7467 |
| human body | #7474 |
| boiling | #7486 |
| stratification | #7488 |
| bronchi | #7493 |
| spp | #7515 |
| alps | #7515 |
| enrollment | #7519 |
| intestinal diseases | #7523 |
| pediatrics | #7535 |
| toxoplasmosis | #7551 |
| bowel diseases | #7561 |
| allele | #7582 |
| eosinophil | #7586 |
| oropharyngeal | #7591 |
| considerably | #7612 |
| diseases animals | #7613 |
| overt | #7613 |
| worked | #7643 |
| school | #7649 |
| 316 | #7658 |
| haemophilus | #7669 |
| health conditions | #7671 |
| peanut | #7684 |
| prenatal | #7684 |
| rna ribosomal | #7700 |
| 161 | #7725 |
| nox | #7726 |
| europe | #7728 |
| leukocytes | #7731 |
| population | #7736 |
| characterised | #7744 |
| vehicles | #7748 |
| 308 | #7763 |
| single | #7777 |
| flora | #7792 |
| clinical examination | #7797 |
| infant male | #7799 |
| attended | #7802 |
| sputum | #7804 |
| reader | #7805 |
| lymphocyte subsets | #7808 |
| 66 | #7809 |
| 171 | #7839 |
| pyrosequencing | #7845 |
| conjunction | #7848 |
| m3 | #7856 |
| pa | #7859 |
| participation | #7865 |
| 1996 | #7881 |
| investigators | #7882 |
| specific | #7895 |
| deficiencies | #7898 |
| asked | #7899 |
| specificities | #7907 |
| months age | #7912 |
| parasitic | #7915 |
| epigenesis genetic | #7919 |
| neisseria | #7922 |
| 160 | #7928 |
| protective role | #7929 |
| egg | #7933 |
| therapeutic intervention | #7939 |
| listeria monocytogenes | #7941 |
| pbmcs | #7944 |
| fall | #7947 |
| unresolved | #7949 |
| lockdown | #7950 |
| prevalence incidence | #7950 |
| immune function | #7953 |
| altering | #7959 |
| human subjects | #7966 |
| collecting | #7980 |
| explanatory | #7997 |
| fatty acid composition | #8002 |
| lacking | #8024 |
| 264 | #8040 |
| bordetella | #8049 |
| phorbol | #8077 |
| separately | #8084 |
| rising | #8086 |
| 304 | #8087 |
| helper inducer | #8091 |
| weight infant | #8101 |
| 088 | #8109 |
| regarded | #8119 |
| determinants | #8119 |
| multiple logistic | #8132 |
| career | #8149 |
| factor binding | #8160 |
| polymorphism genetic | #8162 |
| gene regulation | #8172 |
| etiologies | #8201 |
| omega3 | #8202 |
| mutually | #8209 |
| initiative | #8212 |
| sophisticated | #8214 |
| 140 | #8224 |
| community based | #8228 |
| epigenesis | #8236 |
| emerged | #8237 |
| 266 | #8255 |
| hypotheses | #8257 |
| cars | #8265 |
| examination | #8283 |
| modifiable | #8285 |
| adolescent | #8294 |
| 242 | #8295 |
| hc | #8303 |
| belonged | #8306 |
| humans immunization | #8308 |
| based cohort | #8312 |
| nights | #8331 |
| objectives | #8337 |
| critical roles | #8342 |
| 111 | #8348 |
| nasal mucosa | #8351 |
| nineteen | #8357 |
| genera | #8357 |
| pylori infection | #8359 |
| normal weight | #8367 |
| instillation | #8385 |
| interleukin10 | #8388 |
| relative abundance | #8412 |
| latest | #8415 |
| author | #8420 |
| spearman | #8422 |
| infant low | #8429 |
| covariate | #8435 |
| authorities | #8438 |
| aspergillosis | #8440 |
| reduce risk | #8441 |
| 16s | #8447 |
| 113 | #8460 |
| multifactorial | #8460 |
| anhydride | #8462 |
| syncytial | #8462 |
| contrasting | #8463 |
| minor | #8478 |
| similarities | #8478 |
| profound | #8479 |
| investigate | #8497 |
| asthmatic patients | #8506 |
| resembles | #8511 |
| mass body | #8521 |
| genetic factors | #8538 |
| relations | #8543 |
| cytokines | #8544 |
| so2 | #8558 |
| prospective cohort study | #8565 |
| extract | #8568 |
| 4 years | #8590 |
| inclusion | #8598 |
| genetic loci | #8618 |
| humidity | #8633 |
| facilitates | #8642 |
| strong evidence | #8645 |
| logistic | #8648 |
| animal | #8656 |
| dendritic cells dcs | #8665 |
| adaptive | #8676 |
| 101 | #8677 |
| oropharynx | #8681 |
| defines | #8685 |
| histamine | #8716 |
| responsiveness | #8726 |
| increased odds | #8730 |
| choosing | #8732 |
| prevention | #8737 |
| 193 | #8776 |
| exploring | #8780 |
| 30 years | #8799 |
| airborne | #8805 |
| vdr | #8811 |
| incidence infant | #8815 |
| integrates | #8824 |
| unknown | #8840 |
| alveoli | #8852 |
| antibody levels | #8861 |
| traditional | #8865 |
| 155 | #8867 |
| association analysis | #8868 |
| humans logistic | #8879 |
| cesarean | #8884 |
| burden disease | #8884 |
| ears | #8884 |
| utilization | #8888 |
| residence | #8903 |
| bdnf | #8911 |
| pools | #8916 |
| 273 | #8926 |
| processed | #8935 |
| reactive protein | #8944 |
| pattern recognition | #8957 |
| lipopolysaccharide lps | #8958 |
| olive | #8963 |
| phase | #8966 |
| 177 | #8983 |
| 194 | #8996 |
| 0007 | #8998 |
| underlying | #9006 |
| 172 | #9017 |
| preschool humans | #9028 |
| surveyed | #9029 |
| humans lung | #9031 |
| sequelae | #9032 |
| receptor 4 | #9040 |
| population surveillance | #9046 |
| transferase | #9049 |
| cytokine | #9057 |
| boys girls | #9070 |
| london | #9088 |
| lower risk | #9095 |
| median duration | #9096 |
| parturition | #9101 |
| flanking | #9109 |
| nutritional physiological | #9139 |
| determinant | #9154 |
| statistical methods | #9170 |
| differing | #9175 |
| study selection | #9180 |
| butyrate | #9182 |
| secretions | #9187 |
| food | #9198 |
| exert | #9209 |
| dogs | #9217 |
| fungi | #9222 |
| 186 | #9234 |
| accompanying | #9239 |
| pattern | #9248 |
| human skin | #9259 |
| popularity | #9269 |
| multivariate analyses | #9269 |
| 04 | #9278 |
| 275 | #9282 |
| counts | #9296 |
| quintile | #9297 |
| controversial | #9299 |
| tract | #9302 |
| 95 women | #9304 |
| allele frequency | #9306 |
| haplotype | #9306 |
| outcome measures | #9309 |
| 345 | #9313 |
| anova | #9328 |
| prospectively | #9334 |
| eosinophilia | #9338 |
| vocs | #9351 |
| logistic regression analysis | #9353 |
| funded | #9360 |
| olds | #9364 |
| responders | #9364 |
| proteinase | #9366 |
| urban | #9376 |
| tlr4 | #9383 |
| infantile | #9386 |
| numerous | #9388 |
| 232 | #9392 |
| maldi | #9404 |
| ages | #9407 |
| newborn | #9409 |
| incidence | #9412 |
| 286 | #9422 |
| 5000 | #9432 |
| streptococcus | #9438 |
| extrinsic | #9445 |
| sick | #9460 |
| countries | #9478 |
| 016 | #9481 |
| anthropometric | #9495 |
| worker | #9498 |
| fatty acids | #9509 |
| longitudinally | #9512 |
| comprise | #9517 |
| markers | #9532 |
| antigen presenting | #9554 |
| 256 | #9559 |
| body composition | #9561 |
| airway obstruction | #9573 |
| 165 | #9574 |
| pharyngeal | #9579 |
| global health | #9583 |
| social class | #9585 |
| ifn gamma | #9589 |
| actinobacteria | #9597 |
| nutritive | #9598 |
| replicated | #9599 |
| occurrence | #9605 |
| lessons | #9617 |
| increases risk | #9627 |
| substances | #9659 |
| mucous | #9666 |
| adult mice | #9669 |
| crude | #9672 |
| dietary supplements | #9672 |
| child child | #9678 |
| reference | #9687 |
| obesity | #9698 |
| common genetic | #9743 |
| diagnoses | #9743 |
| populationbased study | #9744 |
| 9 | #9746 |
| p004 | #9752 |
| mothers | #9753 |
| mononuclear cells | #9760 |
| il10 | #9761 |
| proinflammatory | #9761 |
| publications | #9772 |
| directly | #9772 |
| 1 protein | #9773 |
| obstruction | #9774 |
| body mass bmi | #9788 |
| reliable | #9790 |
| 158 | #9800 |
| electrophoretic | #9807 |
| therapeutic strategies | #9818 |
| prove | #9826 |
| 20th | #9843 |
| random allocation | #9844 |
| cluster | #9849 |
| 102 | #9849 |
| modifying | #9850 |
| rrna | #9873 |
| nps | #9884 |
| restrictive | #9899 |
| altogether | #9903 |
| reality | #9904 |
| receptors | #9909 |
| immunomodulatory | #9920 |
| tagging | #9925 |
| intranasal | #9929 |
| century | #9933 |
| 39 | #9935 |
| southern | #9938 |
| bacterial infections | #9964 |
| 1991 | #9964 |
| tnf α | #9973 |
| 0002 | #9995 |
| exclusively | #10002 |
| 152 | #10006 |
| lavage fluid | #10012 |
| presenting cells | #10012 |
| particulate matter | #10015 |
| mass bmi | #10020 |
| health outcomes | #10050 |
| reproducible | #10052 |
| 57 | #10065 |
| disappeared | #10087 |
| 87 | #10096 |
| elucidation | #10099 |
| parts | #10121 |
| superoxide dismutase | #10123 |
| immune cell | #10127 |
| 072 | #10143 |
| nasal | #10159 |
| exist | #10160 |
| bias | #10162 |
| expression genes | #10164 |
| ascertained | #10166 |
| sedentary behavior | #10168 |
| exclusions | #10169 |
| 4 months | #10169 |
| timing | #10174 |
| incidence prevalence | #10175 |
| discover | #10203 |
| western | #10210 |
| microbial communities | #10218 |
| fungal | #10222 |
| adaptor proteins | #10226 |
| alpha subunit | #10236 |
| weaker | #10259 |
| influenzae | #10264 |
| 212 | #10290 |
| study children | #10303 |
| ghana | #10324 |
| aim | #10332 |
| analyze | #10356 |
| factorial | #10361 |
| interleukin12 | #10361 |
| 142 | #10364 |
| concepts | #10386 |
| centrally | #10386 |
| methodologies | #10387 |
| ulcerative colitis | #10399 |
| respiratory disease | #10403 |
| 17 | #10408 |
| polyunsaturated | #10422 |
| parasites | #10430 |
| scientific | #10436 |
| modelled | #10448 |
| nose | #10465 |
| flow rate | #10471 |
| bronchiolitis | #10473 |
| exposed | #10477 |
| 07 | #10499 |
| realtime pcr | #10503 |
| c3h | #10522 |
| twothirds | #10527 |
| interquartile range | #10528 |
| adjusted | #10532 |
| acetates | #10561 |
| 94 | #10565 |
| new zealand | #10576 |
| biodiversity | #10595 |
| 010 | #10595 |
| societal | #10603 |
| france | #10605 |
| priming | #10614 |
| homeodomain | #10623 |
| time pcr | #10638 |
| boys | #10643 |
| indirectly | #10650 |
| bacteriological | #10653 |
| 206 | #10664 |
| 004 | #10665 |
| ribosomal | #10691 |
| vitamins | #10703 |
| bidirectional | #10706 |
| positivity | #10711 |
| possibilities | #10723 |
| 008 | #10728 |
| items | #10729 |
| newborn infant | #10763 |
| ancestry female | #10768 |
| nitrous | #10770 |
| swabs | #10771 |
| entered | #10774 |
| regulation humans | #10776 |
| female gastrointestinal | #10776 |
| responses | #10786 |
| skin | #10787 |
| transferases | #10789 |
| increased production | #10799 |
| national institute | #10805 |
| suppressing | #10825 |
| workshop | #10850 |
| physical activity | #10855 |
| postnatal | #10859 |
| prevent | #10862 |
| bronchoalveolar | #10864 |
| fvc | #10873 |
| km2 | #10911 |
| functional role | #10915 |
| standardization | #10926 |
| 2002 | #10934 |
| 036 | #10944 |
| carriers | #10949 |
| subclinical | #10957 |
| microbiological | #10968 |
| subsequent | #10971 |
| 16s rrna | #10983 |
| immunoglobulins | #10986 |
| lps | #10988 |
| 217 | #10992 |
| roc | #10992 |
| 191 | #10993 |
| constituents | #10993 |
| harm | #10994 |
| 197 | #10996 |
| aerosol | #11002 |
| swiss | #11006 |
| inconsistent | #11009 |
| chance | #11022 |
| poland | #11028 |
| antibody responses | #11043 |
| amniotic | #11054 |
| 6 12 | #11055 |
| low birth | #11092 |
| serology | #11092 |
| passive | #11120 |
| chromosomes human | #11127 |
| ulcerative | #11134 |
| disturbed | #11159 |
| 235 | #11177 |
| crohn | #11187 |
| community | #11188 |
| 144 | #11222 |
| gut | #11232 |
| il12 | #11233 |
| confined | #11247 |
| environmental pollutants | #11258 |
| fourth | #11270 |
| 157 | #11286 |
| rna messenger | #11289 |
| duration | #11314 |
| regulatory mechanisms | #11327 |
| highest risk | #11328 |
| intron | #11330 |
| studies diet | #11351 |
| persistent | #11353 |
| chronic diseases | #11376 |
| 040 | #11389 |
| birth weight | #11397 |
| juvenile | #11415 |
| nitrogen dioxide | #11427 |
| cell function | #11428 |
| modulate | #11435 |
| supplements | #11440 |
| 18 years | #11446 |
| discuss | #11455 |
| female | #11457 |
| 105 | #11459 |
| epigenetics | #11463 |
| gut microbiota | #11475 |
| quinolines | #11485 |
| genetic susceptibility | #11493 |
| 128 | #11502 |
| factor1 | #11515 |
| 86 | #11521 |
| haemophilus influenzae | #11522 |
| late onset | #11524 |
| helicobacter | #11533 |
| biomarker | #11536 |
| 012 | #11542 |
| cd28 | #11550 |
| interact | #11564 |
| 78 | #11583 |
| proteases | #11587 |
| households | #11587 |
| variant | #11588 |
| physiological phenomena | #11594 |
| healthy control | #11597 |
| 130 | #11601 |
| celiac | #11633 |
| risk disease | #11636 |
| dispersion | #11666 |
| narrative | #11668 |
| interquartile | #11709 |
| gene polymorphisms | #11736 |
| introduction | #11752 |
| trimester pregnancy | #11755 |
| confirmation | #11758 |
| harmful | #11806 |
| lipopolysaccharides | #11813 |
| 222 | #11824 |
| gram negative | #11824 |
| irrespective | #11831 |
| 075 | #11858 |
| subtypes | #11860 |
| episodes | #11867 |
| incident | #11881 |
| insight | #11899 |
| fetal | #11900 |
| 230 | #11904 |
| air | #11924 |
| started | #11931 |
| genetic | #11936 |
| ifn | #11939 |
| 1990 | #11944 |
| autoantigens | #11967 |
| natural | #11982 |
| lowest | #11990 |
| genetic association | #11992 |
| protein levels | #11997 |
| finding | #12007 |
| initially | #12014 |
| 151 | #12047 |
| solely | #12055 |
| quantifying | #12075 |
| pcr | #12106 |
| case control | #12121 |
| ultimately | #12124 |
| upregulation | #12127 |
| immunologic factors | #12176 |
| subsets | #12179 |
| estimating | #12184 |
| country | #12201 |
| young children | #12219 |
| 149 | #12221 |
| inflammatory response | #12238 |
| leukocyte count | #12248 |
| fish oil | #12249 |
| december | #12256 |
| sle | #12270 |
| shifted | #12297 |
| began | #12327 |
| relapsing | #12330 |
| antibiotics | #12339 |
| 006 | #12341 |
| gm | #12351 |
| completed | #12354 |
| european continental | #12371 |
| minority | #12421 |
| linkage | #12422 |
| reasons | #12444 |
| ifngamma | #12445 |
| relevance | #12447 |
| lung tissue | #12462 |
| colonization | #12463 |
| 170 | #12467 |
| european | #12469 |
| inflammatory cytokine | #12469 |
| lymphocyte activation | #12520 |
| saline | #12546 |
| 17 years | #12583 |
| scarce | #12583 |
| 117 | #12590 |
| defense | #12609 |
| length polymorphism | #12616 |
| predictors | #12620 |
| tobacco | #12634 |
| crohns disease | #12638 |
| discriminating | #12641 |
| 203 | #12655 |
| residence characteristics | #12657 |
| tested | #12664 |
| collect | #12680 |
| detectable | #12682 |
| 156 | #12683 |
| cd3 | #12684 |
| total | #12687 |
| child development | #12695 |
| cystic fibrosis | #12696 |
| contributing | #12697 |
| residential | #12708 |
| multicentre | #12731 |
| beta2 | #12735 |
| aspect | #12741 |
| swedish | #12751 |
| enhancer | #12752 |
| 204 | #12773 |
| clinical manifestations | #12796 |
| 184 | #12815 |
| lung diseases | #12819 |
| combinations | #12856 |
| 104 | #12860 |
| pregnancy | #12873 |
| aspects | #12899 |
| sedentary | #12908 |
| translated | #12918 |
| elevated levels | #12943 |
| infants | #12943 |
| united kingdom | #12946 |
| debate | #12955 |
| human genome | #12959 |
| inflammatory bowel | #12963 |
| coded | #12998 |
| 154 | #13016 |
| 52 | #13056 |
| annually | #13056 |
| 220 | #13057 |
| elusive | #13067 |
| extracellular vesicles | #13082 |
| suffer | #13086 |
| future | #13086 |
| glucocorticoids humans | #13096 |
| genetic rna | #13096 |
| intrauterine | #13097 |
| measurable | #13120 |
| delayed | #13147 |
| conversely | #13160 |
| schistosomiasis | #13161 |
| differential effects | #13191 |
| strong association | #13209 |
| glucocorticoid | #13217 |
| methodological | #13236 |
| great | #13255 |
| developing countries | #13257 |
| 127 | #13262 |
| consultation | #13264 |
| 276 | #13267 |
| 018 | #13274 |
| proportions | #13279 |
| stimulated | #13297 |
| weaning | #13299 |
| hallmark | #13313 |
| 017 | #13323 |
| manifestations | #13333 |
| gene | #13338 |
| odds ratios | #13351 |
| nucleotide risk | #13354 |
| pediatric | #13397 |
| crp | #13407 |
| initiate | #13419 |
| 11 | #13424 |
| burden | #13446 |
| bowel | #13447 |
| kingdom | #13448 |
| auc | #13449 |
| mechanisms underlying | #13450 |
| 210 | #13457 |
| 20th century | #13476 |
| younger | #13480 |
| secretion | #13500 |
| 129 | #13518 |
| considerable | #13527 |
| 045 | #13543 |
| relevant | #13545 |
| confirm | #13567 |
| beijing | #13578 |
| visits | #13581 |
| 188 | #13602 |
| statistically | #13612 |
| respiratory syncytial | #13621 |
| 1989 | #13652 |
| inheritance | #13663 |
| 181 | #13690 |
| argue | #13695 |
| 020 | #13702 |
| depending | #13723 |
| lavage | #13735 |
| 014 | #13736 |
| pneumonia | #13774 |
| study association | #13782 |
| neighboring | #13790 |
| impairment | #13810 |
| sweden | #13833 |
| schistosoma | #13835 |
| severe | #13852 |
| concerns | #13856 |
| cohorts | #13856 |
| establishing | #13859 |
| genomics humans | #13875 |
| human pair | #13893 |
| ranged | #13900 |
| multiplex | #13937 |
| loci | #13953 |
| membrane glycoproteins | #14048 |
| mental health | #14054 |
| additionally | #14064 |
| chromosomes | #14069 |
| fat mass | #14090 |
| restore | #14107 |
| tendency | #14138 |
| nucleotide polymorphism | #14141 |
| establish | #14142 |
| subgroups | #14166 |
| immigrants | #14182 |
| randomly selected | #14189 |
| examples | #14202 |
| fetal development | #14226 |
| expand | #14234 |
| 183 | #14237 |
| concomitant | #14257 |
| socioeconomic status | #14258 |
| multigene | #14259 |
| disease genome | #14278 |
| refined | #14314 |
| breast | #14318 |
| unsaturated | #14320 |
| addresses | #14337 |
| independently | #14350 |
| health organization | #14355 |
| tightly | #14399 |
| amniotic fluid | #14424 |
| severity | #14432 |
| 121 | #14439 |
| penicillium | #14441 |
| epidemiologic studies | #14443 |
| tuberculosis | #14444 |
| 1 month | #14454 |
| studying | #14492 |
| 007 | #14492 |
| derivation | #14517 |
| tolerance | #14521 |
| contributed | #14529 |
| conclude | #14532 |
| systematically | #14533 |
| elevated | #14573 |
| humans | #14580 |
| factors socioeconomic | #14586 |
| cystic | #14593 |
| stranded | #14599 |
| food intake | #14600 |
| horse | #14606 |
| animals antigens | #14624 |
| 6 | #14638 |
| differentially expressed | #14641 |
| effector cells | #14675 |
| 205 | #14693 |
| striking | #14700 |
| lymphocyte count | #14703 |
| lipopolysaccharide | #14704 |
| filament | #14706 |
| transcription | #14707 |
| representative | #14726 |
| tetradecanoylphorbol | #14755 |
| classify | #14766 |
| trimester | #14772 |
| operate | #14777 |
| represents | #14788 |
| glycoproteins | #14799 |
| maximal | #14801 |
| cells patients | #14821 |
| determines | #14831 |
| 2 years | #14850 |
| seropositivity | #14866 |
| genetic analysis | #14890 |
| mice mice | #14912 |
| 002 | #14917 |
| ancestry | #14925 |
| maternal age | #14929 |
| clostridium | #14981 |
| marker | #14999 |
| ctla4 | #15005 |
| 162 | #15012 |
| ethnic | #15032 |
| male | #15042 |
| receptor | #15068 |
| compared healthy | #15084 |
| modulates | #15087 |
| disparities | #15118 |
| 00001 | #15123 |
| stronger | #15140 |
| p00001 | #15177 |
| luciferase | #15184 |
| gram | #15200 |
| longitudinal studies | #15223 |
| immune cells | #15233 |
| 131 | #15264 |
| hong kong | #15269 |
| cumulative | #15330 |
| copd | #15346 |
| nfkappab | #15356 |
| environmental monitoring | #15362 |
| socioeconomic | #15368 |
| gestational age | #15392 |
| curve | #15407 |
| physician | #15419 |
| integrate | #15467 |
| induce | #15469 |
| assessing | #15476 |
| modulated | #15501 |
| cells dcs | #15509 |
| perinatal | #15516 |
| pregnancy risk | #15527 |
| gonadal | #15550 |
| marked | #15553 |
| dysregulation | #15556 |
| feces | #15556 |
| 003 | #15556 |
| 110 | #15569 |
| built | #15581 |
| archaea | #15621 |
| tgfβ | #15667 |
| cytometry | #15669 |
| controlling | #15688 |
| inflammatory agents | #15708 |
| dietary fats | #15739 |
| cell surface receptors | #15743 |
| igg | #15765 |
| genotype | #15766 |
| il1 | #15772 |
| imply | #15830 |
| pregnant | #15831 |
| exclusive | #15843 |
| developed countries | #15863 |
| 47 | #15874 |
| cells animals | #15894 |
| 116 | #15895 |
| socioeconomic factors | #15901 |
| sensitivity specificity | #15922 |
| reflected | #15966 |
| humans inflammation | #15992 |
| agreement | #16016 |
| varies | #16017 |
| diagnosed | #16043 |
| unrelated | #16046 |
| casecontrol study | #16049 |
| filled | #16050 |
| transient | #16060 |
| conditional | #16084 |
| interleukin1beta | #16103 |
| major | #16105 |
| 12 | #16129 |
| located | #16168 |
| homozygous | #16182 |
| effector | #16208 |
| inducer | #16232 |
| anti inflammatory | #16238 |
| transducing | #16239 |
| psychosocial | #16242 |
| 93 | #16314 |
| born | #16347 |
| dendritic cells | #16365 |
| define | #16372 |
| causing | #16382 |
| bacterial | #16387 |
| 7 | #16394 |
| genome wide | #16420 |
| varied | #16428 |
| squared | #16431 |
| volatile | #16432 |
| 082 | #16433 |
| bacteria | #16447 |
| represented | #16476 |
| height | #16488 |
| ibd | #16518 |
| established | #16536 |
| identifying | #16549 |
| participants | #16561 |
| thought | #16634 |
| triggered | #16636 |
| areas | #16662 |
| broad | #16671 |
| academic | #16675 |
| functionally | #16694 |
| microsatellite | #16697 |
| genetic polymorphism | #16725 |
| characterizing | #16726 |
| 0006 | #16756 |
| dendritic | #16762 |
| centre | #16765 |
| 084 | #16783 |
| distributed | #16795 |
| agricultural | #16798 |
| dead | #16800 |
| nitric oxide | #16855 |
| chromosome | #16895 |
| bowel disease | #16898 |
| personal | #16912 |
| 09 | #16918 |
| 91 | #16918 |
| investigating | #16978 |
| utilize | #16980 |
| opportunities | #17033 |
| promoter | #17034 |
| steroid | #17056 |
| anti bacterial | #17061 |
| dna bacterial | #17074 |
| 81 | #17089 |
| mother | #17091 |
| epigenetic | #17095 |
| continuing | #17105 |
| messenger | #17106 |
| progression | #17115 |
| monocytes | #17130 |
| genotypes | #17190 |
| confirms | #17201 |
| individual | #17225 |
| seasons | #17244 |
| 53 | #17287 |
| untranslated | #17292 |
| denmark | #17301 |
| 137 | #17321 |
| retinoic | #17351 |
| earlier | #17361 |
| drug therapy | #17361 |
| cross | #17377 |
| encountered | #17387 |
| taxonomic | #17423 |
| visible | #17455 |
| strong | #17549 |
| excluding | #17551 |
| tnfalpha | #17598 |
| heterozygote | #17605 |
| alleles | #17619 |
| avoidance | #17647 |
| bronchoalveolar lavage | #17656 |
| bacterial agents | #17666 |
| introduced | #17690 |
| cd4 cells | #17717 |
| dcs | #17724 |
| initiating | #17727 |
| comparing | #17740 |
| newborns | #17784 |
| quantified | #17787 |
| regression | #17798 |
| lesser | #17810 |
| geographical | #17857 |
| interviewed | #17866 |
| 84 | #17903 |
| covering | #17927 |
| prospective | #17949 |
| bmi | #17963 |
| animals | #17994 |
| 009 | #18003 |
| drawn | #18014 |
| disease chronic | #18024 |
| longitudinal | #18047 |
| particulate | #18073 |
| monthly | #18086 |
| 77 | #18100 |
| altered | #18146 |
| 085 | #18150 |
| publication administration | #18171 |
| children adolescents | #18178 |
| snp | #18187 |
| neurotrophic | #18224 |
| systemic lupus erythematosus | #18235 |
| samples | #18263 |
| restriction fragment | #18268 |
| negative | #18269 |
| dismutase | #18321 |
| susceptibility | #18324 |
| demographics | #18339 |
| recognize | #18347 |
| inflammatory responses | #18460 |
| inflammatory bowel disease | #18499 |
| chemokines | #18511 |
| served | #18518 |
| difference | #18526 |
| mast cell | #18536 |
| 148 | #18545 |
| replication | #18548 |
| exists | #18580 |
| immunization | #18589 |
| remain | #18590 |
| intervals | #18593 |
| secretory | #18604 |
| carried | #18634 |
| fold | #18655 |
| provided | #18675 |
| 83 | #18683 |
| 36 | #18709 |
| symptom | #18710 |
| differentially | #18718 |
| variation genome | #18742 |
| rise | #18757 |
| weight | #18797 |
| epithelial cells | #18798 |
| candidate | #18807 |
| sum | #18807 |
| additional | #18812 |
| immunophenotyping | #18818 |
| families | #18838 |
| 1997 | #18843 |
| basis | #18843 |
| 28 | #18854 |
| maintain | #18856 |
| variants | #18858 |
| 13 | #18882 |
| fragment length | #18919 |
| missing | #18966 |
| lower | #18985 |
| sampling | #19004 |
| receptors cell | #19024 |
| intake | #19030 |
| vitamin | #19034 |
| experiencing | #19122 |
| susceptible | #19133 |
| fats | #19173 |
| balb mice | #19208 |
| crosssectional study | #19250 |
| c57bl mice | #19256 |
| promoter regions | #19283 |
| polymerase | #19291 |
| locus | #19302 |
| clinical presentation | #19308 |
| 1992 | #19352 |
| contributes | #19382 |
| termed | #19414 |
| mouse model | #19415 |
| trait loci | #19415 |
| clear | #19476 |
| partially | #19504 |
| completely | #19506 |
| elucidate | #19510 |
| socio | #19512 |
| × 10 | #19521 |
| pollutants | #19552 |
| validated | #19554 |
| necrosis | #19582 |
| illustrate | #19602 |
| lasting | #19718 |
| time polymerase | #19720 |
| healthrelated quality | #19789 |
| polymerase chain | #19797 |
| 1998 | #19855 |
| inbred balb mice | #19855 |
| chronic obstructive | #19868 |
| 5 years | #19869 |
| selecting | #19937 |
| carrying | #19967 |
| context | #19977 |
| baseline | #19977 |
| negatively | #19998 |
| 95 confidence interval | #20023 |
| inbred balb | #20051 |
| interferon gamma | #20056 |
| easy | #20065 |
| acetaminophen | #20066 |
| shared | #20130 |
| 74 | #20150 |
| 64 | #20157 |
| health | #20163 |
| activates | #20164 |
| summary | #20181 |
| reporter | #20212 |
| serological | #20244 |
| adjusting | #20271 |
| 1 year | #20289 |
| interacting | #20295 |
| autoimmune diseases | #20301 |
| 61 | #20339 |
| stimulation | #20363 |
| 14 | #20418 |
| identifies | #20457 |
| demonstrating | #20473 |
| 2003 | #20528 |
| humans longitudinal | #20557 |
| returned | #20566 |
| ratio | #20593 |
| 26 | #20613 |
| inflammatory | #20615 |
| interactions | #20618 |
| behavior female | #20629 |
| nitric | #20636 |
| chain reaction | #20655 |
| upregulated | #20694 |
| highest | #20707 |
| genetically | #20746 |
| immunologic | #20771 |
| recurrent | #20779 |
| cells female | #20794 |
| interleukin | #20806 |
| wide | #20813 |
| clarify | #20844 |
| blood | #20864 |
| 51 | #20870 |
| cd4 cell | #20884 |
| rodents | #20894 |
| infectious | #20895 |
| causal | #20898 |
| create | #20974 |
| mucosal | #20983 |
| named | #20988 |
| obstructive | #20991 |
| interval | #21015 |
| suggesting | #21054 |
| 59 | #21130 |
| hereditary | #21187 |
| identical | #21192 |
| followup | #21199 |
| regulation | #21207 |
| epithelial cell | #21236 |
| essentially | #21325 |
| kappab | #21354 |
| variety | #21563 |
| mast | #21565 |
| celiac disease | #21617 |
| infection | #21622 |
| endpoint | #21718 |
| tumor necrosis | #21799 |
| reduced | #21829 |
| 10 years | #21837 |
| measures | #21851 |
| stress psychological | #21874 |
| alterations | #22024 |
| definitive | #22102 |
| assess | #22118 |
| continued | #22161 |
| correlate | #22201 |
| familial | #22235 |
| ensure | #22257 |
| frequency | #22288 |
| abolished | #22332 |
| continental ancestry | #22431 |
| reflecting | #22432 |
| unchanged | #22438 |
| validation | #22455 |
| score | #22546 |
| frequent | #22558 |
| tumor necrosis factor | #22615 |
| 95 confidence | #22620 |
| balb | #22645 |
| closely | #22684 |
| genes | #22753 |
| coupled | #22803 |
| continuously | #22829 |
| reactive | #22841 |
| indicating | #22843 |
| comparable | #22875 |
| murine | #22957 |
| 22 | #22977 |
| neonatal | #22988 |
| supported | #23008 |
| introduce | #23009 |
| type 1 | #23013 |
| report | #23048 |
| ifnγ | #23104 |
| necrosis factor | #23137 |
| predict | #23148 |
| lived | #23179 |
| increasingly | #23205 |
| rich | #23217 |
| count | #23292 |
| smoking | #23305 |
| modulating | #23348 |
| late | #23357 |
| mechanisms | #23394 |
| confidence | #23438 |
| 1 | #23526 |
| young | #23528 |
| adjustment | #23611 |
| exclude | #23665 |
| endopeptidases | #23709 |
| adolescents | #23720 |
| factors united | #23849 |
| defined | #23927 |
| extensive | #23929 |
| body | #24002 |
| dietary | #24027 |
| intracellular | #24110 |
| 5 | #24167 |
| 3 | #24232 |
| lymphocytes | #24242 |
| aimed | #24342 |
| increasing | #24355 |
| symptomatic | #24455 |
| depend | #24530 |
| reduces | #24548 |
| interaction | #24609 |
| collected | #24626 |
| adults | #24658 |
| remains | #24734 |
| needed | #24798 |
| responsible | #24851 |
| rsv | #24888 |
| 15 | #24969 |
| putative | #25032 |
| identification | #25068 |
| enrolled | #25223 |
| representing | #25239 |
| yielded | #25263 |
| determine | #25273 |
| extracellular | #25281 |
| analysis performed | #25297 |
| sex factors | #25359 |
| documented | #25522 |
| anti | #25535 |
| describing | #25574 |
| comprised | #25660 |
| matter | #25795 |
| transcriptase polymerase | #25871 |
| continue | #25896 |
| lymphocyte | #25994 |
| decreased | #26047 |
| enabling | #26157 |
| diminished | #26261 |
| previous | #26271 |
| healthy | #26310 |
| 16 | #26319 |
| profiling gene | #26374 |
| implicated | #26377 |
| dioxide | #26380 |
| inflammation | #26386 |
| tended | #26519 |
| applied | #26644 |
| contained | #26780 |
| describes | #26787 |
| generally | #26891 |
| multivariate | #26969 |
| capable | #27003 |
| unaffected | #27064 |
| presenting | #27110 |
| moderate | #27144 |
| 18 | #27195 |
| heterozygous | #27203 |
| acquired | #27213 |
| oligonucleotide | #27226 |
| concluded | #27331 |
| undergone | #27359 |
| topic | #27376 |
| proteins signal | #27393 |
| reached | #27432 |
| large | #27637 |
| recognized | #27654 |
| positive lymphocytes | #27691 |
| 001 | #27802 |
| linked | #27832 |
| preschool female | #27932 |
| models genetic | #27987 |
| predicted | #28046 |
| 0005 | #28071 |
| subsequently | #28087 |
| quantitative | #28099 |
| respect | #28131 |
| represent | #28157 |
| impaired | #28234 |
| reverse transcriptase | #28434 |
| continental | #28581 |
| plays | #28633 |
| positive | #28648 |
| immunoenzyme | #28655 |
| occurring | #28707 |
| screened | #28708 |
| square distribution | #28750 |
| transcriptase | #29017 |
| quantitative trait | #29137 |
| versus | #29158 |
| allowed | #29194 |
| comparison | #29267 |
| affect | #29339 |
| administered | #29469 |
| easily | #29520 |
| human | #29690 |
| weak | #29736 |
| possess | #29786 |
| physical | #29792 |
| pair | #29885 |
| correlated | #29909 |
| chain | #29911 |
| characterize | #29984 |
| gastrointestinal | #30316 |
| providing | #30537 |
| 005 | #30590 |
| aims | #30608 |
| factual | #30658 |
| 2 | #30659 |
| confirmed | #30719 |
| markedly | #30761 |
| 4 | #30907 |
| eligible | #31311 |
| fatty | #31332 |
| upper | #31437 |
| frequently | #32564 |
| mice knockout | #32696 |
| predictive tests | #32836 |
| peripheral | #32944 |
| humanized | #33092 |
| expression | #33163 |
| registered | #33261 |
| functional | #33617 |
| dominated | #33759 |
| selected | #33999 |
| mediated | #34372 |
| independent | #34407 |
| activate | #34542 |
| acids | #34703 |
| occur | #34769 |
| mediate | #35225 |
| conducted | #35568 |
| national | #35610 |
| evaluate | #35821 |
| 0001 | #35859 |
| developed | #36145 |
| characterized | #36394 |
| measurements | #36573 |
| express | #37054 |
| measured | #37778 |
| follow studies | #37967 |
| appears | #37978 |
| biological | #38141 |
| examined | #38373 |
| include | #39853 |
| adult | #39859 |
| clinically | #40140 |
| united | #42200 |
| mice inbred | #42559 |
| consistent | #42590 |
| excluded | #42832 |
| expression regulation | #43143 |
| inbred | #45657 |
运行报告 | |
Prominent publications by Erika RM von Mutius
KOL-Index: 23349
BACKGROUND: Exposure to paracetamol during intrauterine life, childhood, and adult life may increase the risk of developing asthma. We studied 6-7-year-old children from Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) programme to investigate the association between paracetamol consumption and asthma.
METHODS: As part of Phase Three of ISAAC, parents or guardians of children aged 6-7 years completed written questionnaires about symptoms of asthma, ...
| 闻名 Risk Asthma | 7 Years | Year Life | Children Aged | Rhinoconjunctivitis Eczema |
KOL-Index: 18397
BACKGROUND: Phase III of the International Study of Asthma and Allergies in Childhood measured the global prevalence of symptoms of asthma, rhinoconjunctivitis, and eczema in children.
OBJECTIVE: To investigate the associations between the use of antibiotics in the first year of life and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old.
METHODS: Parents or guardians of children 6 and 7 years old completed written questionnaires on current symptoms and ...
| 闻名 International Study | Rhinoconjunctivitis Eczema | Year Life | Symptoms Asthma | 95 Risk Factors |
Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood
[ PUBLICATION ]
Importance: Atopic dermatitis is an inflammatory, pruritic skin disease that often occurs in early infancy with a chronic course. However, a specific description of subtypes of atopic dermatitis depending on the timing of onset and progression of the disease in childhood is lacking.
Objective: To identify different phenotypes of atopic dermatitis using a definition based on symptoms before age 6 years and to determine whether some subtypes are more at risk for developing other allergic ...
| 闻名 Atopic Dermatitis | 6 Years | Age Children | Allergic Diseases | Food Allergy |
KOL-Index: 17686
BACKGROUND: Associations between exposure to cats and dogs and respiratory and allergic outcomes in children have been reported in affluent countries, but little is known about such associations in less-affluent countries.
METHODS: The International Study of Asthma and Allergies in Childhood, phase 3 was carried out in children aged 6-7 years and adolescents aged 13-14 years across the world. Questions about cats and dogs in the home were included in an additional questionnaire. Using ...
| 闻名 Cats Dogs | Asthma Rhinoconjunctivitis | Affluent Countries | Children Adolescents | International Study |
KOL-Index: 15451
BACKGROUND: There is increasing evidence that environmental exposures determining childhood illnesses operate early in life. Prenatal exposure to a farming environment through the mother might also play an important role.
OBJECTIVE: We sought to investigate the role of maternal exposures to environments rich in microbial compounds for the development of atopic sensitization, asthma, and corresponding alterations in the innate immune system in offspring.
METHODS: In the children of the ...
| 闻名 Atopic Sensitization | Innate Immunity | Farm Exposure | Microbial Compounds | Expression Receptors |
Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study
[ PUBLICATION ]
BACKGROUND: Reduced lung function is a feature of chronic asthma, which becomes apparent at school age. Unknown factors between birth and school age determine the progressive loss of pulmonary function in children with persistent asthma. We investigated the role of allergic sensitisation and allergen exposure early in life.
METHODS: The German Multicentre Allergy Study followed 1314 children from birth to 13 years of age. We regularly interviewed parents about their child's asthma and ...
| 闻名 Chronic Asthma | School Age | Life Children | Birth Cohort | Allergen Exposure |
Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison.
[ PUBLICATION ]
OBJECTIVES: To compare the prevalence of asthma and allergic disorders among children in Munich, western Germany, and Leipzig, eastern Germany, where environmental exposure, particularly air concentrations of sulphur dioxide and particulate matter, and living conditions have differed over the past 45 years.
DESIGN: Prevalence surveys among school-children aged 9-11 years in Leipzig and Munich. Self completion of written questionnaire by the children's parents and lung function ...
| 闻名 Allergic Disorders | Munich Leipzig | Prevalence Asthma | Seasonal Surveys | Living Conditions |
KOL-Index: 14833
BACKGROUND: Asthma is a complex disease that has genetic and environmental causes. The genetic factors associated with susceptibility to asthma remain largely unknown.
METHODS: We carried out a genomewide association study involving children with asthma. The sample included 793 North American children of European ancestry with persistent asthma who required daily inhaled glucocorticoid therapy and 1988 matched controls (the discovery set). We also tested for genomewide association in an ...
| 闻名 European Ancestry | Association Asthma | Single Nucleotide Receptors | Tumor Necrosis Factor | Human Pair |
Early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema: an ISAAC Phase Three Study
[ PUBLICATION ]
BACKGROUND: Associations between early life exposure to farm animals and respiratory symptoms and allergy in children have been reported in developed countries, but little is known about such associations in developing countries.
OBJECTIVE: To study the association between early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema in a worldwide study.
METHODS: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) was carried ...
| 闻名 Farm Animals | Asthma Rhinoconjunctivitis | Isaac Phase | Early Life | Affluent Countries |
KOL-Index: 14598
The German reunification offers a unique opportunity to study the impact of environmental factors on the development of childhood respiratory and allergic disorders in ethnically similar populations. We investigated the prevalence of asthma, hay fever, atopy, and bronchial hyperresponsiveness (BHR) in 9- to 11-year old children in West Germany (n = 5,030) and East Germany (n = 2,623). A self-administered questionnaire was distributed to the parents. Children underwent cold air challenge ...
| 闻名 East Germany | Asthma Fever | Prevalence Bhr | Environmental Factors | Atopic Sensitization |
Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods
[ PUBLICATION ]
International comparative studies, investigating whether disease incidence or prevalence rates differ between populations and, if so, which factors explain the observed differences, have made important contributions to the understanding of disease aetiology in many areas. In Phase I of the International Study of Asthma and Allergies in Childhood (ISAAC), the prevalence rates of symptoms of asthma, allergic rhinitis and atopic eczema in 13-14-yr-olds, assessed by standardised ...
| 闻名 International Study | Asthma Allergies | Prevalence Rates | Atopic Eczema | Childhood Isaac |
KOL-Index: 13844
BACKGROUND: Mutations in the filaggrin gene (FLG) have been shown to play a significant role in ichthyosis vulgaris and eczema, 2 common chronic skin diseases. However, their role in the development of other atopic diseases such as asthma and rhinitis has not yet been clarified in large population-based studies.
OBJECTIVES: To study the effect of FLG mutations at the population level and their effect on other atopic phenotypes.
METHODS: Association analysis of the 2 common FLG-null ...
| 闻名 Filaggrin Mutations | Atopic Eczema | Allergic Rhinitis Asthma | Role Development | Disease Genotype Humans |
Increased food diversity in the first year of life is inversely associated with allergic diseases
[ PUBLICATION ]
BACKGROUND: The role of dietary factors in the development of allergies is a topic of debate, especially the potential associations between infant feeding practices and allergic diseases. Previously, we reported that increased food diversity introduced during the first year of life reduced the risk of atopic dermatitis.
OBJECTIVE: In this study we investigated the association between the introduction of food during the first year of life and the development of asthma, allergic rhinitis, ...
| 闻名 Food Diversity | Allergic Diseases | Year Life | Development Asthma | Atopic Sensitization |
关键人物 Atopic Dermatitis
世界顶级科尔斯
Erika RM von Mutius:专家影响
哪个概念Erika RM von Mutius具有直接影响:Atopic dermatitis, Childhood asthma, Allergic diseases, Atopic sensitization, Allergic rhinitis, International study, Farm milk, East germany.
Erika RM von Mutius:KOL的影响
与其他作者的工作有关的概念for which Erika RM von Mutius 有影响力:Atopic dermatitis, Allergic rhinitis, Childhood asthma, Food allergy, Lung function, Air pollution, Early life.
Tools
这是您的个人资料吗？ 要求您的个人资料 复制URL 嵌入到您的个人资料的链接 |